id	sid	tid	token	lemma	pos
cuesj-178	1	1	21	21	NUM
cuesj-178	1	2	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-178	1	3	cuesj	cuesj	NOUN
cuesj-178	1	4	2020	2020	NUM
cuesj-178	1	5	,	,	PUNCT
cuesj-178	1	6	4	4	NUM
cuesj-178	1	7	(	(	PUNCT
cuesj-178	1	8	1	1	NUM
cuesj-178	1	9	):	):	PUNCT
cuesj-178	1	10	21	21	NUM
cuesj-178	1	11	-	-	SYM
cuesj-178	1	12	25	25	NUM
cuesj-178	1	13	research	research	NOUN
cuesj-178	1	14	article	article	NOUN
cuesj-178	1	15	levels	level	NOUN
cuesj-178	1	16	of	of	ADP
cuesj-178	1	17	apelin	apelin	PROPN
cuesj-178	1	18	,	,	PUNCT
cuesj-178	1	19	endoglin	endoglin	NOUN
cuesj-178	1	20	,	,	PUNCT
cuesj-178	1	21	and	and	CCONJ
cuesj-178	1	22	transforming	transform	VERB
cuesj-178	1	23	growth	growth	NOUN
cuesj-178	1	24	factor	factor	NOUN
cuesj-178	1	25	beta	beta	NOUN
cuesj-178	1	26	1	1	NUM
cuesj-178	1	27	in	in	ADP
cuesj-178	1	28	iraqi	iraqi	ADJ
cuesj-178	1	29	women	woman	NOUN
cuesj-178	1	30	with	with	ADP
cuesj-178	1	31	polycystic	polycystic	ADJ
cuesj-178	1	32	ovary	ovary	ADJ
cuesj-178	1	33	syndrome	syndrome	NOUN
cuesj-178	1	34	noor	noor	PROPN
cuesj-178	1	35	alhuda	alhuda	PROPN
cuesj-178	1	36	k.	k.	PROPN
cuesj-178	1	37	ibrahim1	ibrahim1	PROPN
cuesj-178	1	38	,	,	PUNCT
cuesj-178	1	39	wasnaa	wasnaa	NOUN
cuesj-178	1	40	j.	j.	PROPN
cuesj-178	1	41	mohammad1	mohammad1	PROPN
cuesj-178	1	42	,	,	PUNCT
cuesj-178	1	43	sanan	sanan	PROPN
cuesj-178	1	44	t.	t.	PROPN
cuesj-178	1	45	abdawahab2	abdawahab2	PROPN
cuesj-178	2	1	*	*	PROPN
cuesj-178	3	1	1department	1department	NUM
cuesj-178	3	2	of	of	ADP
cuesj-178	3	3	basic	basic	ADJ
cuesj-178	3	4	sciences	science	NOUN
cuesj-178	3	5	,	,	PUNCT
cuesj-178	3	6	college	college	NOUN
cuesj-178	3	7	of	of	ADP
cuesj-178	3	8	nursing	nursing	NOUN
cuesj-178	3	9	,	,	PUNCT
cuesj-178	3	10	baghdad	baghdad	PROPN
cuesj-178	3	11	university	university	PROPN
cuesj-178	3	12	,	,	PUNCT
cuesj-178	3	13	baghdad	baghdad	PROPN
cuesj-178	3	14	,	,	PUNCT
cuesj-178	3	15	iraq	iraq	PROPN
cuesj-178	3	16	,	,	PUNCT
cuesj-178	3	17	2department	2department	NUM
cuesj-178	3	18	of	of	ADP
cuesj-178	3	19	medical	medical	ADJ
cuesj-178	3	20	laboratory	laboratory	NOUN
cuesj-178	3	21	techniques	technique	NOUN
cuesj-178	3	22	,	,	PUNCT
cuesj-178	3	23	dijlah	dijlah	PROPN
cuesj-178	3	24	university	university	PROPN
cuesj-178	3	25	college	college	PROPN
cuesj-178	3	26	,	,	PUNCT
cuesj-178	3	27	baghdad	baghdad	PROPN
cuesj-178	3	28	,	,	PUNCT
cuesj-178	3	29	iraq	iraq	PROPN
cuesj-178	3	30	abstract	abstract	ADJ
cuesj-178	3	31	polycystic	polycystic	ADJ
cuesj-178	3	32	ovary	ovary	ADJ
cuesj-178	3	33	syndrome	syndrome	NOUN
cuesj-178	3	34	(	(	PUNCT
cuesj-178	3	35	pcos	pcos	PROPN
cuesj-178	3	36	)	)	PUNCT
cuesj-178	3	37	is	be	AUX
cuesj-178	3	38	one	one	NUM
cuesj-178	3	39	of	of	ADP
cuesj-178	3	40	the	the	DET
cuesj-178	3	41	most	most	ADV
cuesj-178	3	42	common	common	ADJ
cuesj-178	3	43	causes	cause	NOUN
cuesj-178	3	44	of	of	ADP
cuesj-178	3	45	infertility	infertility	NOUN
cuesj-178	3	46	in	in	ADP
cuesj-178	3	47	women	woman	NOUN
cuesj-178	3	48	of	of	ADP
cuesj-178	3	49	reproductive	reproductive	ADJ
cuesj-178	3	50	age	age	NOUN
cuesj-178	3	51	.	.	PUNCT
cuesj-178	4	1	the	the	DET
cuesj-178	4	2	aim	aim	NOUN
cuesj-178	4	3	of	of	ADP
cuesj-178	4	4	the	the	DET
cuesj-178	4	5	study	study	NOUN
cuesj-178	4	6	was	be	AUX
cuesj-178	4	7	to	to	PART
cuesj-178	4	8	determine	determine	VERB
cuesj-178	4	9	the	the	DET
cuesj-178	4	10	level	level	NOUN
cuesj-178	4	11	of	of	ADP
cuesj-178	4	12	apelin	apelin	NOUN
cuesj-178	4	13	,	,	PUNCT
cuesj-178	4	14	insulin	insulin	NOUN
cuesj-178	4	15	resistance	resistance	NOUN
cuesj-178	4	16	(	(	PUNCT
cuesj-178	4	17	ir	ir	NOUN
cuesj-178	4	18	)	)	PUNCT
cuesj-178	4	19	,	,	PUNCT
cuesj-178	4	20	transforming	transform	VERB
cuesj-178	4	21	growth	growth	NOUN
cuesj-178	4	22	factor	factor	NOUN
cuesj-178	4	23	beta	beta	NOUN
cuesj-178	4	24	1	1	NUM
cuesj-178	4	25	(	(	PUNCT
cuesj-178	4	26	tgf	tgf	NOUN
cuesj-178	4	27	-	-	PUNCT
cuesj-178	4	28	β1	β1	PROPN
cuesj-178	4	29	)	)	PUNCT
cuesj-178	4	30	,	,	PUNCT
cuesj-178	4	31	and	and	CCONJ
cuesj-178	4	32	endoglin	endoglin	NOUN
cuesj-178	4	33	in	in	ADP
cuesj-178	4	34	women	woman	NOUN
cuesj-178	4	35	with	with	ADP
cuesj-178	4	36	polycystic	polycystic	ADJ
cuesj-178	4	37	ovary	ovary	ADJ
cuesj-178	4	38	syndrome	syndrome	NOUN
cuesj-178	4	39	.	.	PUNCT
cuesj-178	5	1	fifty	fifty	NUM
cuesj-178	5	2	pcos	pcos	NOUN
cuesj-178	5	3	patients	patient	NOUN
cuesj-178	5	4	and	and	CCONJ
cuesj-178	5	5	40	40	NUM
cuesj-178	5	6	non	non	ADJ
cuesj-178	5	7	-	-	ADJ
cuesj-178	5	8	pcos	pcos	ADJ
cuesj-178	5	9	infertile	infertile	NOUN
cuesj-178	5	10	patients	patient	NOUN
cuesj-178	5	11	were	be	AUX
cuesj-178	5	12	recruited	recruit	VERB
cuesj-178	5	13	.	.	PUNCT
cuesj-178	6	1	the	the	DET
cuesj-178	6	2	fasting	fast	VERB
cuesj-178	6	3	serum	serum	NOUN
cuesj-178	6	4	levels	level	NOUN
cuesj-178	6	5	of	of	ADP
cuesj-178	6	6	folliclestimulating	folliclestimulating	NOUN
cuesj-178	6	7	hormone	hormone	NOUN
cuesj-178	6	8	(	(	PUNCT
cuesj-178	6	9	fsh	fsh	NOUN
cuesj-178	6	10	)	)	PUNCT
cuesj-178	6	11	,	,	PUNCT
cuesj-178	6	12	luteinizing	luteinize	VERB
cuesj-178	6	13	hormone	hormone	NOUN
cuesj-178	6	14	(	(	PUNCT
cuesj-178	6	15	lh	lh	PROPN
cuesj-178	6	16	)	)	PUNCT
cuesj-178	6	17	,	,	PUNCT
cuesj-178	6	18	testosterone	testosterone	NOUN
cuesj-178	6	19	(	(	PUNCT
cuesj-178	6	20	t	t	PROPN
cuesj-178	6	21	)	)	PUNCT
cuesj-178	6	22	,	,	PUNCT
cuesj-178	6	23	prolactin	prolactin	NOUN
cuesj-178	6	24	,	,	PUNCT
cuesj-178	6	25	fasting	fast	VERB
cuesj-178	6	26	blood	blood	NOUN
cuesj-178	6	27	glucose	glucose	NOUN
cuesj-178	6	28	,	,	PUNCT
cuesj-178	6	29	insulin	insulin	NOUN
cuesj-178	6	30	,	,	PUNCT
cuesj-178	6	31	and	and	CCONJ
cuesj-178	6	32	apelin	apelin	PROPN
cuesj-178	6	33	at	at	ADP
cuesj-178	6	34	the	the	DET
cuesj-178	6	35	early	early	ADJ
cuesj-178	6	36	follicular	follicular	ADJ
cuesj-178	6	37	phase	phase	NOUN
cuesj-178	6	38	were	be	AUX
cuesj-178	6	39	measured	measure	VERB
cuesj-178	6	40	.	.	PUNCT
cuesj-178	7	1	levels	level	NOUN
cuesj-178	7	2	of	of	ADP
cuesj-178	7	3	apelin	apelin	PROPN
cuesj-178	7	4	,	,	PUNCT
cuesj-178	7	5	lh	lh	PROPN
cuesj-178	7	6	,	,	PUNCT
cuesj-178	7	7	lh	lh	PROPN
cuesj-178	7	8	/	/	SYM
cuesj-178	7	9	fsh	fsh	NOUN
cuesj-178	7	10	,	,	PUNCT
cuesj-178	7	11	t	t	PROPN
cuesj-178	7	12	,	,	PUNCT
cuesj-178	7	13	and	and	CCONJ
cuesj-178	7	14	fasting	fast	VERB
cuesj-178	7	15	insulin	insulin	NOUN
cuesj-178	7	16	,	,	PUNCT
cuesj-178	7	17	as	as	ADV
cuesj-178	7	18	well	well	ADV
cuesj-178	7	19	as	as	ADP
cuesj-178	7	20	homeostatic	homeostatic	ADJ
cuesj-178	7	21	model	model	NOUN
cuesj-178	7	22	assessment	assessment	NOUN
cuesj-178	7	23	of	of	ADP
cuesj-178	7	24	ir	ir	PROPN
cuesj-178	7	25	(	(	PUNCT
cuesj-178	7	26	homa	homa	NOUN
cuesj-178	7	27	-	-	PUNCT
cuesj-178	7	28	ir	ir	NOUN
cuesj-178	7	29	)	)	PUNCT
cuesj-178	7	30	in	in	ADP
cuesj-178	7	31	pcos	pcos	NOUN
cuesj-178	7	32	patients	patient	NOUN
cuesj-178	7	33	,	,	PUNCT
cuesj-178	7	34	were	be	AUX
cuesj-178	7	35	significantly	significantly	ADV
cuesj-178	7	36	higher	high	ADJ
cuesj-178	7	37	than	than	ADP
cuesj-178	7	38	in	in	ADP
cuesj-178	7	39	the	the	DET
cuesj-178	7	40	control	control	NOUN
cuesj-178	7	41	group	group	NOUN
cuesj-178	7	42	.	.	PUNCT
cuesj-178	8	1	correlation	correlation	NOUN
cuesj-178	8	2	analysis	analysis	NOUN
cuesj-178	8	3	showed	show	VERB
cuesj-178	8	4	that	that	SCONJ
cuesj-178	8	5	apelin	apelin	PROPN
cuesj-178	8	6	level	level	NOUN
cuesj-178	8	7	was	be	AUX
cuesj-178	8	8	positively	positively	ADV
cuesj-178	8	9	correlated	correlate	VERB
cuesj-178	8	10	with	with	ADP
cuesj-178	8	11	body	body	NOUN
cuesj-178	8	12	mass	mass	NOUN
cuesj-178	8	13	index	index	NOUN
cuesj-178	8	14	and	and	CCONJ
cuesj-178	8	15	homa	homa	PROPN
cuesj-178	8	16	-	-	PUNCT
cuesj-178	8	17	ir	ir	PROPN
cuesj-178	8	18	.	.	PUNCT
cuesj-178	9	1	apelin	apelin	PROPN
cuesj-178	9	2	levels	level	NOUN
cuesj-178	9	3	and	and	CCONJ
cuesj-178	9	4	tgf	tgf	PROPN
cuesj-178	9	5	-	-	PUNCT
cuesj-178	9	6	β1	β1	PROPN
cuesj-178	9	7	were	be	AUX
cuesj-178	9	8	significantly	significantly	ADV
cuesj-178	9	9	increased	increase	VERB
cuesj-178	9	10	in	in	ADP
cuesj-178	9	11	pcos	pcos	PROPN
cuesj-178	9	12	patients	patient	NOUN
cuesj-178	9	13	while	while	SCONJ
cuesj-178	9	14	show	show	VERB
cuesj-178	9	15	decrease	decrease	NOUN
cuesj-178	9	16	levels	level	NOUN
cuesj-178	9	17	of	of	ADP
cuesj-178	9	18	endoglin	endoglin	NOUN
cuesj-178	9	19	.	.	PUNCT
cuesj-178	10	1	keywords	keyword	NOUN
cuesj-178	10	2	:	:	PUNCT
cuesj-178	11	1	apelin	apelin	PROPN
cuesj-178	11	2	,	,	PUNCT
cuesj-178	11	3	endoglin	endoglin	NOUN
cuesj-178	11	4	,	,	PUNCT
cuesj-178	11	5	transforming	transform	VERB
cuesj-178	11	6	growth	growth	NOUN
cuesj-178	11	7	factor	factor	NOUN
cuesj-178	11	8	beta	beta	NOUN
cuesj-178	11	9	introduction	introduction	NOUN
cuesj-178	11	10	polycystic	polycystic	ADJ
cuesj-178	11	11	ovary	ovary	ADJ
cuesj-178	11	12	syndrome	syndrome	NOUN
cuesj-178	11	13	(	(	PUNCT
cuesj-178	11	14	pcos	pcos	PROPN
cuesj-178	11	15	)	)	PUNCT
cuesj-178	11	16	is	be	AUX
cuesj-178	11	17	the	the	DET
cuesj-178	11	18	most	most	ADV
cuesj-178	11	19	common	common	ADJ
cuesj-178	11	20	endocrine	endocrine	NOUN
cuesj-178	11	21	disease	disease	NOUN
cuesj-178	11	22	affecting	affect	VERB
cuesj-178	11	23	women	woman	NOUN
cuesj-178	11	24	of	of	ADP
cuesj-178	11	25	reproductive	reproductive	ADJ
cuesj-178	11	26	age	age	NOUN
cuesj-178	11	27	.	.	PUNCT
cuesj-178	12	1	the	the	DET
cuesj-178	12	2	prevalence	prevalence	NOUN
cuesj-178	12	3	of	of	ADP
cuesj-178	12	4	pcos	pcos	PROPN
cuesj-178	12	5	varies	vary	VERB
cuesj-178	12	6	according	accord	VERB
cuesj-178	12	7	to	to	ADP
cuesj-178	12	8	the	the	DET
cuesj-178	12	9	diagnostic	diagnostic	ADJ
cuesj-178	12	10	criteria	criterion	NOUN
cuesj-178	12	11	used	use	VERB
cuesj-178	12	12	,	,	PUNCT
cuesj-178	12	13	with	with	ADP
cuesj-178	12	14	estimates	estimate	NOUN
cuesj-178	12	15	ranging	range	VERB
cuesj-178	12	16	from	from	ADP
cuesj-178	12	17	9	9	NUM
cuesj-178	12	18	%	%	NOUN
cuesj-178	12	19	in	in	ADP
cuesj-178	12	20	women	woman	NOUN
cuesj-178	12	21	of	of	ADP
cuesj-178	12	22	reproductive	reproductive	ADJ
cuesj-178	12	23	age	age	NOUN
cuesj-178	12	24	,	,	PUNCT
cuesj-178	12	25	according	accord	VERB
cuesj-178	12	26	to	to	ADP
cuesj-178	12	27	nih	nih	PROPN
cuesj-178	12	28	criteria	criteria	PROPN
cuesj-178	12	29	,	,	PUNCT
cuesj-178	12	30	up	up	ADV
cuesj-178	12	31	to	to	PART
cuesj-178	12	32	18	18	NUM
cuesj-178	12	33	%	%	NOUN
cuesj-178	12	34	,	,	PUNCT
cuesj-178	12	35	with	with	ADP
cuesj-178	12	36	the	the	DET
cuesj-178	12	37	rotterdam	rotterdam	PROPN
cuesj-178	12	38	criteria.[1	criteria.[1	NOUN
cuesj-178	12	39	]	]	X
cuesj-178	13	1	it	it	PRON
cuesj-178	13	2	is	be	AUX
cuesj-178	13	3	primarily	primarily	ADV
cuesj-178	13	4	characterized	characterize	VERB
cuesj-178	13	5	by	by	ADP
cuesj-178	13	6	ovulatory	ovulatory	ADJ
cuesj-178	13	7	dysfunction	dysfunction	NOUN
cuesj-178	13	8	and	and	CCONJ
cuesj-178	13	9	hyperandrogenism,[2	hyperandrogenism,[2	NUM
cuesj-178	13	10	]	]	PUNCT
cuesj-178	13	11	but	but	CCONJ
cuesj-178	13	12	the	the	DET
cuesj-178	13	13	clinical	clinical	ADJ
cuesj-178	13	14	presentation	presentation	NOUN
cuesj-178	13	15	is	be	AUX
cuesj-178	13	16	heterogeneous	heterogeneous	ADJ
cuesj-178	13	17	and	and	CCONJ
cuesj-178	13	18	patients	patient	NOUN
cuesj-178	13	19	may	may	AUX
cuesj-178	13	20	present	present	VERB
cuesj-178	13	21	some	some	PRON
cuesj-178	13	22	of	of	ADP
cuesj-178	13	23	various	various	ADJ
cuesj-178	13	24	signs	sign	NOUN
cuesj-178	13	25	and	and	CCONJ
cuesj-178	13	26	symptoms	symptom	NOUN
cuesj-178	13	27	.	.	PUNCT
cuesj-178	14	1	this	this	DET
cuesj-178	14	2	heterogeneity	heterogeneity	NOUN
cuesj-178	14	3	seems	seem	VERB
cuesj-178	14	4	to	to	PART
cuesj-178	14	5	be	be	AUX
cuesj-178	14	6	modulated	modulate	VERB
cuesj-178	14	7	by	by	ADP
cuesj-178	14	8	multiple	multiple	ADJ
cuesj-178	14	9	factors	factor	NOUN
cuesj-178	14	10	such	such	ADJ
cuesj-178	14	11	as	as	ADP
cuesj-178	14	12	prenatal	prenatal	ADJ
cuesj-178	14	13	androgen	androgen	NOUN
cuesj-178	14	14	exposure	exposure	NOUN
cuesj-178	14	15	,	,	PUNCT
cuesj-178	14	16	nutritional	nutritional	ADJ
cuesj-178	14	17	status	status	NOUN
cuesj-178	14	18	in	in	ADP
cuesj-178	14	19	the	the	DET
cuesj-178	14	20	uterus	uterus	NOUN
cuesj-178	14	21	,	,	PUNCT
cuesj-178	14	22	genetic	genetic	ADJ
cuesj-178	14	23	factors	factor	NOUN
cuesj-178	14	24	,	,	PUNCT
cuesj-178	14	25	and	and	CCONJ
cuesj-178	14	26	ethnicity	ethnicity	NOUN
cuesj-178	14	27	,	,	PUNCT
cuesj-178	14	28	insulin	insulin	NOUN
cuesj-178	14	29	resistance	resistance	NOUN
cuesj-178	14	30	(	(	PUNCT
cuesj-178	14	31	ir	ir	NOUN
cuesj-178	14	32	)	)	PUNCT
cuesj-178	14	33	of	of	ADP
cuesj-178	14	34	puberty	puberty	PROPN
cuesj-178	14	35	and/or	and/or	CCONJ
cuesj-178	14	36	exaggerated	exaggerated	ADJ
cuesj-178	14	37	adrenarche	adrenarche	NOUN
cuesj-178	14	38	and	and	CCONJ
cuesj-178	14	39	changes	change	NOUN
cuesj-178	14	40	in	in	ADP
cuesj-178	14	41	body	body	NOUN
cuesj-178	14	42	weight.[3	weight.[3	NOUN
cuesj-178	14	43	]	]	PUNCT
cuesj-178	14	44	environmental	environmental	ADJ
cuesj-178	14	45	factors	factor	NOUN
cuesj-178	14	46	,	,	PUNCT
cuesj-178	14	47	such	such	ADJ
cuesj-178	14	48	as	as	ADP
cuesj-178	14	49	obesity	obesity	NOUN
cuesj-178	14	50	,	,	PUNCT
cuesj-178	14	51	appear	appear	VERB
cuesj-178	14	52	to	to	PART
cuesj-178	14	53	exacerbate	exacerbate	VERB
cuesj-178	14	54	the	the	DET
cuesj-178	14	55	underlying	underlying	ADJ
cuesj-178	14	56	genetic	genetic	ADJ
cuesj-178	14	57	predisposition	predisposition	NOUN
cuesj-178	14	58	.	.	PUNCT
cuesj-178	15	1	concerning	concern	VERB
cuesj-178	15	2	ethnicity	ethnicity	NOUN
cuesj-178	15	3	,	,	PUNCT
cuesj-178	15	4	the	the	DET
cuesj-178	15	5	presence	presence	NOUN
cuesj-178	15	6	of	of	ADP
cuesj-178	15	7	hirsutism	hirsutism	NOUN
cuesj-178	15	8	is	be	AUX
cuesj-178	15	9	less	less	ADV
cuesj-178	15	10	frequent	frequent	ADJ
cuesj-178	15	11	in	in	ADP
cuesj-178	15	12	asian	asian	ADJ
cuesj-178	15	13	patients	patient	NOUN
cuesj-178	15	14	(	(	PUNCT
cuesj-178	15	15	around	around	ADP
cuesj-178	15	16	10	10	NUM
cuesj-178	15	17	%	%	NOUN
cuesj-178	15	18	)	)	PUNCT
cuesj-178	15	19	,	,	PUNCT
cuesj-178	15	20	compared	compare	VERB
cuesj-178	15	21	to	to	ADP
cuesj-178	15	22	caucasian	caucasian	ADJ
cuesj-178	15	23	ones	one	NOUN
cuesj-178	15	24	(	(	PUNCT
cuesj-178	15	25	70%).[4	70%).[4	X
cuesj-178	15	26	]	]	X
cuesj-178	15	27	obesity	obesity	NOUN
cuesj-178	15	28	is	be	AUX
cuesj-178	15	29	a	a	DET
cuesj-178	15	30	prevalent	prevalent	ADJ
cuesj-178	15	31	characteristic	characteristic	NOUN
cuesj-178	15	32	of	of	ADP
cuesj-178	15	33	pcos	pcos	PROPN
cuesj-178	15	34	,	,	PUNCT
cuesj-178	15	35	ranging	range	VERB
cuesj-178	15	36	from	from	ADP
cuesj-178	15	37	12.5	12.5	NUM
cuesj-178	15	38	%	%	NOUN
cuesj-178	15	39	to	to	PART
cuesj-178	15	40	100	100	NUM
cuesj-178	15	41	%	%	NOUN
cuesj-178	15	42	,	,	PUNCT
cuesj-178	15	43	with	with	ADP
cuesj-178	15	44	a	a	DET
cuesj-178	15	45	pooled	pool	VERB
cuesj-178	15	46	estimated	estimate	VERB
cuesj-178	15	47	prevalence	prevalence	NOUN
cuesj-178	15	48	of	of	ADP
cuesj-178	15	49	49	49	NUM
cuesj-178	15	50	%	%	NOUN
cuesj-178	15	51	,	,	PUNCT
cuesj-178	15	52	as	as	SCONJ
cuesj-178	15	53	shown	show	VERB
cuesj-178	15	54	by	by	ADP
cuesj-178	15	55	a	a	DET
cuesj-178	15	56	recent	recent	ADJ
cuesj-178	15	57	meta	meta	NOUN
cuesj-178	15	58	-	-	PUNCT
cuesj-178	15	59	analysis.[5	analysis.[5	NOUN
cuesj-178	15	60	]	]	X
cuesj-178	15	61	the	the	DET
cuesj-178	15	62	presence	presence	NOUN
cuesj-178	15	63	of	of	ADP
cuesj-178	15	64	obesity	obesity	NOUN
cuesj-178	15	65	may	may	AUX
cuesj-178	15	66	exacerbate	exacerbate	VERB
cuesj-178	15	67	the	the	DET
cuesj-178	15	68	metabolic	metabolic	NOUN
cuesj-178	15	69	and	and	CCONJ
cuesj-178	15	70	reproductive	reproductive	ADJ
cuesj-178	15	71	disorders	disorder	NOUN
cuesj-178	15	72	associated	associate	VERB
cuesj-178	15	73	with	with	ADP
cuesj-178	15	74	the	the	DET
cuesj-178	15	75	syndrome	syndrome	NOUN
cuesj-178	15	76	,	,	PUNCT
cuesj-178	15	77	including	include	VERB
cuesj-178	15	78	ir	ir	PROPN
cuesj-178	15	79	,	,	PUNCT
cuesj-178	15	80	dyslipidemia	dyslipidemia	NOUN
cuesj-178	15	81	,	,	PUNCT
cuesj-178	15	82	and	and	CCONJ
cuesj-178	15	83	metabolic	metabolic	NOUN
cuesj-178	15	84	syndrome.[6	syndrome.[6	NOUN
cuesj-178	15	85	]	]	X
cuesj-178	15	86	a	a	DET
cuesj-178	15	87	meta	meta	NOUN
cuesj-178	15	88	-	-	PUNCT
cuesj-178	15	89	analysis[7	analysis[7	NOUN
cuesj-178	15	90	]	]	PUNCT
cuesj-178	15	91	has	have	AUX
cuesj-178	15	92	shown	show	VERB
cuesj-178	15	93	that	that	SCONJ
cuesj-178	15	94	women	woman	NOUN
cuesj-178	15	95	with	with	ADP
cuesj-178	15	96	pcos	pcos	PROPN
cuesj-178	15	97	have	have	VERB
cuesj-178	15	98	higher	high	ADJ
cuesj-178	15	99	levels	level	NOUN
cuesj-178	15	100	of	of	ADP
cuesj-178	15	101	triglycerides	triglyceride	NOUN
cuesj-178	15	102	(	(	PUNCT
cuesj-178	15	103	tg	tg	NOUN
cuesj-178	15	104	)	)	PUNCT
cuesj-178	15	105	,	,	PUNCT
cuesj-178	15	106	low	low	ADJ
cuesj-178	15	107	-	-	PUNCT
cuesj-178	15	108	density	density	NOUN
cuesj-178	15	109	lipoprotein	lipoprotein	NOUN
cuesj-178	15	110	(	(	PUNCT
cuesj-178	15	111	ldl)-cholesterol	ldl)-cholesterol	NOUN
cuesj-178	15	112	and	and	CCONJ
cuesj-178	15	113	total	total	ADJ
cuesj-178	15	114	cholesterol	cholesterol	NOUN
cuesj-178	15	115	(	(	PUNCT
cuesj-178	15	116	tc	tc	NOUN
cuesj-178	15	117	)	)	PUNCT
cuesj-178	15	118	,	,	PUNCT
cuesj-178	15	119	and	and	CCONJ
cuesj-178	15	120	lower	low	ADJ
cuesj-178	15	121	high	high	ADJ
cuesj-178	15	122	-	-	PUNCT
cuesj-178	15	123	density	density	NOUN
cuesj-178	15	124	lipoprotein	lipoprotein	ADJ
cuesj-178	15	125	(	(	PUNCT
cuesj-178	15	126	hdl)-cholesterol	hdl)-cholesterol	PROPN
cuesj-178	15	127	levels	level	NOUN
cuesj-178	15	128	compared	compare	VERB
cuesj-178	15	129	with	with	ADP
cuesj-178	15	130	control	control	NOUN
cuesj-178	15	131	women	woman	NOUN
cuesj-178	15	132	,	,	PUNCT
cuesj-178	15	133	regardless	regardless	ADV
cuesj-178	15	134	of	of	ADP
cuesj-178	15	135	body	body	NOUN
cuesj-178	15	136	mass	mass	NOUN
cuesj-178	15	137	index	index	NOUN
cuesj-178	15	138	(	(	PUNCT
cuesj-178	15	139	bmi	bmi	PROPN
cuesj-178	15	140	)	)	PUNCT
cuesj-178	15	141	.	.	PUNCT
cuesj-178	16	1	in	in	ADP
cuesj-178	16	2	addition	addition	NOUN
cuesj-178	16	3	,	,	PUNCT
cuesj-178	16	4	pcos	pcos	ADJ
cuesj-178	16	5	women	woman	NOUN
cuesj-178	16	6	present	present	VERB
cuesj-178	16	7	higher	high	ADJ
cuesj-178	16	8	risk	risk	NOUN
cuesj-178	16	9	for	for	ADP
cuesj-178	16	10	type	type	NOUN
cuesj-178	16	11	2	2	NUM
cuesj-178	16	12	diabetes	diabetes	NOUN
cuesj-178	16	13	.	.	PUNCT
cuesj-178	17	1	pcos	pcos	PROPN
cuesj-178	17	2	is	be	AUX
cuesj-178	17	3	also	also	ADV
cuesj-178	17	4	associated	associate	VERB
cuesj-178	17	5	with	with	ADP
cuesj-178	17	6	a	a	DET
cuesj-178	17	7	clustering	clustering	NOUN
cuesj-178	17	8	of	of	ADP
cuesj-178	17	9	cardiovascular	cardiovascular	ADJ
cuesj-178	17	10	risk	risk	NOUN
cuesj-178	17	11	factors.[8	factors.[8	NOUN
cuesj-178	17	12	]	]	PUNCT
cuesj-178	17	13	however	however	ADV
cuesj-178	17	14	,	,	PUNCT
cuesj-178	17	15	there	there	PRON
cuesj-178	17	16	is	be	VERB
cuesj-178	17	17	no	no	DET
cuesj-178	17	18	definitive	definitive	ADJ
cuesj-178	17	19	evidence	evidence	NOUN
cuesj-178	17	20	for	for	ADP
cuesj-178	17	21	increased	increase	VERB
cuesj-178	17	22	cardiovascular	cardiovascular	ADJ
cuesj-178	17	23	events	event	NOUN
cuesj-178	17	24	,	,	PUNCT
cuesj-178	17	25	nor	nor	CCONJ
cuesj-178	17	26	data	datum	NOUN
cuesj-178	17	27	showing	show	VERB
cuesj-178	17	28	that	that	SCONJ
cuesj-178	17	29	pcos	pcos	PROPN
cuesj-178	17	30	alone	alone	ADV
cuesj-178	17	31	leads	lead	VERB
cuesj-178	17	32	to	to	ADP
cuesj-178	17	33	increased	increase	VERB
cuesj-178	17	34	cardiovascular	cardiovascular	ADJ
cuesj-178	17	35	risk	risk	NOUN
cuesj-178	17	36	independent	independent	ADJ
cuesj-178	17	37	of	of	ADP
cuesj-178	17	38	associated	associated	ADJ
cuesj-178	17	39	risk	risk	NOUN
cuesj-178	17	40	factors	factor	NOUN
cuesj-178	17	41	.	.	PUNCT
cuesj-178	18	1	in	in	ADP
cuesj-178	18	2	fact	fact	NOUN
cuesj-178	18	3	,	,	PUNCT
cuesj-178	18	4	more	more	ADV
cuesj-178	18	5	rigorous	rigorous	ADJ
cuesj-178	18	6	cohort	cohort	NOUN
cuesj-178	18	7	studies	study	NOUN
cuesj-178	18	8	of	of	ADP
cuesj-178	18	9	longterm	longterm	ADJ
cuesj-178	18	10	cardiovascular	cardiovascular	ADJ
cuesj-178	18	11	outcomes	outcome	NOUN
cuesj-178	18	12	and	and	CCONJ
cuesj-178	18	13	clinical	clinical	ADJ
cuesj-178	18	14	trials	trial	NOUN
cuesj-178	18	15	of	of	ADP
cuesj-178	18	16	risk	risk	NOUN
cuesj-178	18	17	factor	factor	NOUN
cuesj-178	18	18	modification	modification	NOUN
cuesj-178	18	19	are	be	AUX
cuesj-178	18	20	required	require	VERB
cuesj-178	18	21	for	for	ADP
cuesj-178	18	22	women	woman	NOUN
cuesj-178	18	23	with	with	ADP
cuesj-178	18	24	pcos	pcos	PROPN
cuesj-178	18	25	.	.	PUNCT
cuesj-178	19	1	in	in	ADP
cuesj-178	19	2	addition	addition	NOUN
cuesj-178	19	3	,	,	PUNCT
cuesj-178	19	4	evidence	evidence	NOUN
cuesj-178	19	5	suggests	suggest	VERB
cuesj-178	19	6	clinical	clinical	ADJ
cuesj-178	19	7	phenotypes	phenotype	NOUN
cuesj-178	19	8	are	be	AUX
cuesj-178	19	9	related	relate	VERB
cuesj-178	19	10	with	with	ADP
cuesj-178	19	11	different	different	ADJ
cuesj-178	19	12	metabolic	metabolic	NOUN
cuesj-178	19	13	risks	risk	NOUN
cuesj-178	19	14	.	.	PUNCT
cuesj-178	20	1	in	in	ADP
cuesj-178	20	2	this	this	DET
cuesj-178	20	3	sense	sense	NOUN
cuesj-178	20	4	,	,	PUNCT
cuesj-178	20	5	ir	ir	PROPN
cuesj-178	20	6	seems	seem	VERB
cuesj-178	20	7	to	to	PART
cuesj-178	20	8	be	be	AUX
cuesj-178	20	9	a	a	DET
cuesj-178	20	10	specific	specific	ADJ
cuesj-178	20	11	feature	feature	NOUN
cuesj-178	20	12	of	of	ADP
cuesj-178	20	13	the	the	DET
cuesj-178	20	14	classic	classic	ADJ
cuesj-178	20	15	phenotype	phenotype	NOUN
cuesj-178	20	16	and	and	CCONJ
cuesj-178	20	17	,	,	PUNCT
cuesj-178	20	18	to	to	ADP
cuesj-178	20	19	a	a	DET
cuesj-178	20	20	lesser	less	ADJ
cuesj-178	20	21	extent	extent	NOUN
cuesj-178	20	22	,	,	PUNCT
cuesj-178	20	23	of	of	ADP
cuesj-178	20	24	the	the	DET
cuesj-178	20	25	ovulatory	ovulatory	ADJ
cuesj-178	20	26	phenotype	phenotype	NOUN
cuesj-178	20	27	.	.	PUNCT
cuesj-178	21	1	non	non	ADJ
cuesj-178	21	2	-	-	ADJ
cuesj-178	21	3	hyperandrogenic	hyperandrogenic	ADJ
cuesj-178	21	4	phenotype	phenotype	NOUN
cuesj-178	21	5	behaves	behave	VERB
cuesj-178	21	6	as	as	ADP
cuesj-178	21	7	a	a	DET
cuesj-178	21	8	separate	separate	ADJ
cuesj-178	21	9	group	group	NOUN
cuesj-178	21	10	that	that	PRON
cuesj-178	21	11	is	be	AUX
cuesj-178	21	12	metabolically	metabolically	ADV
cuesj-178	21	13	similar	similar	ADJ
cuesj-178	21	14	to	to	ADP
cuesj-178	21	15	non	non	ADJ
cuesj-178	21	16	-	-	ADJ
cuesj-178	21	17	pcos	pcos	ADJ
cuesj-178	21	18	women.[7	women.[7	X
cuesj-178	21	19	]	]	X
cuesj-178	21	20	cihan	cihan	VERB
cuesj-178	21	21	university	university	NOUN
cuesj-178	21	22	-	-	PUNCT
cuesj-178	21	23	erbil	erbil	PROPN
cuesj-178	21	24	scientific	scientific	ADJ
cuesj-178	21	25	journal	journal	NOUN
cuesj-178	21	26	(	(	PUNCT
cuesj-178	21	27	cuesj	cuesj	PROPN
cuesj-178	21	28	)	)	PUNCT
cuesj-178	21	29	corresponding	correspond	VERB
cuesj-178	21	30	author	author	NOUN
cuesj-178	21	31	:	:	PUNCT
cuesj-178	21	32	sanan	sanan	PROPN
cuesj-178	21	33	t.	t.	PROPN
cuesj-178	21	34	abdawahab	abdawahab	PROPN
cuesj-178	21	35	,	,	PUNCT
cuesj-178	21	36	department	department	NOUN
cuesj-178	21	37	of	of	ADP
cuesj-178	21	38	medical	medical	ADJ
cuesj-178	21	39	laboratory	laboratory	NOUN
cuesj-178	21	40	techniques	technique	NOUN
cuesj-178	21	41	,	,	PUNCT
cuesj-178	21	42	dijlah	dijlah	PROPN
cuesj-178	21	43	university	university	PROPN
cuesj-178	21	44	college	college	PROPN
cuesj-178	21	45	,	,	PUNCT
cuesj-178	21	46	baghdad	baghdad	PROPN
cuesj-178	21	47	,	,	PUNCT
cuesj-178	21	48	iraq	iraq	PROPN
cuesj-178	21	49	.	.	PUNCT
cuesj-178	22	1	e	e	X
cuesj-178	22	2	-	-	NOUN
cuesj-178	22	3	mail	mail	NOUN
cuesj-178	22	4	:	:	PUNCT
cuesj-178	22	5	sanan.thaer@duc.edu.iq	sanan.thaer@duc.edu.iq	NOUN
cuesj-178	22	6	received	receive	VERB
cuesj-178	22	7	:	:	PUNCT
cuesj-178	22	8	apr	apr	NOUN
cuesj-178	22	9	11	11	NUM
cuesj-178	22	10	,	,	PUNCT
cuesj-178	22	11	2019	2019	NUM
cuesj-178	22	12	accepted	accept	VERB
cuesj-178	22	13	:	:	PUNCT
cuesj-178	22	14	apr	apr	NOUN
cuesj-178	22	15	22	22	NUM
cuesj-178	22	16	,	,	PUNCT
cuesj-178	22	17	2019	2019	NUM
cuesj-178	22	18	published	publish	VERB
cuesj-178	22	19	:	:	PUNCT
cuesj-178	22	20	jan	jan	PROPN
cuesj-178	22	21	20	20	NUM
cuesj-178	22	22	,	,	PUNCT
cuesj-178	22	23	2020	2020	NUM
cuesj-178	22	24	doi	doi	NOUN
cuesj-178	22	25	:	:	PUNCT
cuesj-178	22	26	10.24086	10.24086	NUM
cuesj-178	22	27	/	/	SYM
cuesj-178	22	28	cuesj.v4n1y2020.pp21	cuesj.v4n1y2020.pp21	NUM
cuesj-178	22	29	-	-	PUNCT
cuesj-178	22	30	25	25	NUM
cuesj-178	22	31	copyright	copyright	NOUN
cuesj-178	22	32	©	©	PROPN
cuesj-178	22	33	2020	2020	NUM
cuesj-178	22	34	noor	noor	PROPN
cuesj-178	22	35	alhuda	alhuda	PROPN
cuesj-178	22	36	k.	k.	PROPN
cuesj-178	22	37	ibrahim	ibrahim	PROPN
cuesj-178	22	38	,	,	PUNCT
cuesj-178	22	39	wasnaa	wasnaa	PROPN
cuesj-178	22	40	j.	j.	PROPN
cuesj-178	22	41	mohammad	mohammad	PROPN
cuesj-178	22	42	,	,	PUNCT
cuesj-178	22	43	sanan	sanan	PROPN
cuesj-178	22	44	t.	t.	PROPN
cuesj-178	22	45	abdawahab	abdawahab	PROPN
cuesj-178	22	46	.	.	PUNCT
cuesj-178	23	1	this	this	PRON
cuesj-178	23	2	is	be	AUX
cuesj-178	23	3	an	an	DET
cuesj-178	23	4	open	open	ADJ
cuesj-178	23	5	-	-	PUNCT
cuesj-178	23	6	access	access	NOUN
cuesj-178	23	7	article	article	NOUN
cuesj-178	23	8	distributed	distribute	VERB
cuesj-178	23	9	under	under	ADP
cuesj-178	23	10	the	the	DET
cuesj-178	23	11	creative	creative	ADJ
cuesj-178	23	12	commons	common	NOUN
cuesj-178	23	13	attribution	attribution	NOUN
cuesj-178	23	14	license	license	NOUN
cuesj-178	23	15	.	.	PUNCT
cuesj-178	24	1	https://creativecommons.org/licenses/by-nc-nd/4.0/	https://creativecommons.org/licenses/by-nc-nd/4.0/	PROPN
cuesj-178	24	2	ibrahim	ibrahim	PROPN
cuesj-178	24	3	,	,	PUNCT
cuesj-178	24	4	et	et	PROPN
cuesj-178	24	5	al	al	PROPN
cuesj-178	24	6	.	.	PUNCT
cuesj-178	24	7	:	:	PUNCT
cuesj-178	25	1	apelin	apelin	PROPN
cuesj-178	25	2	,	,	PUNCT
cuesj-178	25	3	endoglin	endoglin	PROPN
cuesj-178	25	4	,	,	PUNCT
cuesj-178	25	5	and	and	CCONJ
cuesj-178	25	6	tgf	tgf	PROPN
cuesj-178	25	7	-	-	PUNCT
cuesj-178	25	8	β1	β1	PROPN
cuesj-178	25	9	in	in	ADP
cuesj-178	25	10	polycystic	polycystic	ADJ
cuesj-178	25	11	ovary	ovary	ADJ
cuesj-178	25	12	syndrome	syndrome	NOUN
cuesj-178	25	13	22	22	NUM
cuesj-178	25	14	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-178	25	15	cuesj	cuesj	NOUN
cuesj-178	25	16	2020	2020	NUM
cuesj-178	25	17	,	,	PUNCT
cuesj-178	25	18	4	4	NUM
cuesj-178	25	19	(	(	PUNCT
cuesj-178	25	20	1	1	NUM
cuesj-178	25	21	):	):	PUNCT
cuesj-178	25	22	21	21	NUM
cuesj-178	25	23	-	-	SYM
cuesj-178	25	24	25	25	NUM
cuesj-178	25	25	adipose	adipose	NOUN
cuesj-178	25	26	tissue	tissue	NOUN
cuesj-178	25	27	is	be	AUX
cuesj-178	25	28	considered	consider	VERB
cuesj-178	25	29	not	not	PART
cuesj-178	25	30	only	only	ADV
cuesj-178	25	31	a	a	DET
cuesj-178	25	32	storage	storage	NOUN
cuesj-178	25	33	tissue	tissue	NOUN
cuesj-178	25	34	but	but	CCONJ
cuesj-178	25	35	also	also	ADV
cuesj-178	25	36	aproper	aproper	VERB
cuesj-178	25	37	endocrine	endocrine	NOUN
cuesj-178	25	38	organ	organ	NOUN
cuesj-178	25	39	,	,	PUNCT
cuesj-178	25	40	metabolically	metabolically	NOUN
cuesj-178	25	41	active.[6	active.[6	NOUN
cuesj-178	25	42	]	]	PUNCT
cuesj-178	26	1	ir	ir	PROPN
cuesj-178	26	2	is	be	AUX
cuesj-178	26	3	considered	consider	VERB
cuesj-178	26	4	the	the	DET
cuesj-178	26	5	main	main	ADJ
cuesj-178	26	6	pathogenic	pathogenic	ADJ
cuesj-178	26	7	factor	factor	NOUN
cuesj-178	26	8	in	in	ADP
cuesj-178	26	9	the	the	DET
cuesj-178	26	10	background	background	NOUN
cuesj-178	26	11	of	of	ADP
cuesj-178	26	12	increased	increase	VERB
cuesj-178	26	13	metabolic	metabolic	NOUN
cuesj-178	26	14	disturbances	disturbance	NOUN
cuesj-178	26	15	in	in	ADP
cuesj-178	26	16	women	woman	NOUN
cuesj-178	26	17	with	with	ADP
cuesj-178	26	18	pcos	pco	NOUN
cuesj-178	26	19	which	which	PRON
cuesj-178	26	20	can	can	AUX
cuesj-178	26	21	explain	explain	VERB
cuesj-178	26	22	hyperandrogenism	hyperandrogenism	NOUN
cuesj-178	26	23	,	,	PUNCT
cuesj-178	26	24	menstrual	menstrual	ADJ
cuesj-178	26	25	irregularity	irregularity	NOUN
cuesj-178	26	26	,	,	PUNCT
cuesj-178	26	27	and	and	CCONJ
cuesj-178	26	28	other	other	ADJ
cuesj-178	26	29	metabolic	metabolic	NOUN
cuesj-178	26	30	manifestations	manifestation	NOUN
cuesj-178	26	31	seen	see	VERB
cuesj-178	26	32	in	in	ADP
cuesj-178	26	33	this	this	PRON
cuesj-178	26	34	disease.[7	disease.[7	NOUN
cuesj-178	26	35	]	]	PUNCT
cuesj-178	26	36	however	however	ADV
cuesj-178	26	37	,	,	PUNCT
cuesj-178	26	38	it	it	PRON
cuesj-178	26	39	is	be	AUX
cuesj-178	26	40	not	not	PART
cuesj-178	26	41	a	a	DET
cuesj-178	26	42	diagnostic	diagnostic	ADJ
cuesj-178	26	43	criterion	criterion	NOUN
cuesj-178	26	44	for	for	ADP
cuesj-178	26	45	pcos.[8	pcos.[8	NOUN
cuesj-178	26	46	]	]	PUNCT
cuesj-178	26	47	obesity	obesity	NOUN
cuesj-178	26	48	alters	alter	VERB
cuesj-178	26	49	the	the	DET
cuesj-178	26	50	expression	expression	NOUN
cuesj-178	26	51	,	,	PUNCT
cuesj-178	26	52	circulating	circulate	VERB
cuesj-178	26	53	levels	level	NOUN
cuesj-178	26	54	,	,	PUNCT
cuesj-178	26	55	and	and	CCONJ
cuesj-178	26	56	signaling	signal	VERB
cuesj-178	26	57	mechanisms	mechanism	NOUN
cuesj-178	26	58	of	of	ADP
cuesj-178	26	59	adipose	adipose	NOUN
cuesj-178	26	60	-	-	PUNCT
cuesj-178	26	61	secreted	secrete	VERB
cuesj-178	26	62	factors	factor	NOUN
cuesj-178	26	63	and	and	CCONJ
cuesj-178	26	64	these	these	DET
cuesj-178	26	65	changes	change	NOUN
cuesj-178	26	66	have	have	AUX
cuesj-178	26	67	been	be	AUX
cuesj-178	26	68	linked	link	VERB
cuesj-178	26	69	to	to	ADP
cuesj-178	26	70	the	the	DET
cuesj-178	26	71	development	development	NOUN
cuesj-178	26	72	of	of	ADP
cuesj-178	26	73	ir	ir	PROPN
cuesj-178	26	74	,	,	PUNCT
cuesj-178	26	75	type	type	NOUN
cuesj-178	26	76	2	2	NUM
cuesj-178	26	77	diabetes	diabetes	NOUN
cuesj-178	26	78	,	,	PUNCT
cuesj-178	26	79	dyslipidemia	dyslipidemia	NOUN
cuesj-178	26	80	,	,	PUNCT
cuesj-178	26	81	atherosclerosis	atherosclerosis	NOUN
cuesj-178	26	82	,	,	PUNCT
cuesj-178	26	83	cancer	cancer	NOUN
cuesj-178	26	84	,	,	PUNCT
cuesj-178	26	85	and	and	CCONJ
cuesj-178	26	86	other	other	ADJ
cuesj-178	26	87	diseases.[9	diseases.[9	X
cuesj-178	26	88	]	]	X
cuesj-178	26	89	apelin	apelin	PROPN
cuesj-178	26	90	is	be	AUX
cuesj-178	26	91	an	an	DET
cuesj-178	26	92	endogenous	endogenous	ADJ
cuesj-178	26	93	cytokine,[10	cytokine,[10	NOUN
cuesj-178	26	94	]	]	X
cuesj-178	26	95	an	an	DET
cuesj-178	26	96	adipokine,[11	adipokine,[11	NOUN
cuesj-178	26	97	]	]	X
cuesj-178	26	98	a	a	DET
cuesj-178	26	99	regulatory	regulatory	ADJ
cuesj-178	26	100	peptide,[12	peptide,[12	NOUN
cuesj-178	26	101	]	]	X
cuesj-178	26	102	and	and	CCONJ
cuesj-178	26	103	a	a	DET
cuesj-178	26	104	neuropeptide[13	neuropeptide[13	NOUN
cuesj-178	26	105	]	]	PUNCT
cuesj-178	26	106	that	that	PRON
cuesj-178	26	107	has	have	AUX
cuesj-178	26	108	been	be	AUX
cuesj-178	26	109	linked	link	VERB
cuesj-178	26	110	to	to	ADP
cuesj-178	26	111	obesity	obesity	NOUN
cuesj-178	26	112	and	and	CCONJ
cuesj-178	26	113	ir	ir	PROPN
cuesj-178	27	1	.	.	PROPN
cuesj-178	27	2	apelin	apelin	PROPN
cuesj-178	27	3	is	be	AUX
cuesj-178	27	4	a	a	DET
cuesj-178	27	5	36	36	NUM
cuesj-178	27	6	-	-	PUNCT
cuesj-178	27	7	amino	amino	NOUN
cuesj-178	27	8	acid	acid	NOUN
cuesj-178	27	9	peptide	peptide	NOUN
cuesj-178	27	10	(	(	PUNCT
cuesj-178	27	11	ap-36	ap-36	NOUN
cuesj-178	27	12	)	)	PUNCT
cuesj-178	27	13	generated	generate	VERB
cuesj-178	27	14	from	from	ADP
cuesj-178	27	15	a	a	DET
cuesj-178	27	16	larger	large	ADJ
cuesj-178	27	17	precursor	precursor	NOUN
cuesj-178	27	18	the	the	DET
cuesj-178	27	19	77	77	NUM
cuesj-178	27	20	-	-	PUNCT
cuesj-178	27	21	amino	amino	NOUN
cuesj-178	27	22	acid	acid	NOUN
cuesj-178	27	23	proapelin	proapelin	PROPN
cuesj-178	27	24	.	.	PUNCT
cuesj-178	28	1	the	the	DET
cuesj-178	28	2	human	human	ADJ
cuesj-178	28	3	preproapelin	preproapelin	NOUN
cuesj-178	28	4	gene	gene	NOUN
cuesj-178	28	5	is	be	AUX
cuesj-178	28	6	located	locate	VERB
cuesj-178	28	7	on	on	ADP
cuesj-178	28	8	chromosome	chromosome	NOUN
cuesj-178	28	9	x	x	PUNCT
cuesj-178	28	10	at	at	ADP
cuesj-178	28	11	locus	locus	NOUN
cuesj-178	28	12	xq25	xq25	PROPN
cuesj-178	28	13	-	-	PUNCT
cuesj-178	28	14	q26.1.[10	q26.1.[10	PROPN
cuesj-178	28	15	]	]	PUNCT
cuesj-178	28	16	collected	collect	VERB
cuesj-178	28	17	data	datum	NOUN
cuesj-178	28	18	from	from	ADP
cuesj-178	28	19	both	both	CCONJ
cuesj-178	28	20	the	the	DET
cuesj-178	28	21	clinical	clinical	ADJ
cuesj-178	28	22	and	and	CCONJ
cuesj-178	28	23	basic	basic	ADJ
cuesj-178	28	24	settings	setting	NOUN
cuesj-178	28	25	show	show	VERB
cuesj-178	28	26	that	that	SCONJ
cuesj-178	28	27	ap	ap	PROPN
cuesj-178	28	28	(	(	PUNCT
cuesj-178	28	29	1	1	X
cuesj-178	28	30	)	)	PUNCT
cuesj-178	28	31	correlates	correlate	VERB
cuesj-178	28	32	with	with	ADP
cuesj-178	28	33	states	state	NOUN
cuesj-178	28	34	of	of	ADP
cuesj-178	28	35	ir	ir	PROPN
cuesj-178	28	36	and	and	CCONJ
cuesj-178	28	37	obesity	obesity	NOUN
cuesj-178	28	38	,	,	PUNCT
cuesj-178	28	39	(	(	PUNCT
cuesj-178	28	40	2	2	NUM
cuesj-178	28	41	)	)	PUNCT
cuesj-178	28	42	stimulates	stimulate	VERB
cuesj-178	28	43	glucose	glucose	NOUN
cuesj-178	28	44	utilization	utilization	NOUN
cuesj-178	28	45	,	,	PUNCT
cuesj-178	28	46	(	(	PUNCT
cuesj-178	28	47	3	3	X
cuesj-178	28	48	)	)	PUNCT
cuesj-178	28	49	decreases	decrease	VERB
cuesj-178	28	50	insulin	insulin	NOUN
cuesj-178	28	51	secretion	secretion	NOUN
cuesj-178	28	52	,	,	PUNCT
cuesj-178	28	53	and	and	CCONJ
cuesj-178	28	54	(	(	PUNCT
cuesj-178	28	55	4	4	X
cuesj-178	28	56	)	)	PUNCT
cuesj-178	28	57	negatively	negatively	ADV
cuesj-178	28	58	regulates	regulate	VERB
cuesj-178	28	59	catecholamine	catecholamine	NOUN
cuesj-178	28	60	-	-	PUNCT
cuesj-178	28	61	mediated	mediate	VERB
cuesj-178	28	62	lipolysis	lipolysis	NOUN
cuesj-178	28	63	.	.	PUNCT
cuesj-178	29	1	ap	ap	PROPN
cuesj-178	29	2	seems	seem	VERB
cuesj-178	29	3	to	to	PART
cuesj-178	29	4	be	be	AUX
cuesj-178	29	5	a	a	DET
cuesj-178	29	6	key	key	ADJ
cuesj-178	29	7	regulator	regulator	NOUN
cuesj-178	29	8	in	in	ADP
cuesj-178	29	9	glucose	glucose	NOUN
cuesj-178	29	10	and	and	CCONJ
cuesj-178	29	11	lipid	lipid	NOUN
cuesj-178	29	12	metabolism	metabolism	NOUN
cuesj-178	29	13	and	and	CCONJ
cuesj-178	29	14	may	may	AUX
cuesj-178	29	15	be	be	AUX
cuesj-178	29	16	associated	associate	VERB
cuesj-178	29	17	with	with	ADP
cuesj-178	29	18	ir	ir	PROPN
cuesj-178	29	19	and	and	CCONJ
cuesj-178	29	20	possibly	possibly	ADV
cuesj-178	29	21	implicated	implicate	VERB
cuesj-178	29	22	in	in	ADP
cuesj-178	29	23	pcos	pcos	PROPN
cuesj-178	29	24	which	which	PRON
cuesj-178	29	25	is	be	AUX
cuesj-178	29	26	known	know	VERB
cuesj-178	29	27	to	to	PART
cuesj-178	29	28	be	be	AUX
cuesj-178	29	29	associated	associate	VERB
cuesj-178	29	30	with	with	ADP
cuesj-178	29	31	increased	increase	VERB
cuesj-178	29	32	ir[14	ir[14	PROPN
cuesj-178	29	33	]	]	PUNCT
cuesj-178	29	34	and	and	CCONJ
cuesj-178	29	35	from	from	ADP
cuesj-178	29	36	hence	hence	ADV
cuesj-178	29	37	the	the	DET
cuesj-178	29	38	possible	possible	ADJ
cuesj-178	29	39	link	link	NOUN
cuesj-178	29	40	to	to	ADP
cuesj-178	29	41	apelin	apelin	PROPN
cuesj-178	29	42	levels	level	NOUN
cuesj-178	29	43	.	.	PUNCT
cuesj-178	30	1	endoglin	endoglin	NOUN
cuesj-178	30	2	(	(	PUNCT
cuesj-178	30	3	seng)/cd105	seng)/cd105	NOUN
cuesj-178	30	4	is	be	AUX
cuesj-178	30	5	a	a	DET
cuesj-178	30	6	transmembrane	transmembrane	ADJ
cuesj-178	30	7	auxiliary	auxiliary	ADJ
cuesj-178	30	8	receptor	receptor	NOUN
cuesj-178	30	9	for	for	ADP
cuesj-178	30	10	transforming	transform	VERB
cuesj-178	30	11	growth	growth	NOUN
cuesj-178	30	12	factor	factor	NOUN
cuesj-178	30	13	beta	beta	NOUN
cuesj-178	30	14	(	(	PUNCT
cuesj-178	30	15	tgf	tgf	PROPN
cuesj-178	30	16	-	-	PUNCT
cuesj-178	30	17	b	b	NOUN
cuesj-178	30	18	)	)	PUNCT
cuesj-178	30	19	it	it	PRON
cuesj-178	30	20	works	work	VERB
cuesj-178	30	21	as	as	ADP
cuesj-178	30	22	a	a	DET
cuesj-178	30	23	non	non	ADJ
cuesj-178	30	24	-	-	ADJ
cuesj-178	30	25	signaling	signaling	ADJ
cuesj-178	30	26	coreceptor	coreceptor	NOUN
cuesj-178	30	27	of	of	ADP
cuesj-178	30	28	the	the	DET
cuesj-178	30	29	tgf	tgf	PROPN
cuesj-178	30	30	-	-	PUNCT
cuesj-178	30	31	b	b	NOUN
cuesj-178	30	32	modulating	modulate	VERB
cuesj-178	30	33	its	its	PRON
cuesj-178	30	34	responses	response	NOUN
cuesj-178	30	35	.	.	PUNCT
cuesj-178	31	1	there	there	PRON
cuesj-178	31	2	are	be	VERB
cuesj-178	31	3	a	a	DET
cuesj-178	31	4	number	number	NOUN
cuesj-178	31	5	of	of	ADP
cuesj-178	31	6	reports	report	NOUN
cuesj-178	31	7	suggesting	suggest	VERB
cuesj-178	31	8	that	that	SCONJ
cuesj-178	31	9	soluble	soluble	ADJ
cuesj-178	31	10	endoglin	endoglin	NOUN
cuesj-178	31	11	may	may	AUX
cuesj-178	31	12	be	be	AUX
cuesj-178	31	13	regarded	regard	VERB
cuesj-178	31	14	as	as	ADP
cuesj-178	31	15	a	a	DET
cuesj-178	31	16	biomarker	biomarker	NOUN
cuesj-178	31	17	of	of	ADP
cuesj-178	31	18	endothelial	endothelial	ADJ
cuesj-178	31	19	dysfunction	dysfunction	NOUN
cuesj-178	31	20	,	,	PUNCT
cuesj-178	31	21	for	for	ADP
cuesj-178	31	22	instance	instance	NOUN
cuesj-178	31	23	,	,	PUNCT
cuesj-178	31	24	atherosclerosis	atherosclerosis	NOUN
cuesj-178	31	25	,	,	PUNCT
cuesj-178	31	26	hypercholesterolemia,[15	hypercholesterolemia,[15	SYM
cuesj-178	31	27	]	]	PUNCT
cuesj-178	31	28	type	type	NOUN
cuesj-178	31	29	2	2	NUM
cuesj-178	31	30	diabetes	diabetes	NOUN
cuesj-178	31	31	mellitus	mellitus	NOUN
cuesj-178	31	32	(	(	PUNCT
cuesj-178	31	33	t2	t2	NOUN
cuesj-178	31	34	dm	dm	PROPN
cuesj-178	31	35	)	)	PUNCT
cuesj-178	31	36	,	,	PUNCT
cuesj-178	31	37	and	and	CCONJ
cuesj-178	31	38	hypertension.[16	hypertension.[16	PROPN
cuesj-178	31	39	]	]	X
cuesj-178	31	40	tgf	tgf	PROPN
cuesj-178	31	41	-	-	PUNCT
cuesj-178	31	42	b1	b1	PROPN
cuesj-178	31	43	is	be	AUX
cuesj-178	31	44	a	a	DET
cuesj-178	31	45	multifunctional	multifunctional	ADJ
cuesj-178	31	46	cytokine	cytokine	NOUN
cuesj-178	31	47	that	that	PRON
cuesj-178	31	48	is	be	AUX
cuesj-178	31	49	produced	produce	VERB
cuesj-178	31	50	by	by	ADP
cuesj-178	31	51	a	a	DET
cuesj-178	31	52	variety	variety	NOUN
cuesj-178	31	53	of	of	ADP
cuesj-178	31	54	cells	cell	NOUN
cuesj-178	31	55	and	and	CCONJ
cuesj-178	31	56	its	its	PRON
cuesj-178	31	57	level	level	NOUN
cuesj-178	31	58	dysregulated	dysregulate	VERB
cuesj-178	31	59	in	in	ADP
cuesj-178	31	60	women	woman	NOUN
cuesj-178	31	61	with	with	ADP
cuesj-178	31	62	pcos	pco	NOUN
cuesj-178	31	63	,	,	PUNCT
cuesj-178	31	64	which	which	PRON
cuesj-178	31	65	might	might	AUX
cuesj-178	31	66	play	play	VERB
cuesj-178	31	67	a	a	DET
cuesj-178	31	68	role	role	NOUN
cuesj-178	31	69	in	in	ADP
cuesj-178	31	70	the	the	DET
cuesj-178	31	71	pathophysiology	pathophysiology	NOUN
cuesj-178	31	72	of	of	ADP
cuesj-178	31	73	this	this	DET
cuesj-178	31	74	syndrome	syndrome	NOUN
cuesj-178	31	75	.	.	PUNCT
cuesj-178	32	1	substantial	substantial	ADJ
cuesj-178	32	2	evidences	evidence	NOUN
cuesj-178	32	3	implicate	implicate	VERB
cuesj-178	32	4	that	that	SCONJ
cuesj-178	32	5	tgf	tgf	PROPN
cuesj-178	32	6	-	-	PUNCT
cuesj-178	32	7	b1	b1	NOUN
cuesj-178	32	8	activation	activation	NOUN
cuesj-178	32	9	is	be	AUX
cuesj-178	32	10	closely	closely	ADV
cuesj-178	32	11	associated	associate	VERB
cuesj-178	32	12	with	with	ADP
cuesj-178	32	13	endothelial	endothelial	ADJ
cuesj-178	32	14	dysfunction	dysfunction	NOUN
cuesj-178	32	15	and	and	CCONJ
cuesj-178	32	16	hypertension.[17	hypertension.[17	PROPN
cuesj-178	32	17	]	]	X
cuesj-178	32	18	there	there	PRON
cuesj-178	32	19	is	be	VERB
cuesj-178	32	20	scattered	scatter	VERB
cuesj-178	32	21	evidence	evidence	NOUN
cuesj-178	32	22	for	for	ADP
cuesj-178	32	23	the	the	DET
cuesj-178	32	24	association	association	NOUN
cuesj-178	32	25	between	between	ADP
cuesj-178	32	26	tgf	tgf	PROPN
cuesj-178	32	27	-	-	PUNCT
cuesj-178	32	28	b1	b1	NOUN
cuesj-178	32	29	,	,	PUNCT
cuesj-178	32	30	visceral	visceral	ADJ
cuesj-178	32	31	adiposity	adiposity	NOUN
cuesj-178	32	32	,	,	PUNCT
cuesj-178	32	33	metabolic	metabolic	NOUN
cuesj-178	32	34	syndrome	syndrome	NOUN
cuesj-178	32	35	,	,	PUNCT
cuesj-178	32	36	nonalcoholic	nonalcoholic	NOUN
cuesj-178	32	37	fatty	fatty	NOUN
cuesj-178	32	38	liver	liver	NOUN
cuesj-178	32	39	disease	disease	NOUN
cuesj-178	32	40	,	,	PUNCT
cuesj-178	32	41	and	and	CCONJ
cuesj-178	32	42	t2dm.[15	t2dm.[15	NUM
cuesj-178	32	43	]	]	PUNCT
cuesj-178	32	44	methods	method	VERB
cuesj-178	32	45	this	this	DET
cuesj-178	32	46	case	case	NOUN
cuesj-178	32	47	–	–	PUNCT
cuesj-178	32	48	control	control	NOUN
cuesj-178	32	49	study	study	NOUN
cuesj-178	32	50	was	be	AUX
cuesj-178	32	51	conducted	conduct	VERB
cuesj-178	32	52	at	at	ADP
cuesj-178	32	53	the	the	DET
cuesj-178	32	54	obstetrics	obstetric	NOUN
cuesj-178	32	55	and	and	CCONJ
cuesj-178	32	56	gynecology	gynecology	NOUN
cuesj-178	32	57	department	department	NOUN
cuesj-178	32	58	in	in	ADP
cuesj-178	32	59	medical	medical	ADJ
cuesj-178	32	60	city	city	NOUN
cuesj-178	32	61	in	in	ADP
cuesj-178	32	62	baghdad	baghdad	PROPN
cuesj-178	32	63	.	.	PUNCT
cuesj-178	33	1	it	it	PRON
cuesj-178	33	2	was	be	AUX
cuesj-178	33	3	conducted	conduct	VERB
cuesj-178	33	4	on	on	ADP
cuesj-178	33	5	ninety	ninety	NUM
cuesj-178	33	6	women	woman	NOUN
cuesj-178	33	7	during	during	ADP
cuesj-178	33	8	the	the	DET
cuesj-178	33	9	period	period	NOUN
cuesj-178	33	10	from	from	ADP
cuesj-178	33	11	march	march	PROPN
cuesj-178	33	12	2018	2018	NUM
cuesj-178	33	13	to	to	ADP
cuesj-178	33	14	september	september	PROPN
cuesj-178	33	15	2018	2018	NUM
cuesj-178	33	16	.	.	PUNCT
cuesj-178	34	1	these	these	PRON
cuesj-178	34	2	were	be	AUX
cuesj-178	34	3	divided	divide	VERB
cuesj-178	34	4	into	into	ADP
cuesj-178	34	5	two	two	NUM
cuesj-178	34	6	groups	group	NOUN
cuesj-178	34	7	:	:	PUNCT
cuesj-178	34	8	group	group	NOUN
cuesj-178	34	9	i	i	PRON
cuesj-178	34	10	:	:	PUNCT
cuesj-178	34	11	fifty	fifty	NUM
cuesj-178	34	12	overweight	overweight	NOUN
cuesj-178	34	13	and	and	CCONJ
cuesj-178	34	14	obese	obese	ADJ
cuesj-178	34	15	women	woman	NOUN
cuesj-178	34	16	with	with	ADP
cuesj-178	34	17	pcos	pcos	PROPN
cuesj-178	34	18	(	(	PUNCT
cuesj-178	34	19	pcos	pcos	PROPN
cuesj-178	34	20	group	group	NOUN
cuesj-178	34	21	)	)	PUNCT
cuesj-178	34	22	and	and	CCONJ
cuesj-178	34	23	group	group	PROPN
cuesj-178	34	24	ii	ii	PROPN
cuesj-178	34	25	:	:	PUNCT
cuesj-178	34	26	forty	forty	NUM
cuesj-178	34	27	overweight	overweight	NOUN
cuesj-178	34	28	and	and	CCONJ
cuesj-178	34	29	obese	obese	ADJ
cuesj-178	34	30	women	woman	NOUN
cuesj-178	34	31	without	without	ADP
cuesj-178	34	32	pcos	pcos	PROPN
cuesj-178	34	33	(	(	PUNCT
cuesj-178	34	34	non	non	ADJ
cuesj-178	34	35	-	-	ADJ
cuesj-178	34	36	pcos	pcos	ADJ
cuesj-178	34	37	group	group	NOUN
cuesj-178	34	38	)	)	PUNCT
cuesj-178	34	39	.	.	PUNCT
cuesj-178	35	1	the	the	DET
cuesj-178	35	2	recruited	recruit	VERB
cuesj-178	35	3	women	woman	NOUN
cuesj-178	35	4	were	be	AUX
cuesj-178	35	5	counseled	counsel	VERB
cuesj-178	35	6	and	and	CCONJ
cuesj-178	35	7	written	write	VERB
cuesj-178	35	8	informed	informed	ADJ
cuesj-178	35	9	consent	consent	NOUN
cuesj-178	35	10	was	be	AUX
cuesj-178	35	11	obtained	obtain	VERB
cuesj-178	35	12	from	from	ADP
cuesj-178	35	13	each	each	DET
cuesj-178	35	14	woman	woman	NOUN
cuesj-178	35	15	before	before	ADP
cuesj-178	35	16	her	her	PRON
cuesj-178	35	17	participation	participation	NOUN
cuesj-178	35	18	in	in	ADP
cuesj-178	35	19	the	the	DET
cuesj-178	35	20	study	study	NOUN
cuesj-178	35	21	.	.	PUNCT
cuesj-178	36	1	diagnosis	diagnosis	NOUN
cuesj-178	36	2	of	of	ADP
cuesj-178	36	3	pcos	pcos	PROPN
cuesj-178	36	4	was	be	AUX
cuesj-178	36	5	made	make	VERB
cuesj-178	36	6	according	accord	VERB
cuesj-178	36	7	to	to	ADP
cuesj-178	36	8	the	the	DET
cuesj-178	36	9	rotterdam	rotterdam	PROPN
cuesj-178	36	10	criteria[18	criteria[18	PROPN
cuesj-178	36	11	]	]	PUNCT
cuesj-178	36	12	in	in	ADP
cuesj-178	36	13	the	the	DET
cuesj-178	36	14	presence	presence	NOUN
cuesj-178	36	15	of	of	ADP
cuesj-178	36	16	at	at	ADV
cuesj-178	36	17	least	least	ADV
cuesj-178	36	18	two	two	NUM
cuesj-178	36	19	of	of	ADP
cuesj-178	36	20	the	the	DET
cuesj-178	36	21	following	following	NOUN
cuesj-178	36	22	:	:	PUNCT
cuesj-178	36	23	(	(	PUNCT
cuesj-178	36	24	a	a	X
cuesj-178	36	25	)	)	PUNCT
cuesj-178	36	26	oligomenorrhea	oligomenorrhea	PROPN
cuesj-178	36	27	and/or	and/or	CCONJ
cuesj-178	36	28	anovulation	anovulation	NOUN
cuesj-178	36	29	,	,	PUNCT
cuesj-178	36	30	(	(	PUNCT
cuesj-178	36	31	b	b	NOUN
cuesj-178	36	32	)	)	PUNCT
cuesj-178	36	33	biochemical	biochemical	ADJ
cuesj-178	36	34	and/or	and/or	CCONJ
cuesj-178	36	35	clinical	clinical	ADJ
cuesj-178	36	36	hyperandrogenism	hyperandrogenism	NOUN
cuesj-178	36	37	,	,	PUNCT
cuesj-178	36	38	and	and	CCONJ
cuesj-178	36	39	(	(	PUNCT
cuesj-178	36	40	c	c	NOUN
cuesj-178	36	41	)	)	PUNCT
cuesj-178	36	42	ultrasound	ultrasound	ADJ
cuesj-178	36	43	appearance	appearance	NOUN
cuesj-178	36	44	of	of	ADP
cuesj-178	36	45	polycystic	polycystic	ADJ
cuesj-178	36	46	ovaries	ovary	NOUN
cuesj-178	36	47	(	(	PUNCT
cuesj-178	36	48	multiple	multiple	ADJ
cuesj-178	36	49	cysts	cyst	NOUN
cuesj-178	36	50	>	>	X
cuesj-178	36	51	12	12	NUM
cuesj-178	36	52	in	in	ADP
cuesj-178	36	53	number	number	NOUN
cuesj-178	36	54	of	of	ADP
cuesj-178	36	55	2–9	2–9	NUM
cuesj-178	36	56	mm	mm	PROPN
cuesj-178	36	57	size),[3	size),[3	NOUN
cuesj-178	36	58	]	]	PUNCT
cuesj-178	36	59	bmi	bmi	PROPN
cuesj-178	36	60	p	p	PROPN
cuesj-178	36	61	25	25	NUM
cuesj-178	36	62	kg	kg	NOUN
cuesj-178	36	63	/	/	SYM
cuesj-178	36	64	m2	m2	PROPN
cuesj-178	36	65	.	.	PUNCT
cuesj-178	37	1	samples	sample	NOUN
cuesj-178	37	2	were	be	AUX
cuesj-178	37	3	obtained	obtain	VERB
cuesj-178	37	4	between	between	ADP
cuesj-178	37	5	days	day	NOUN
cuesj-178	37	6	2	2	NUM
cuesj-178	37	7	and	and	CCONJ
cuesj-178	37	8	5	5	NUM
cuesj-178	37	9	of	of	ADP
cuesj-178	37	10	normal	normal	ADJ
cuesj-178	37	11	spontaneous	spontaneous	ADJ
cuesj-178	37	12	or	or	CCONJ
cuesj-178	37	13	withdrawn	withdraw	VERB
cuesj-178	37	14	menstrual	menstrual	ADJ
cuesj-178	37	15	cycle	cycle	NOUN
cuesj-178	37	16	.	.	PUNCT
cuesj-178	38	1	blood	blood	NOUN
cuesj-178	38	2	allowed	allow	VERB
cuesj-178	38	3	to	to	PART
cuesj-178	38	4	clot	clot	VERB
cuesj-178	38	5	for	for	ADP
cuesj-178	38	6	10–20	10–20	NUM
cuesj-178	38	7	min	min	NOUN
cuesj-178	38	8	at	at	ADP
cuesj-178	38	9	room	room	NOUN
cuesj-178	38	10	temperature	temperature	NOUN
cuesj-178	38	11	and	and	CCONJ
cuesj-178	38	12	centrifuged	centrifuge	VERB
cuesj-178	38	13	at	at	ADP
cuesj-178	38	14	(	(	PUNCT
cuesj-178	38	15	2000–3000	2000–3000	NUM
cuesj-178	38	16	rpm	rpm	NOUN
cuesj-178	38	17	)	)	PUNCT
cuesj-178	38	18	for	for	ADP
cuesj-178	38	19	approximately	approximately	ADV
cuesj-178	38	20	20	20	NUM
cuesj-178	38	21	min	min	NOUN
cuesj-178	38	22	to	to	PART
cuesj-178	38	23	separate	separate	VERB
cuesj-178	38	24	the	the	DET
cuesj-178	38	25	serum	serum	NOUN
cuesj-178	38	26	from	from	ADP
cuesj-178	38	27	the	the	DET
cuesj-178	38	28	cells	cell	NOUN
cuesj-178	38	29	.	.	PUNCT
cuesj-178	39	1	2	2	NUM
cuesj-178	39	2	ml	ml	NOUN
cuesj-178	39	3	serum	serum	NOUN
cuesj-178	39	4	was	be	AUX
cuesj-178	39	5	stored	store	VERB
cuesj-178	39	6	at	at	ADP
cuesj-178	39	7	_	_	PROPN
cuesj-178	39	8	20_c	20_c	NUM
cuesj-178	39	9	until	until	ADP
cuesj-178	39	10	the	the	DET
cuesj-178	39	11	time	time	NOUN
cuesj-178	39	12	of	of	ADP
cuesj-178	39	13	ap-36	ap-36	NOUN
cuesj-178	39	14	and	and	CCONJ
cuesj-178	39	15	hormonal	hormonal	ADJ
cuesj-178	39	16	profile	profile	NOUN
cuesj-178	39	17	assay	assay	VERB
cuesj-178	39	18	.	.	PUNCT
cuesj-178	40	1	hormonal	hormonal	ADJ
cuesj-178	40	2	evaluation	evaluation	NOUN
cuesj-178	40	3	included	include	VERB
cuesj-178	40	4	a	a	DET
cuesj-178	40	5	baseline	baseline	ADJ
cuesj-178	40	6	plasma	plasma	NOUN
cuesj-178	40	7	determination	determination	NOUN
cuesj-178	40	8	of	of	ADP
cuesj-178	40	9	luteinizing	luteinize	VERB
cuesj-178	40	10	hormone	hormone	NOUN
cuesj-178	40	11	(	(	PUNCT
cuesj-178	40	12	lh	lh	PROPN
cuesj-178	40	13	)	)	PUNCT
cuesj-178	40	14	,	,	PUNCT
cuesj-178	40	15	follicle	follicle	NOUN
cuesj-178	40	16	-	-	PUNCT
cuesj-178	40	17	stimulating	stimulate	VERB
cuesj-178	40	18	hormone	hormone	NOUN
cuesj-178	40	19	(	(	PUNCT
cuesj-178	40	20	fsh	fsh	NOUN
cuesj-178	40	21	)	)	PUNCT
cuesj-178	40	22	,	,	PUNCT
cuesj-178	40	23	dehydroepiandrosterone	dehydroepiandrosterone	NOUN
cuesj-178	40	24	sulfate	sulfate	NOUN
cuesj-178	40	25	,	,	PUNCT
cuesj-178	40	26	tsh	tsh	NOUN
cuesj-178	40	27	,	,	PUNCT
cuesj-178	40	28	e2	e2	NOUN
cuesj-178	40	29	,	,	PUNCT
cuesj-178	40	30	and	and	CCONJ
cuesj-178	40	31	free	free	ADJ
cuesj-178	40	32	testosterone	testosterone	NOUN
cuesj-178	40	33	.	.	PUNCT
cuesj-178	41	1	all	all	DET
cuesj-178	41	2	hormones	hormone	NOUN
cuesj-178	41	3	were	be	AUX
cuesj-178	41	4	measured	measure	VERB
cuesj-178	41	5	by	by	ADP
cuesj-178	41	6	radioimmunoassay	radioimmunoassay	PROPN
cuesj-178	41	7	methods	method	NOUN
cuesj-178	41	8	using	use	VERB
cuesj-178	41	9	commercial	commercial	ADJ
cuesj-178	41	10	kits	kit	NOUN
cuesj-178	41	11	(	(	PUNCT
cuesj-178	41	12	dsl	dsl	PROPN
cuesj-178	41	13	inc	inc	PROPN
cuesj-178	41	14	.	.	PROPN
cuesj-178	41	15	,	,	PUNCT
cuesj-178	41	16	webster	webster	PROPN
cuesj-178	41	17	,	,	PUNCT
cuesj-178	41	18	texas	texas	PROPN
cuesj-178	41	19	,	,	PUNCT
cuesj-178	41	20	usa	usa	PROPN
cuesj-178	41	21	)	)	PUNCT
cuesj-178	41	22	.	.	PUNCT
cuesj-178	42	1	the	the	DET
cuesj-178	42	2	fasting	fast	VERB
cuesj-178	42	3	insulin	insulin	NOUN
cuesj-178	42	4	was	be	AUX
cuesj-178	42	5	measured	measure	VERB
cuesj-178	42	6	by	by	ADP
cuesj-178	42	7	radioimmunoassay	radioimmunoassay	PROPN
cuesj-178	42	8	methods	method	NOUN
cuesj-178	42	9	using	use	VERB
cuesj-178	42	10	commercial	commercial	ADJ
cuesj-178	42	11	kits	kit	NOUN
cuesj-178	42	12	(	(	PUNCT
cuesj-178	42	13	the	the	DET
cuesj-178	42	14	intra	intra	ADJ
cuesj-178	42	15	and	and	CCONJ
cuesj-178	42	16	inter	inter	ADJ
cuesj-178	42	17	-	-	ADJ
cuesj-178	42	18	assay	assay	ADJ
cuesj-178	42	19	coefficients	coefficient	NOUN
cuesj-178	42	20	of	of	ADP
cuesj-178	42	21	variation	variation	NOUN
cuesj-178	42	22	were	be	AUX
cuesj-178	42	23	1.98	1.98	NUM
cuesj-178	42	24	%	%	NOUN
cuesj-178	42	25	and	and	CCONJ
cuesj-178	42	26	0.84	0.84	NUM
cuesj-178	42	27	%	%	NOUN
cuesj-178	42	28	,	,	PUNCT
cuesj-178	42	29	respectively	respectively	ADV
cuesj-178	42	30	)	)	PUNCT
cuesj-178	42	31	(	(	PUNCT
cuesj-178	42	32	immunospect	immunospect	NOUN
cuesj-178	42	33	corporation	corporation	NOUN
cuesj-178	42	34	,	,	PUNCT
cuesj-178	42	35	owensmouth	owensmouth	PROPN
cuesj-178	42	36	ave	ave	PROPN
cuesj-178	42	37	,	,	PUNCT
cuesj-178	42	38	canoga	canoga	PROPN
cuesj-178	42	39	park	park	NOUN
cuesj-178	42	40	,	,	PUNCT
cuesj-178	42	41	ca	ca	NOUN
cuesj-178	42	42	)	)	PUNCT
cuesj-178	42	43	.	.	PUNCT
cuesj-178	43	1	fasting	fast	VERB
cuesj-178	43	2	glucose	glucose	NOUN
cuesj-178	43	3	was	be	AUX
cuesj-178	43	4	measured	measure	VERB
cuesj-178	43	5	by	by	ADP
cuesj-178	43	6	the	the	DET
cuesj-178	43	7	glucose	glucose	NOUN
cuesj-178	43	8	oxidase	oxidase	NOUN
cuesj-178	43	9	method	method	NOUN
cuesj-178	43	10	(	(	PUNCT
cuesj-178	43	11	yellow	yellow	ADJ
cuesj-178	43	12	springs	spring	NOUN
cuesj-178	43	13	instrument	instrument	NOUN
cuesj-178	43	14	,	,	PUNCT
cuesj-178	43	15	yellow	yellow	ADJ
cuesj-178	43	16	springs	spring	NOUN
cuesj-178	43	17	,	,	PUNCT
cuesj-178	43	18	oh	oh	INTJ
cuesj-178	43	19	,	,	PUNCT
cuesj-178	43	20	usa	usa	PROPN
cuesj-178	43	21	)	)	PUNCT
cuesj-178	43	22	.	.	PUNCT
cuesj-178	44	1	tc	tc	X
cuesj-178	44	2	,	,	PUNCT
cuesj-178	44	3	tg	tg	PROPN
cuesj-178	44	4	,	,	PUNCT
cuesj-178	44	5	and	and	CCONJ
cuesj-178	44	6	hdl	hdl	PROPN
cuesj-178	44	7	were	be	AUX
cuesj-178	44	8	assayed	assayed	ADJ
cuesj-178	44	9	using	use	VERB
cuesj-178	44	10	fully	fully	ADV
cuesj-178	44	11	automated	automate	VERB
cuesj-178	44	12	clinical	clinical	ADJ
cuesj-178	44	13	chemistry	chemistry	NOUN
cuesj-178	44	14	autoanalyzer	autoanalyzer	NOUN
cuesj-178	44	15	system	system	NOUN
cuesj-178	44	16	konelab	konelab	PROPN
cuesj-178	44	17	20i	20i	PROPN
cuesj-178	44	18	ldl	ldl	PROPN
cuesj-178	44	19	was	be	AUX
cuesj-178	44	20	calculated	calculate	VERB
cuesj-178	44	21	according	accord	VERB
cuesj-178	44	22	to	to	ADP
cuesj-178	44	23	friedewald	friedewald	ADJ
cuesj-178	44	24	formula	formula	NOUN
cuesj-178	44	25	:	:	PUNCT
cuesj-178	44	26	ldl	ldl	NOUN
cuesj-178	44	27	=	=	NOUN
cuesj-178	44	28	tc−(tg/5+hdl).[19	tc−(tg/5+hdl).[19	NOUN
cuesj-178	44	29	]	]	X
cuesj-178	44	30	ir	ir	NOUN
cuesj-178	44	31	was	be	AUX
cuesj-178	44	32	calculated	calculate	VERB
cuesj-178	44	33	by	by	ADP
cuesj-178	44	34	homeostatic	homeostatic	ADJ
cuesj-178	44	35	model	model	NOUN
cuesj-178	44	36	assessment	assessment	NOUN
cuesj-178	44	37	(	(	PUNCT
cuesj-178	44	38	homa	homa	PROPN
cuesj-178	44	39	)	)	PUNCT
cuesj-178	44	40	using	use	VERB
cuesj-178	44	41	the	the	DET
cuesj-178	44	42	following	follow	VERB
cuesj-178	44	43	formula	formula	NOUN
cuesj-178	44	44	:	:	PUNCT
cuesj-178	44	45	homa	homa	NOUN
cuesj-178	44	46	-	-	PUNCT
cuesj-178	44	47	ir	ir	NOUN
cuesj-178	44	48	=	=	PUNCT
cuesj-178	44	49	(	(	PUNCT
cuesj-178	44	50	[	[	X
cuesj-178	44	51	fg	fg	X
cuesj-178	44	52	in	in	ADP
cuesj-178	44	53	mg	mg	PROPN
cuesj-178	44	54	/	/	SYM
cuesj-178	44	55	dl_0.05551	dl_0.05551	PROPN
cuesj-178	44	56	]	]	X
cuesj-178	44	57	_	_	PRON
cuesj-178	44	58	fi	fi	NOUN
cuesj-178	44	59	in	in	ADP
cuesj-178	44	60	mu	mu	NOUN
cuesj-178	44	61	/	/	SYM
cuesj-178	44	62	ml)/22.5	ml)/22.5	NOUN
cuesj-178	44	63	.	.	PUNCT
cuesj-178	45	1	a	a	DET
cuesj-178	45	2	diagnosis	diagnosis	NOUN
cuesj-178	45	3	of	of	ADP
cuesj-178	45	4	ir	ir	PROPN
cuesj-178	45	5	established	establish	VERB
cuesj-178	45	6	for	for	ADP
cuesj-178	45	7	homa	homa	NOUN
cuesj-178	45	8	-	-	PUNCT
cuesj-178	45	9	ir	ir	PROPN
cuesj-178	45	10	values	value	NOUN
cuesj-178	45	11	>	>	X
cuesj-178	45	12	2.71	2.71	NUM
cuesj-178	45	13	nmol_mu	nmol_mu	PROPN
cuesj-178	45	14	/	/	SYM
cuesj-178	45	15	l[20	l[20	PROPN
cuesj-178	45	16	]	]	PUNCT
cuesj-178	45	17	equal	equal	ADJ
cuesj-178	45	18	(	(	PUNCT
cuesj-178	45	19	fg	fg	PROPN
cuesj-178	45	20	in	in	ADP
cuesj-178	45	21	mg	mg	PROPN
cuesj-178	45	22	/	/	SYM
cuesj-178	45	23	dl_fi	dl_fi	PROPN
cuesj-178	45	24	in	in	ADP
cuesj-178	45	25	mu/	mu/	PROPN
cuesj-178	45	26	ml)/405	ml)/405	PROPN
cuesj-178	45	27	.	.	PUNCT
cuesj-178	46	1	ir	ir	PROPN
cuesj-178	46	2	was	be	AUX
cuesj-178	46	3	diagnosed	diagnose	VERB
cuesj-178	46	4	according	accord	VERB
cuesj-178	46	5	to	to	ADP
cuesj-178	46	6	the	the	DET
cuesj-178	46	7	fg	fg	PROPN
cuesj-178	46	8	to	to	ADP
cuesj-178	46	9	fi	fi	NOUN
cuesj-178	46	10	ratio	ratio	NOUN
cuesj-178	46	11	.	.	PUNCT
cuesj-178	47	1	if	if	SCONJ
cuesj-178	47	2	a	a	DET
cuesj-178	47	3	participant	participant	NOUN
cuesj-178	47	4	’s	’s	PART
cuesj-178	47	5	fg	fg	PROPN
cuesj-178	47	6	/	/	SYM
cuesj-178	47	7	fi	fi	NOUN
cuesj-178	47	8	was	be	AUX
cuesj-178	47	9	4.5	4.5	NUM
cuesj-178	47	10	or	or	CCONJ
cuesj-178	47	11	less	less	ADJ
cuesj-178	47	12	,	,	PUNCT
cuesj-178	47	13	she	she	PRON
cuesj-178	47	14	would	would	AUX
cuesj-178	47	15	be	be	AUX
cuesj-178	47	16	classified	classify	VERB
cuesj-178	47	17	as	as	ADP
cuesj-178	47	18	being	be	AUX
cuesj-178	47	19	ir	ir	PRON
cuesj-178	47	20	and	and	CCONJ
cuesj-178	47	21	if	if	SCONJ
cuesj-178	47	22	her	her	PRON
cuesj-178	47	23	fg	fg	ADJ
cuesj-178	47	24	/	/	SYM
cuesj-178	47	25	fi	fi	NOUN
cuesj-178	47	26	was	be	AUX
cuesj-178	47	27	>	>	X
cuesj-178	47	28	4.5	4.5	NUM
cuesj-178	47	29	,	,	PUNCT
cuesj-178	47	30	she	she	PRON
cuesj-178	47	31	would	would	AUX
cuesj-178	47	32	be	be	AUX
cuesj-178	47	33	classified	classify	VERB
cuesj-178	47	34	as	as	ADP
cuesj-178	47	35	being	be	AUX
cuesj-178	47	36	non	non	ADJ
cuesj-178	47	37	-	-	ADJ
cuesj-178	47	38	ir.[21	ir.[21	ADJ
cuesj-178	47	39	]	]	PUNCT
cuesj-178	47	40	results	result	VERB
cuesj-178	47	41	the	the	DET
cuesj-178	47	42	results	result	NOUN
cuesj-178	47	43	obtained	obtain	VERB
cuesj-178	47	44	are	be	AUX
cuesj-178	47	45	shown	show	VERB
cuesj-178	47	46	in	in	ADP
cuesj-178	47	47	table	table	NOUN
cuesj-178	47	48	1	1	NUM
cuesj-178	47	49	and	and	CCONJ
cuesj-178	47	50	table	table	NOUN
cuesj-178	47	51	2	2	NUM
cuesj-178	47	52	.	.	PUNCT
cuesj-178	48	1	the	the	DET
cuesj-178	48	2	group	group	NOUN
cuesj-178	48	3	mean±sd	mean±sd	ADP
cuesj-178	48	4	p	p	ADJ
cuesj-178	48	5	-	-	PUNCT
cuesj-178	48	6	value	value	NOUN
cuesj-178	48	7	pcos	pcos	PROPN
cuesj-178	48	8	control	control	NOUN
cuesj-178	48	9	age	age	NOUN
cuesj-178	48	10	(	(	PUNCT
cuesj-178	48	11	year	year	NOUN
cuesj-178	48	12	)	)	PUNCT
cuesj-178	48	13	28.28±5.11	28.28±5.11	NUM
cuesj-178	48	14	33.27±6018	33.27±6018	NUM
cuesj-178	48	15	0.00033	0.00033	NUM
cuesj-178	48	16	*	*	SYM
cuesj-178	48	17	bmi	bmi	X
cuesj-178	48	18	(	(	PUNCT
cuesj-178	48	19	kg	kg	NOUN
cuesj-178	48	20	/	/	SYM
cuesj-178	48	21	m2	m2	PROPN
cuesj-178	48	22	)	)	PUNCT
cuesj-178	48	23	32.16±2.28	32.16±2.28	PROPN
cuesj-178	48	24	29.07±1.40	29.07±1.40	NUM
cuesj-178	48	25	0.00001	0.00001	NUM
cuesj-178	48	26	*	*	PUNCT
cuesj-178	48	27	hirsutism	hirsutism	NOUN
cuesj-178	48	28	score	score	NOUN
cuesj-178	48	29	13.79±1.2	13.79±1.2	NUM
cuesj-178	48	30	5.33±0.75	5.33±0.75	NUM
cuesj-178	48	31	0.00001	0.00001	NUM
cuesj-178	48	32	*	*	PUNCT
cuesj-178	48	33	tgf	tgf	PROPN
cuesj-178	48	34	-	-	PUNCT
cuesj-178	48	35	β1	β1	PROPN
cuesj-178	48	36	(	(	PUNCT
cuesj-178	48	37	ng	ng	PROPN
cuesj-178	48	38	/	/	SYM
cuesj-178	48	39	ml	ml	PROPN
cuesj-178	48	40	)	)	PUNCT
cuesj-178	48	41	19.34±2.73	19.34±2.73	PROPN
cuesj-178	48	42	12.29±1.19	12.29±1.19	NUM
cuesj-178	48	43	0.00001	0.00001	NUM
cuesj-178	48	44	*	*	PUNCT
cuesj-178	48	45	table	table	NOUN
cuesj-178	48	46	1	1	NUM
cuesj-178	48	47	:	:	PUNCT
cuesj-178	48	48	the	the	DET
cuesj-178	48	49	mean	mean	NOUN
cuesj-178	48	50	and	and	CCONJ
cuesj-178	48	51	sd	sd	NOUN
cuesj-178	48	52	of	of	ADP
cuesj-178	48	53	biochemical	biochemical	ADJ
cuesj-178	48	54	and	and	CCONJ
cuesj-178	48	55	immune	immune	ADJ
cuesj-178	48	56	markers	marker	NOUN
cuesj-178	48	57	level	level	NOUN
cuesj-178	48	58	in	in	ADP
cuesj-178	48	59	the	the	DET
cuesj-178	48	60	patients	patient	NOUN
cuesj-178	48	61	group	group	NOUN
cuesj-178	48	62	and	and	CCONJ
cuesj-178	48	63	healthy	healthy	ADJ
cuesj-178	48	64	control	control	NOUN
cuesj-178	48	65	group	group	NOUN
cuesj-178	48	66	(	(	PUNCT
cuesj-178	48	67	contd	contd	PROPN
cuesj-178	48	68	...	...	PUNCT
cuesj-178	48	69	)	)	PUNCT
cuesj-178	49	1	ibrahim	ibrahim	PROPN
cuesj-178	49	2	,	,	PUNCT
cuesj-178	49	3	et	et	PROPN
cuesj-178	49	4	al	al	PROPN
cuesj-178	49	5	.	.	PUNCT
cuesj-178	49	6	:	:	PUNCT
cuesj-178	50	1	apelin	apelin	PROPN
cuesj-178	50	2	,	,	PUNCT
cuesj-178	50	3	endoglin	endoglin	PROPN
cuesj-178	50	4	,	,	PUNCT
cuesj-178	50	5	and	and	CCONJ
cuesj-178	50	6	tgf	tgf	PROPN
cuesj-178	50	7	-	-	PUNCT
cuesj-178	50	8	β1	β1	PROPN
cuesj-178	50	9	in	in	ADP
cuesj-178	50	10	polycystic	polycystic	ADJ
cuesj-178	50	11	ovary	ovary	ADJ
cuesj-178	50	12	syndrome	syndrome	NOUN
cuesj-178	50	13	23	23	NUM
cuesj-178	50	14	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-178	50	15	cuesj	cuesj	NOUN
cuesj-178	50	16	2020	2020	NUM
cuesj-178	50	17	,	,	PUNCT
cuesj-178	50	18	4	4	NUM
cuesj-178	50	19	(	(	PUNCT
cuesj-178	50	20	1	1	NUM
cuesj-178	50	21	):	):	PUNCT
cuesj-178	50	22	21	21	NUM
cuesj-178	50	23	-	-	SYM
cuesj-178	50	24	25	25	NUM
cuesj-178	50	25	table	table	NOUN
cuesj-178	50	26	2	2	NUM
cuesj-178	50	27	:	:	PUNCT
cuesj-178	50	28	correlation	correlation	NOUN
cuesj-178	50	29	between	between	ADP
cuesj-178	50	30	apelin	apelin	PROPN
cuesj-178	50	31	,	,	PUNCT
cuesj-178	50	32	transforming	transform	VERB
cuesj-178	50	33	growth	growth	NOUN
cuesj-178	50	34	factor	factor	NOUN
cuesj-178	50	35	beta	beta	NOUN
cuesj-178	50	36	,	,	PUNCT
cuesj-178	50	37	and	and	CCONJ
cuesj-178	50	38	endoglin	endoglin	NOUN
cuesj-178	50	39	with	with	ADP
cuesj-178	50	40	other	other	ADJ
cuesj-178	50	41	parameters	parameter	NOUN
cuesj-178	50	42	in	in	ADP
cuesj-178	50	43	the	the	DET
cuesj-178	50	44	pcos	pcos	PROPN
cuesj-178	50	45	disease	disease	NOUN
cuesj-178	50	46	patients	patient	VERB
cuesj-178	50	47	the	the	DET
cuesj-178	50	48	group	group	NOUN
cuesj-178	50	49	correlation	correlation	NOUN
cuesj-178	50	50	coefficient	coefficient	NOUN
cuesj-178	50	51	(	(	PUNCT
cuesj-178	50	52	r	r	NOUN
cuesj-178	50	53	)	)	PUNCT
cuesj-178	50	54	tgf	tgf	PROPN
cuesj-178	50	55	-	-	PUNCT
cuesj-178	50	56	β1	β1	PROPN
cuesj-178	50	57	(	(	PUNCT
cuesj-178	50	58	ng	ng	PROPN
cuesj-178	50	59	/	/	SYM
cuesj-178	50	60	ml	ml	NOUN
cuesj-178	50	61	)	)	PUNCT
cuesj-178	50	62	s	s	NOUN
cuesj-178	50	63	-	-	PUNCT
cuesj-178	50	64	endoglin	endoglin	PROPN
cuesj-178	50	65	ng	ng	PROPN
cuesj-178	50	66	/	/	SYM
cuesj-178	50	67	ml	ml	PROPN
cuesj-178	50	68	apelin	apelin	PROPN
cuesj-178	50	69	(	(	PUNCT
cuesj-178	50	70	pg	pg	NOUN
cuesj-178	50	71	/	/	SYM
cuesj-178	50	72	ml	ml	NOUN
cuesj-178	50	73	)	)	PUNCT
cuesj-178	50	74	age	age	NOUN
cuesj-178	50	75	(	(	PUNCT
cuesj-178	50	76	year	year	NOUN
cuesj-178	50	77	)	)	PUNCT
cuesj-178	50	78	0.0917	0.0917	NUM
cuesj-178	50	79	−0.0948	−0.0948	X
cuesj-178	50	80	−0.1572	−0.1572	NUM
cuesj-178	50	81	bmi	bmi	NOUN
cuesj-178	50	82	(	(	PUNCT
cuesj-178	50	83	kg	kg	NOUN
cuesj-178	50	84	/	/	SYM
cuesj-178	50	85	m2	m2	PROPN
cuesj-178	50	86	)	)	PUNCT
cuesj-178	50	87	0.3333	0.3333	NUM
cuesj-178	50	88	0.0379	0.0379	NUM
cuesj-178	50	89	0.0353	0.0353	NUM
cuesj-178	50	90	hirsutism	hirsutism	NOUN
cuesj-178	50	91	score	score	VERB
cuesj-178	50	92	−0.2653	−0.2653	PROPN
cuesj-178	50	93	0.0955	0.0955	NUM
cuesj-178	50	94	−0.1134	−0.1134	DET
cuesj-178	50	95	tgf	tgf	PROPN
cuesj-178	50	96	-	-	PUNCT
cuesj-178	50	97	β1	β1	PROPN
cuesj-178	50	98	(	(	PUNCT
cuesj-178	50	99	ng	ng	PROPN
cuesj-178	50	100	/	/	SYM
cuesj-178	50	101	ml	ml	PROPN
cuesj-178	50	102	)	)	PUNCT
cuesj-178	50	103	0.2007	0.2007	NUM
cuesj-178	50	104	0.1903	0.1903	NUM
cuesj-178	51	1	s	s	NOUN
cuesj-178	51	2	-	-	PUNCT
cuesj-178	51	3	endoglin	endoglin	NOUN
cuesj-178	51	4	ng	ng	PROPN
cuesj-178	51	5	/	/	SYM
cuesj-178	51	6	ml	ml	VERB
cuesj-178	51	7	0.2007	0.2007	NUM
cuesj-178	52	1	−0.0502	−0.0502	NOUN
cuesj-178	53	1	apelin	apelin	NOUN
cuesj-178	54	1	(	(	PUNCT
cuesj-178	54	2	pg	pg	NOUN
cuesj-178	54	3	/	/	SYM
cuesj-178	54	4	ml	ml	VERB
cuesj-178	54	5	)	)	PUNCT
cuesj-178	54	6	0.1903	0.1903	NUM
cuesj-178	55	1	−0.0502	−0.0502	NUM
cuesj-178	56	1	fasting	fast	VERB
cuesj-178	56	2	plasma	plasma	NOUN
cuesj-178	56	3	glucose	glucose	NOUN
cuesj-178	56	4	(	(	PUNCT
cuesj-178	56	5	mg	mg	PROPN
cuesj-178	56	6	/	/	SYM
cuesj-178	56	7	dl	dl	NOUN
cuesj-178	56	8	)	)	PUNCT
cuesj-178	56	9	0.1447	0.1447	NUM
cuesj-178	56	10	−0.0654	−0.0654	PROPN
cuesj-178	56	11	−0.0531	−0.0531	NUM
cuesj-178	56	12	insulin	insulin	NOUN
cuesj-178	56	13	(	(	PUNCT
cuesj-178	56	14	iu	iu	NOUN
cuesj-178	56	15	/	/	SYM
cuesj-178	56	16	ml	ml	NOUN
cuesj-178	56	17	)	)	PUNCT
cuesj-178	56	18	−0.0978	−0.0978	PROPN
cuesj-178	56	19	−0.0906	−0.0906	X
cuesj-178	56	20	0.0132	0.0132	NUM
cuesj-178	56	21	homa	homa	NOUN
cuesj-178	56	22	0.1547	0.1547	NUM
cuesj-178	56	23	−0.1586	−0.1586	NOUN
cuesj-178	56	24	0.1233	0.1233	NUM
cuesj-178	56	25	prolactin	prolactin	NOUN
cuesj-178	56	26	(	(	PUNCT
cuesj-178	56	27	pg	pg	NOUN
cuesj-178	56	28	/	/	SYM
cuesj-178	56	29	ml	ml	VERB
cuesj-178	56	30	)	)	PUNCT
cuesj-178	56	31	−0.1503	−0.1503	NOUN
cuesj-178	56	32	0.3305	0.3305	NUM
cuesj-178	56	33	−0.223	−0.223	NOUN
cuesj-178	56	34	fsh	fsh	NOUN
cuesj-178	56	35	(	(	PUNCT
cuesj-178	56	36	miu	miu	PROPN
cuesj-178	56	37	/	/	SYM
cuesj-178	56	38	ml	ml	NOUN
cuesj-178	56	39	)	)	PUNCT
cuesj-178	56	40	−0.0841	−0.0841	NOUN
cuesj-178	56	41	−0.0611	−0.0611	X
cuesj-178	56	42	−0.1269	−0.1269	X
cuesj-178	56	43	lh	lh	PROPN
cuesj-178	56	44	(	(	PUNCT
cuesj-178	56	45	miu	miu	PROPN
cuesj-178	56	46	/	/	SYM
cuesj-178	56	47	ml	ml	NOUN
cuesj-178	56	48	)	)	PUNCT
cuesj-178	56	49	−0.0413	−0.0413	NOUN
cuesj-178	56	50	0.0798	0.0798	NUM
cuesj-178	56	51	0.2071	0.2071	NUM
cuesj-178	56	52	shbg	shbg	NOUN
cuesj-178	56	53	(	(	PUNCT
cuesj-178	56	54	nmol	nmol	NOUN
cuesj-178	56	55	/	/	SYM
cuesj-178	56	56	l	l	NOUN
cuesj-178	56	57	)	)	PUNCT
cuesj-178	56	58	0.2081	0.2081	NUM
cuesj-178	56	59	−0.189	−0.189	NOUN
cuesj-178	56	60	0.198	0.198	NUM
cuesj-178	56	61	dhea	dhea	PROPN
cuesj-178	56	62	-	-	PUNCT
cuesj-178	56	63	s	s	X
cuesj-178	56	64	(	(	PUNCT
cuesj-178	56	65	mg	mg	PROPN
cuesj-178	56	66	/	/	SYM
cuesj-178	56	67	ml	ml	NOUN
cuesj-178	56	68	)	)	PUNCT
cuesj-178	56	69	−0.1289	−0.1289	NOUN
cuesj-178	56	70	−0.0002	−0.0002	PUNCT
cuesj-178	56	71	−0.1991	−0.1991	NUM
cuesj-178	56	72	total	total	ADJ
cuesj-178	56	73	testosterone	testosterone	NOUN
cuesj-178	56	74	(	(	PUNCT
cuesj-178	56	75	ng	ng	NOUN
cuesj-178	56	76	/	/	SYM
cuesj-178	56	77	ml	ml	VERB
cuesj-178	56	78	)	)	PUNCT
cuesj-178	56	79	0.0887	0.0887	NUM
cuesj-178	56	80	−0.1985	−0.1985	X
cuesj-178	56	81	−0.0872	−0.0872	X
cuesj-178	56	82	free	free	ADJ
cuesj-178	56	83	testosterone	testosterone	NOUN
cuesj-178	56	84	(	(	PUNCT
cuesj-178	56	85	pg	pg	NOUN
cuesj-178	56	86	/	/	SYM
cuesj-178	56	87	ml	ml	VERB
cuesj-178	56	88	)	)	PUNCT
cuesj-178	56	89	0.1543	0.1543	NUM
cuesj-178	56	90	−0.4447	−0.4447	NUM
cuesj-178	56	91	0.0568	0.0568	NUM
cuesj-178	56	92	h	h	NOUN
cuesj-178	56	93	-	-	PUNCT
cuesj-178	56	94	crp	crp	NOUN
cuesj-178	56	95	(	(	PUNCT
cuesj-178	56	96	μg	μg	PROPN
cuesj-178	56	97	/	/	SYM
cuesj-178	56	98	ml	ml	NOUN
cuesj-178	56	99	)	)	PUNCT
cuesj-178	56	100	0.0484	0.0484	NUM
cuesj-178	56	101	−0.1559	−0.1559	X
cuesj-178	56	102	−0.0966	−0.0966	X
cuesj-178	56	103	cholesterol	cholesterol	NOUN
cuesj-178	56	104	mg	mg	PROPN
cuesj-178	56	105	/	/	SYM
cuesj-178	56	106	dl	dl	X
cuesj-178	56	107	−0.1114	−0.1114	X
cuesj-178	56	108	0.0285	0.0285	NUM
cuesj-178	56	109	0.323	0.323	NUM
cuesj-178	56	110	triglyceride	triglyceride	ADJ
cuesj-178	56	111	(	(	PUNCT
cuesj-178	56	112	mg	mg	PROPN
cuesj-178	56	113	/	/	SYM
cuesj-178	56	114	dl	dl	NOUN
cuesj-178	56	115	)	)	PUNCT
cuesj-178	56	116	0.354	0.354	NUM
cuesj-178	56	117	0.1584	0.1584	NUM
cuesj-178	56	118	0.0839	0.0839	NUM
cuesj-178	56	119	hdl	hdl	NOUN
cuesj-178	56	120	(	(	PUNCT
cuesj-178	56	121	mg	mg	PROPN
cuesj-178	56	122	/	/	SYM
cuesj-178	56	123	dl	dl	NOUN
cuesj-178	56	124	)	)	PUNCT
cuesj-178	56	125	−0.1063	−0.1063	PROPN
cuesj-178	56	126	0.1887	0.1887	NUM
cuesj-178	56	127	−0.0182	−0.0182	NOUN
cuesj-178	56	128	ldl	ldl	NOUN
cuesj-178	56	129	(	(	PUNCT
cuesj-178	56	130	mg	mg	PROPN
cuesj-178	56	131	/	/	SYM
cuesj-178	56	132	dl	dl	NOUN
cuesj-178	56	133	)	)	PUNCT
cuesj-178	56	134	−0.1063	−0.1063	NUM
cuesj-178	56	135	−0.1289	−0.1289	NOUN
cuesj-178	57	1	0.43	0.43	NUM
cuesj-178	57	2	*	*	PUNCT
cuesj-178	57	3	(	(	PUNCT
cuesj-178	57	4	p<0.05	p<0.05	NOUN
cuesj-178	57	5	)	)	PUNCT
cuesj-178	57	6	,	,	PUNCT
cuesj-178	57	7	*	*	PUNCT
cuesj-178	57	8	*	*	PUNCT
cuesj-178	57	9	(	(	PUNCT
cuesj-178	57	10	p<0.01	p<0.01	PROPN
cuesj-178	57	11	)	)	PUNCT
cuesj-178	57	12	,	,	PUNCT
cuesj-178	57	13	ns	ns	NUM
cuesj-178	57	14	:	:	PUNCT
cuesj-178	57	15	non	non	ADJ
cuesj-178	57	16	-	-	ADJ
cuesj-178	57	17	significant	significant	ADJ
cuesj-178	57	18	.	.	PUNCT
cuesj-178	58	1	pcos	pco	NOUN
cuesj-178	58	2	:	:	PUNCT
cuesj-178	58	3	polycystic	polycystic	ADJ
cuesj-178	58	4	ovary	ovary	ADJ
cuesj-178	58	5	syndrome	syndrome	NOUN
cuesj-178	58	6	,	,	PUNCT
cuesj-178	58	7	bmi	bmi	PROPN
cuesj-178	58	8	:	:	PUNCT
cuesj-178	58	9	body	body	NOUN
cuesj-178	58	10	mass	mass	PROPN
cuesj-178	58	11	index	index	PROPN
cuesj-178	58	12	,	,	PUNCT
cuesj-178	58	13	tgf	tgf	PROPN
cuesj-178	58	14	:	:	PUNCT
cuesj-178	58	15	transforming	transform	VERB
cuesj-178	58	16	growth	growth	NOUN
cuesj-178	58	17	factor	factor	NOUN
cuesj-178	58	18	,	,	PUNCT
cuesj-178	58	19	homa	homa	NOUN
cuesj-178	58	20	:	:	PUNCT
cuesj-178	58	21	homeostatic	homeostatic	ADJ
cuesj-178	58	22	model	model	NOUN
cuesj-178	58	23	assessment	assessment	NOUN
cuesj-178	58	24	,	,	PUNCT
cuesj-178	58	25	fsh	fsh	PROPN
cuesj-178	58	26	:	:	PUNCT
cuesj-178	58	27	follicle	follicle	NOUN
cuesj-178	58	28	-	-	PUNCT
cuesj-178	58	29	stimulating	stimulate	VERB
cuesj-178	58	30	hormone	hormone	NOUN
cuesj-178	58	31	,	,	PUNCT
cuesj-178	58	32	lh	lh	PROPN
cuesj-178	58	33	:	:	PUNCT
cuesj-178	58	34	luteinizing	luteinize	VERB
cuesj-178	58	35	hormone	hormone	NOUN
cuesj-178	58	36	,	,	PUNCT
cuesj-178	58	37	shbg	shbg	NOUN
cuesj-178	58	38	:	:	PUNCT
cuesj-178	58	39	sex	sex	NOUN
cuesj-178	58	40	hormone	hormone	NOUN
cuesj-178	58	41	-	-	PUNCT
cuesj-178	58	42	binding	bind	VERB
cuesj-178	58	43	globulin	globulin	NOUN
cuesj-178	58	44	,	,	PUNCT
cuesj-178	58	45	dhea	dhea	PROPN
cuesj-178	58	46	:	:	PUNCT
cuesj-178	58	47	dehydroepiandrosterone	dehydroepiandrosterone	PROPN
cuesj-178	58	48	,	,	PUNCT
cuesj-178	58	49	h	h	NOUN
cuesj-178	58	50	-	-	PUNCT
cuesj-178	58	51	crp	crp	NOUN
cuesj-178	58	52	:	:	PUNCT
cuesj-178	58	53	high	high	ADJ
cuesj-178	58	54	sensitivity	sensitivity	NOUN
cuesj-178	58	55	c	c	NOUN
cuesj-178	58	56	-	-	PUNCT
cuesj-178	58	57	reactive	reactive	ADJ
cuesj-178	58	58	protein	protein	NOUN
cuesj-178	58	59	,	,	PUNCT
cuesj-178	58	60	hdl	hdl	NOUN
cuesj-178	58	61	:	:	PUNCT
cuesj-178	58	62	high	high	ADJ
cuesj-178	58	63	-	-	PUNCT
cuesj-178	58	64	density	density	NOUN
cuesj-178	58	65	lipoprotein	lipoprotein	ADJ
cuesj-178	58	66	,	,	PUNCT
cuesj-178	58	67	ldl	ldl	NOUN
cuesj-178	58	68	:	:	PUNCT
cuesj-178	58	69	low	low	ADJ
cuesj-178	58	70	-	-	PUNCT
cuesj-178	58	71	density	density	NOUN
cuesj-178	58	72	lipoprotein	lipoprotein	VERB
cuesj-178	58	73	the	the	DET
cuesj-178	58	74	group	group	NOUN
cuesj-178	58	75	mean±sd	mean±sd	ADP
cuesj-178	58	76	p	p	ADJ
cuesj-178	58	77	-	-	PUNCT
cuesj-178	58	78	value	value	NOUN
cuesj-178	58	79	pcos	pcos	PROPN
cuesj-178	58	80	control	control	NOUN
cuesj-178	58	81	s	s	NOUN
cuesj-178	58	82	-	-	PUNCT
cuesj-178	58	83	endoglin	endoglin	PROPN
cuesj-178	58	84	ng	ng	PROPN
cuesj-178	58	85	/	/	SYM
cuesj-178	58	86	ml	ml	NOUN
cuesj-178	59	1	3.37±1.25	3.37±1.25	NUM
cuesj-178	59	2	5.02±1.34	5.02±1.34	NOUN
cuesj-178	59	3	0.00001	0.00001	NUM
cuesj-178	59	4	*	*	PUNCT
cuesj-178	59	5	apelin	apelin	NOUN
cuesj-178	59	6	(	(	PUNCT
cuesj-178	59	7	pg	pg	NOUN
cuesj-178	59	8	/	/	SYM
cuesj-178	59	9	ml	ml	VERB
cuesj-178	59	10	)	)	PUNCT
cuesj-178	59	11	220.92±16.87	220.92±16.87	NUM
cuesj-178	59	12	367.05±37.87	367.05±37.87	NUM
cuesj-178	59	13	0.00001	0.00001	NUM
cuesj-178	59	14	*	*	PUNCT
cuesj-178	59	15	fasting	fast	VERB
cuesj-178	59	16	plasma	plasma	NOUN
cuesj-178	59	17	glucose	glucose	NOUN
cuesj-178	59	18	(	(	PUNCT
cuesj-178	59	19	mg	mg	PROPN
cuesj-178	59	20	/	/	SYM
cuesj-178	59	21	dl	dl	PROPN
cuesj-178	59	22	)	)	PUNCT
cuesj-178	59	23	94.76±20.71	94.76±20.71	PROPN
cuesj-178	59	24	90.0±14.7	90.0±14.7	NUM
cuesj-178	59	25	0.00001	0.00001	NUM
cuesj-178	59	26	*	*	NOUN
cuesj-178	59	27	insulin	insulin	NOUN
cuesj-178	59	28	(	(	PUNCT
cuesj-178	59	29	iu	iu	NOUN
cuesj-178	59	30	/	/	SYM
cuesj-178	59	31	ml	ml	NOUN
cuesj-178	59	32	)	)	PUNCT
cuesj-178	59	33	18.76±4.33	18.76±4.33	NUM
cuesj-178	59	34	12.0±6.5	12.0±6.5	NUM
cuesj-178	59	35	0.00001	0.00001	NUM
cuesj-178	59	36	*	*	PUNCT
cuesj-178	59	37	homa	homa	PROPN
cuesj-178	59	38	2.44±1.16	2.44±1.16	PROPN
cuesj-178	59	39	1.72±1.01	1.72±1.01	NUM
cuesj-178	59	40	0.001375	0.001375	NUM
cuesj-178	59	41	*	*	NOUN
cuesj-178	59	42	prolactin	prolactin	X
cuesj-178	59	43	(	(	PUNCT
cuesj-178	59	44	pg	pg	NOUN
cuesj-178	59	45	/	/	SYM
cuesj-178	59	46	ml	ml	NOUN
cuesj-178	59	47	)	)	PUNCT
cuesj-178	59	48	13.71±1.25	13.71±1.25	NUM
cuesj-178	59	49	13.14±1.56	13.14±1.56	NUM
cuesj-178	59	50	0.02867	0.02867	NUM
cuesj-178	59	51	*	*	PUNCT
cuesj-178	59	52	fsh	fsh	X
cuesj-178	59	53	(	(	PUNCT
cuesj-178	59	54	miu	miu	PROPN
cuesj-178	59	55	/	/	SYM
cuesj-178	59	56	ml	ml	NOUN
cuesj-178	59	57	)	)	PUNCT
cuesj-178	59	58	7.04±1.13	7.04±1.13	NUM
cuesj-178	59	59	6.03±1.32	6.03±1.32	VERB
cuesj-178	59	60	0.000099	0.000099	NUM
cuesj-178	59	61	*	*	PUNCT
cuesj-178	59	62	lh	lh	PROPN
cuesj-178	59	63	(	(	PUNCT
cuesj-178	59	64	miu	miu	PROPN
cuesj-178	59	65	/	/	SYM
cuesj-178	59	66	ml	ml	PROPN
cuesj-178	59	67	)	)	PUNCT
cuesj-178	59	68	12.13±1.77	12.13±1.77	NUM
cuesj-178	59	69	5.88±1.2	5.88±1.2	NUM
cuesj-178	59	70	0.00001	0.00001	NUM
cuesj-178	59	71	*	*	PUNCT
cuesj-178	59	72	shbg	shbg	NOUN
cuesj-178	59	73	(	(	PUNCT
cuesj-178	59	74	nmol	nmol	NOUN
cuesj-178	59	75	/	/	SYM
cuesj-178	59	76	l	l	NOUN
cuesj-178	59	77	)	)	PUNCT
cuesj-178	60	1	30.25±2.51	30.25±2.51	PROPN
cuesj-178	61	1	54.12±4.3	54.12±4.3	NOUN
cuesj-178	61	2	0.00001	0.00001	NUM
cuesj-178	61	3	*	*	PUNCT
cuesj-178	61	4	dhea	dhea	PROPN
cuesj-178	61	5	-	-	PUNCT
cuesj-178	61	6	s	s	X
cuesj-178	61	7	(	(	PUNCT
cuesj-178	61	8	mg	mg	PROPN
cuesj-178	61	9	/	/	SYM
cuesj-178	61	10	ml	ml	NOUN
cuesj-178	61	11	)	)	PUNCT
cuesj-178	61	12	2.21±0.59	2.21±0.59	NUM
cuesj-178	61	13	0.95±0.3	0.95±0.3	NUM
cuesj-178	62	1	0.00001	0.00001	NUM
cuesj-178	62	2	*	*	NOUN
cuesj-178	62	3	total	total	ADJ
cuesj-178	62	4	testosterone	testosterone	NOUN
cuesj-178	62	5	(	(	PUNCT
cuesj-178	62	6	ng	ng	NOUN
cuesj-178	62	7	/	/	SYM
cuesj-178	62	8	ml	ml	NOUN
cuesj-178	62	9	)	)	PUNCT
cuesj-178	62	10	0.91±0.41	0.91±0.41	NOUN
cuesj-178	62	11	0.59±0.22	0.59±0.22	VERB
cuesj-178	62	12	0.000017	0.000017	NUM
cuesj-178	62	13	*	*	PUNCT
cuesj-178	62	14	free	free	ADJ
cuesj-178	62	15	testosterone	testosterone	NOUN
cuesj-178	62	16	(	(	PUNCT
cuesj-178	62	17	pg	pg	NOUN
cuesj-178	62	18	/	/	SYM
cuesj-178	62	19	ml	ml	NOUN
cuesj-178	62	20	)	)	PUNCT
cuesj-178	62	21	2.65±0.66	2.65±0.66	NUM
cuesj-178	62	22	1.064±0.26	1.064±0.26	NUM
cuesj-178	62	23	0.00001	0.00001	NUM
cuesj-178	62	24	*	*	NUM
cuesj-178	62	25	h	h	NOUN
cuesj-178	62	26	-	-	PUNCT
cuesj-178	62	27	crp	crp	NOUN
cuesj-178	62	28	(	(	PUNCT
cuesj-178	62	29	μg	μg	PROPN
cuesj-178	62	30	/	/	SYM
cuesj-178	62	31	ml	ml	NOUN
cuesj-178	62	32	)	)	PUNCT
cuesj-178	62	33	5.75±1.34	5.75±1.34	NOUN
cuesj-178	63	1	2.3±0.7	2.3±0.7	NUM
cuesj-178	63	2	0.00001	0.00001	NUM
cuesj-178	63	3	*	*	NOUN
cuesj-178	63	4	cholesterol	cholesterol	NOUN
cuesj-178	63	5	mg	mg	PROPN
cuesj-178	63	6	/	/	SYM
cuesj-178	63	7	dl	dl	PROPN
cuesj-178	63	8	172.6±49.9	172.6±49.9	ADJ
cuesj-178	63	9	166.0±27.3	166.0±27.3	PROPN
cuesj-178	63	10	0.254423	0.254423	NUM
cuesj-178	63	11	ns	ns	NUM
cuesj-178	63	12	triglyceride	triglyceride	ADJ
cuesj-178	63	13	(	(	PUNCT
cuesj-178	63	14	mg	mg	PROPN
cuesj-178	63	15	/	/	SYM
cuesj-178	63	16	dl	dl	PROPN
cuesj-178	63	17	)	)	PUNCT
cuesj-178	63	18	155.86±34.69	155.86±34.69	NUM
cuesj-178	63	19	103.0±32.2	103.0±32.2	ADJ
cuesj-178	63	20	0.00001	0.00001	NUM
cuesj-178	63	21	*	*	SYM
cuesj-178	63	22	hdl	hdl	X
cuesj-178	63	23	(	(	PUNCT
cuesj-178	63	24	mg	mg	PROPN
cuesj-178	63	25	/	/	SYM
cuesj-178	63	26	dl	dl	NOUN
cuesj-178	63	27	)	)	PUNCT
cuesj-178	63	28	39.14±10.09	39.14±10.09	NUM
cuesj-178	63	29	39.92±7.15	39.92±7.15	NUM
cuesj-178	63	30	0.347843	0.347843	NUM
cuesj-178	63	31	ns	ns	NUM
cuesj-178	63	32	ldl	ldl	NOUN
cuesj-178	63	33	(	(	PUNCT
cuesj-178	63	34	mg	mg	PROPN
cuesj-178	63	35	/	/	SYM
cuesj-178	63	36	dl	dl	PROPN
cuesj-178	63	37	)	)	PUNCT
cuesj-178	63	38	103.42±36.31	103.42±36.31	NUM
cuesj-178	63	39	101.9±24.2	101.9±24.2	NUM
cuesj-178	63	40	0.413274	0.413274	NUM
cuesj-178	63	41	ns	ns	NUM
cuesj-178	63	42	*	*	NOUN
cuesj-178	63	43	(	(	PUNCT
cuesj-178	63	44	p<0.05	p<0.05	NOUN
cuesj-178	63	45	)	)	PUNCT
cuesj-178	63	46	,	,	PUNCT
cuesj-178	63	47	*	*	PUNCT
cuesj-178	63	48	*	*	PUNCT
cuesj-178	63	49	(	(	PUNCT
cuesj-178	63	50	p<0.01	p<0.01	PROPN
cuesj-178	63	51	)	)	PUNCT
cuesj-178	63	52	,	,	PUNCT
cuesj-178	63	53	ns	ns	NUM
cuesj-178	63	54	:	:	PUNCT
cuesj-178	63	55	non	non	ADJ
cuesj-178	63	56	-	-	ADJ
cuesj-178	63	57	significant	significant	ADJ
cuesj-178	63	58	.	.	PUNCT
cuesj-178	64	1	pcos	pco	NOUN
cuesj-178	64	2	:	:	PUNCT
cuesj-178	64	3	polycystic	polycystic	ADJ
cuesj-178	64	4	ovary	ovary	ADJ
cuesj-178	64	5	syndrome	syndrome	NOUN
cuesj-178	64	6	,	,	PUNCT
cuesj-178	64	7	bmi	bmi	PROPN
cuesj-178	64	8	:	:	PUNCT
cuesj-178	64	9	body	body	NOUN
cuesj-178	64	10	mass	mass	PROPN
cuesj-178	64	11	index	index	PROPN
cuesj-178	64	12	,	,	PUNCT
cuesj-178	64	13	tgf	tgf	PROPN
cuesj-178	64	14	:	:	PUNCT
cuesj-178	64	15	transforming	transform	VERB
cuesj-178	64	16	growth	growth	NOUN
cuesj-178	64	17	factor	factor	NOUN
cuesj-178	64	18	,	,	PUNCT
cuesj-178	64	19	homa	homa	NOUN
cuesj-178	64	20	:	:	PUNCT
cuesj-178	64	21	homeostatic	homeostatic	ADJ
cuesj-178	64	22	model	model	NOUN
cuesj-178	64	23	assessment	assessment	NOUN
cuesj-178	64	24	,	,	PUNCT
cuesj-178	64	25	fsh	fsh	PROPN
cuesj-178	64	26	:	:	PUNCT
cuesj-178	64	27	follicle	follicle	NOUN
cuesj-178	64	28	-	-	PUNCT
cuesj-178	64	29	stimulating	stimulate	VERB
cuesj-178	64	30	hormone	hormone	NOUN
cuesj-178	64	31	,	,	PUNCT
cuesj-178	64	32	lh	lh	PROPN
cuesj-178	64	33	:	:	PUNCT
cuesj-178	64	34	luteinizing	luteinize	VERB
cuesj-178	64	35	hormone	hormone	NOUN
cuesj-178	64	36	,	,	PUNCT
cuesj-178	64	37	shbg	shbg	NOUN
cuesj-178	64	38	:	:	PUNCT
cuesj-178	64	39	sex	sex	NOUN
cuesj-178	64	40	hormone	hormone	NOUN
cuesj-178	64	41	-	-	PUNCT
cuesj-178	64	42	binding	bind	VERB
cuesj-178	64	43	globulin	globulin	NOUN
cuesj-178	64	44	,	,	PUNCT
cuesj-178	64	45	dhea	dhea	PROPN
cuesj-178	64	46	:	:	PUNCT
cuesj-178	64	47	dehydroepiandrosterone	dehydroepiandrosterone	PROPN
cuesj-178	64	48	,	,	PUNCT
cuesj-178	64	49	h	h	NOUN
cuesj-178	64	50	-	-	PUNCT
cuesj-178	64	51	crp	crp	NOUN
cuesj-178	64	52	:	:	PUNCT
cuesj-178	64	53	high	high	ADJ
cuesj-178	64	54	sensitivity	sensitivity	NOUN
cuesj-178	64	55	c	c	NOUN
cuesj-178	64	56	-	-	PUNCT
cuesj-178	64	57	reactive	reactive	ADJ
cuesj-178	64	58	protein	protein	NOUN
cuesj-178	64	59	,	,	PUNCT
cuesj-178	64	60	hdl	hdl	NOUN
cuesj-178	64	61	:	:	PUNCT
cuesj-178	64	62	high	high	ADJ
cuesj-178	64	63	-	-	PUNCT
cuesj-178	64	64	density	density	NOUN
cuesj-178	64	65	lipoprotein	lipoprotein	ADJ
cuesj-178	64	66	,	,	PUNCT
cuesj-178	64	67	ldl	ldl	NOUN
cuesj-178	64	68	:	:	PUNCT
cuesj-178	64	69	low	low	ADJ
cuesj-178	64	70	-	-	PUNCT
cuesj-178	64	71	density	density	NOUN
cuesj-178	64	72	lipoprotein	lipoprotein	ADJ
cuesj-178	64	73	table	table	NOUN
cuesj-178	64	74	1	1	NUM
cuesj-178	64	75	:	:	PUNCT
cuesj-178	64	76	(	(	PUNCT
cuesj-178	64	77	continued	continued	ADJ
cuesj-178	64	78	)	)	PUNCT
cuesj-178	64	79	ibrahim	ibrahim	PROPN
cuesj-178	64	80	,	,	PUNCT
cuesj-178	64	81	et	et	PROPN
cuesj-178	64	82	al	al	PROPN
cuesj-178	64	83	.	.	PUNCT
cuesj-178	64	84	:	:	PUNCT
cuesj-178	65	1	apelin	apelin	PROPN
cuesj-178	65	2	,	,	PUNCT
cuesj-178	65	3	endoglin	endoglin	PROPN
cuesj-178	65	4	,	,	PUNCT
cuesj-178	65	5	and	and	CCONJ
cuesj-178	65	6	tgf	tgf	PROPN
cuesj-178	65	7	-	-	PUNCT
cuesj-178	65	8	β1	β1	PROPN
cuesj-178	65	9	in	in	ADP
cuesj-178	65	10	polycystic	polycystic	ADJ
cuesj-178	65	11	ovary	ovary	ADJ
cuesj-178	65	12	syndrome	syndrome	NOUN
cuesj-178	65	13	24	24	NUM
cuesj-178	65	14	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-178	65	15	cuesj	cuesj	NOUN
cuesj-178	65	16	2020	2020	NUM
cuesj-178	65	17	,	,	PUNCT
cuesj-178	65	18	4	4	NUM
cuesj-178	65	19	(	(	PUNCT
cuesj-178	65	20	1	1	NUM
cuesj-178	65	21	):	):	PUNCT
cuesj-178	65	22	21	21	NUM
cuesj-178	65	23	-	-	SYM
cuesj-178	65	24	25	25	NUM
cuesj-178	65	25	discussion	discussion	NOUN
cuesj-178	65	26	pcos	pcos	NOUN
cuesj-178	65	27	is	be	AUX
cuesj-178	65	28	one	one	NUM
cuesj-178	65	29	of	of	ADP
cuesj-178	65	30	the	the	DET
cuesj-178	65	31	most	most	ADV
cuesj-178	65	32	common	common	ADJ
cuesj-178	65	33	causes	cause	NOUN
cuesj-178	65	34	of	of	ADP
cuesj-178	65	35	infertility	infertility	NOUN
cuesj-178	65	36	in	in	ADP
cuesj-178	65	37	women	woman	NOUN
cuesj-178	65	38	of	of	ADP
cuesj-178	65	39	reproductive	reproductive	ADJ
cuesj-178	65	40	age	age	NOUN
cuesj-178	65	41	.	.	PUNCT
cuesj-178	66	1	ir	ir	PROPN
cuesj-178	66	2	is	be	AUX
cuesj-178	66	3	a	a	DET
cuesj-178	66	4	main	main	ADJ
cuesj-178	66	5	pathophysiologic	pathophysiologic	ADJ
cuesj-178	66	6	feature	feature	NOUN
cuesj-178	66	7	in	in	ADP
cuesj-178	66	8	these	these	DET
cuesj-178	66	9	patients.[2	patients.[2	NOUN
cuesj-178	66	10	]	]	X
cuesj-178	66	11	apelin	apelin	PROPN
cuesj-178	66	12	(	(	PUNCT
cuesj-178	66	13	apln	apln	PROPN
cuesj-178	66	14	)	)	PUNCT
cuesj-178	66	15	is	be	AUX
cuesj-178	66	16	a	a	DET
cuesj-178	66	17	recently	recently	ADV
cuesj-178	66	18	discovered	discover	VERB
cuesj-178	66	19	adipokine	adipokine	NOUN
cuesj-178	66	20	involved	involve	VERB
cuesj-178	66	21	in	in	ADP
cuesj-178	66	22	the	the	DET
cuesj-178	66	23	regulation	regulation	NOUN
cuesj-178	66	24	of	of	ADP
cuesj-178	66	25	various	various	ADJ
cuesj-178	66	26	metabolic	metabolic	NOUN
cuesj-178	66	27	functions	function	NOUN
cuesj-178	66	28	.	.	PUNCT
cuesj-178	67	1	its	its	PRON
cuesj-178	67	2	receptor	receptor	NOUN
cuesj-178	67	3	,	,	PUNCT
cuesj-178	67	4	aplnr	aplnr	PROPN
cuesj-178	67	5	,	,	PUNCT
cuesj-178	67	6	is	be	AUX
cuesj-178	67	7	expressed	express	VERB
cuesj-178	67	8	in	in	ADP
cuesj-178	67	9	reproductive	reproductive	ADJ
cuesj-178	67	10	tissues	tissue	NOUN
cuesj-178	67	11	;	;	PUNCT
cuesj-178	67	12	however	however	ADV
cuesj-178	67	13	,	,	PUNCT
cuesj-178	67	14	its	its	PRON
cuesj-178	67	15	role	role	NOUN
cuesj-178	67	16	in	in	ADP
cuesj-178	67	17	human	human	ADJ
cuesj-178	67	18	ovarian	ovarian	ADJ
cuesj-178	67	19	cells	cell	NOUN
cuesj-178	67	20	is	be	AUX
cuesj-178	67	21	unknown	unknown	ADJ
cuesj-178	67	22	.	.	PUNCT
cuesj-178	68	1	pcos	pcos	NOUN
cuesj-178	68	2	patients	patient	NOUN
cuesj-178	68	3	are	be	AUX
cuesj-178	68	4	more	more	ADV
cuesj-178	68	5	vulnerable	vulnerable	ADJ
cuesj-178	68	6	to	to	PART
cuesj-178	68	7	develop	develop	VERB
cuesj-178	68	8	diabetes	diabetes	NOUN
cuesj-178	68	9	,	,	PUNCT
cuesj-178	68	10	cardiovascular	cardiovascular	ADJ
cuesj-178	68	11	diseases	disease	NOUN
cuesj-178	68	12	,	,	PUNCT
cuesj-178	68	13	and	and	CCONJ
cuesj-178	68	14	metabolic	metabolic	PROPN
cuesj-178	68	15	syndrome.[3	syndrome.[3	PROPN
cuesj-178	68	16	]	]	X
cuesj-178	68	17	ir	ir	PROPN
cuesj-178	68	18	is	be	AUX
cuesj-178	68	19	prevalent	prevalent	ADJ
cuesj-178	68	20	in	in	ADP
cuesj-178	68	21	women	woman	NOUN
cuesj-178	68	22	with	with	ADP
cuesj-178	68	23	pcos	pcos	PROPN
cuesj-178	68	24	independently	independently	ADV
cuesj-178	68	25	of	of	ADP
cuesj-178	68	26	obesity	obesity	NOUN
cuesj-178	68	27	and	and	CCONJ
cuesj-178	68	28	is	be	AUX
cuesj-178	68	29	critically	critically	ADV
cuesj-178	68	30	involved	involve	VERB
cuesj-178	68	31	in	in	ADP
cuesj-178	68	32	reproductive	reproductive	ADJ
cuesj-178	68	33	and	and	CCONJ
cuesj-178	68	34	metabolic	metabolic	NOUN
cuesj-178	68	35	complications	complication	NOUN
cuesj-178	68	36	of	of	ADP
cuesj-178	68	37	the	the	DET
cuesj-178	68	38	syndrome.[10	syndrome.[10	NOUN
cuesj-178	68	39	]	]	PUNCT
cuesj-178	68	40	several	several	ADJ
cuesj-178	68	41	tests	test	NOUN
cuesj-178	68	42	have	have	AUX
cuesj-178	68	43	been	be	AUX
cuesj-178	68	44	developed	develop	VERB
cuesj-178	68	45	to	to	PART
cuesj-178	68	46	measure	measure	VERB
cuesj-178	68	47	ir	ir	PROPN
cuesj-178	68	48	,	,	PUNCT
cuesj-178	68	49	some	some	PRON
cuesj-178	68	50	very	very	ADV
cuesj-178	68	51	reliable	reliable	ADJ
cuesj-178	68	52	but	but	CCONJ
cuesj-178	68	53	complex	complex	ADJ
cuesj-178	68	54	like	like	ADP
cuesj-178	68	55	the	the	DET
cuesj-178	68	56	hyperinsulinemic	hyperinsulinemic	ADJ
cuesj-178	68	57	euglycemic	euglycemic	ADJ
cuesj-178	68	58	glucose	glucose	NOUN
cuesj-178	68	59	clamp	clamp	NOUN
cuesj-178	68	60	and	and	CCONJ
cuesj-178	68	61	others	other	NOUN
cuesj-178	68	62	less	less	ADV
cuesj-178	68	63	precise	precise	ADJ
cuesj-178	68	64	but	but	CCONJ
cuesj-178	68	65	easier	easy	ADJ
cuesj-178	68	66	and	and	CCONJ
cuesj-178	68	67	less	less	ADV
cuesj-178	68	68	invasive	invasive	ADJ
cuesj-178	68	69	like	like	ADP
cuesj-178	68	70	homa	homa	NOUN
cuesj-178	68	71	-	-	PUNCT
cuesj-178	68	72	ir.[22	ir.[22	NOUN
cuesj-178	68	73	]	]	X
cuesj-178	68	74	new	new	ADJ
cuesj-178	68	75	markers	marker	NOUN
cuesj-178	68	76	are	be	AUX
cuesj-178	68	77	needed	need	VERB
cuesj-178	68	78	to	to	PART
cuesj-178	68	79	reach	reach	VERB
cuesj-178	68	80	a	a	DET
cuesj-178	68	81	more	more	ADV
cuesj-178	68	82	reliable	reliable	ADJ
cuesj-178	68	83	assessment	assessment	NOUN
cuesj-178	68	84	of	of	ADP
cuesj-178	68	85	ir	ir	PROPN
cuesj-178	68	86	.	.	PROPN
cuesj-178	68	87	to	to	ADP
cuesj-178	68	88	date	date	NOUN
cuesj-178	68	89	,	,	PUNCT
cuesj-178	68	90	several	several	ADJ
cuesj-178	68	91	surrogate	surrogate	ADJ
cuesj-178	68	92	markers	marker	NOUN
cuesj-178	68	93	have	have	AUX
cuesj-178	68	94	been	be	AUX
cuesj-178	68	95	proposed	propose	VERB
cuesj-178	68	96	in	in	ADP
cuesj-178	68	97	literature	literature	NOUN
cuesj-178	68	98	to	to	PART
cuesj-178	68	99	facilitate	facilitate	VERB
cuesj-178	68	100	and	and	CCONJ
cuesj-178	68	101	improve	improve	VERB
cuesj-178	68	102	the	the	DET
cuesj-178	68	103	determination	determination	NOUN
cuesj-178	68	104	of	of	ADP
cuesj-178	68	105	ir	ir	PROPN
cuesj-178	68	106	.	.	PUNCT
cuesj-178	69	1	many	many	ADJ
cuesj-178	69	2	new	new	ADJ
cuesj-178	69	3	proteins	protein	NOUN
cuesj-178	69	4	are	be	AUX
cuesj-178	69	5	strongly	strongly	ADV
cuesj-178	69	6	involved	involve	VERB
cuesj-178	69	7	with	with	ADP
cuesj-178	69	8	pcos	pcos	PROPN
cuesj-178	69	9	physiopathology	physiopathology	NOUN
cuesj-178	69	10	and	and	CCONJ
cuesj-178	69	11	ir	ir	PROPN
cuesj-178	69	12	such	such	ADJ
cuesj-178	69	13	as	as	ADP
cuesj-178	69	14	some	some	DET
cuesj-178	69	15	adipocytokines	adipocytokine	NOUN
cuesj-178	69	16	(	(	PUNCT
cuesj-178	69	17	adiponectin	adiponectin	NOUN
cuesj-178	69	18	,	,	PUNCT
cuesj-178	69	19	visfatin	visfatin	NOUN
cuesj-178	69	20	,	,	PUNCT
cuesj-178	69	21	vaspin	vaspin	NOUN
cuesj-178	69	22	,	,	PUNCT
cuesj-178	69	23	and	and	CCONJ
cuesj-178	69	24	apelin	apelin	PROPN
cuesj-178	69	25	)	)	PUNCT
cuesj-178	69	26	,	,	PUNCT
cuesj-178	69	27	copeptin	copeptin	NOUN
cuesj-178	69	28	,	,	PUNCT
cuesj-178	69	29	irisin	irisin	NOUN
cuesj-178	69	30	,	,	PUNCT
cuesj-178	69	31	pai-1	pai-1	X
cuesj-178	69	32	,	,	PUNCT
cuesj-178	69	33	and	and	CCONJ
cuesj-178	69	34	zonulin	zonulin	NOUN
cuesj-178	69	35	.	.	PUNCT
cuesj-178	70	1	many	many	ADJ
cuesj-178	70	2	other	other	ADJ
cuesj-178	70	3	proteins	protein	NOUN
cuesj-178	70	4	have	have	AUX
cuesj-178	70	5	been	be	AUX
cuesj-178	70	6	proposed	propose	VERB
cuesj-178	70	7	as	as	ADP
cuesj-178	70	8	potential	potential	ADJ
cuesj-178	70	9	new	new	ADJ
cuesj-178	70	10	markers	marker	NOUN
cuesj-178	70	11	of	of	ADP
cuesj-178	70	12	ir	ir	PROPN
cuesj-178	70	13	in	in	ADP
cuesj-178	70	14	pcos	pcos	PROPN
cuesj-178	70	15	such	such	ADJ
cuesj-178	70	16	as	as	ADP
cuesj-178	70	17	resistin	resistin	NOUN
cuesj-178	70	18	,	,	PUNCT
cuesj-178	70	19	leptin	leptin	NOUN
cuesj-178	70	20	,	,	PUNCT
cuesj-178	70	21	retinol	retinol	NOUN
cuesj-178	70	22	-	-	PUNCT
cuesj-178	70	23	binding	bind	VERB
cuesj-178	70	24	protein	protein	NOUN
cuesj-178	70	25	4	4	NUM
cuesj-178	70	26	(	(	PUNCT
cuesj-178	70	27	rbp4	rbp4	PROPN
cuesj-178	70	28	)	)	PUNCT
cuesj-178	70	29	,	,	PUNCT
cuesj-178	70	30	kisspeptin	kisspeptin	NOUN
cuesj-178	70	31	,	,	PUNCT
cuesj-178	70	32	and	and	CCONJ
cuesj-178	70	33	ghrelin	ghrelin	NOUN
cuesj-178	70	34	,	,	PUNCT
cuesj-178	70	35	but	but	CCONJ
cuesj-178	70	36	their	their	PRON
cuesj-178	70	37	role	role	NOUN
cuesj-178	70	38	is	be	AUX
cuesj-178	70	39	still	still	ADV
cuesj-178	70	40	controversial.[14	controversial.[14	ADJ
cuesj-178	70	41	]	]	PUNCT
cuesj-178	70	42	adipose	adipose	ADP
cuesj-178	70	43	tissue	tissue	NOUN
cuesj-178	70	44	is	be	AUX
cuesj-178	70	45	implicated	implicate	VERB
cuesj-178	70	46	in	in	ADP
cuesj-178	70	47	the	the	DET
cuesj-178	70	48	secretion	secretion	NOUN
cuesj-178	70	49	of	of	ADP
cuesj-178	70	50	several	several	ADJ
cuesj-178	70	51	hormones	hormone	NOUN
cuesj-178	70	52	such	such	ADJ
cuesj-178	70	53	as	as	ADP
cuesj-178	70	54	adiponectin	adiponectin	NOUN
cuesj-178	70	55	,	,	PUNCT
cuesj-178	70	56	resistin	resistin	NOUN
cuesj-178	70	57	,	,	PUNCT
cuesj-178	70	58	leptin	leptin	NOUN
cuesj-178	70	59	,	,	PUNCT
cuesj-178	70	60	visfatin	visfatin	NOUN
cuesj-178	70	61	,	,	PUNCT
cuesj-178	70	62	apelin	apelin	PROPN
cuesj-178	70	63	,	,	PUNCT
cuesj-178	70	64	and	and	CCONJ
cuesj-178	70	65	rbp4	rbp4	NOUN
cuesj-178	70	66	called	call	VERB
cuesj-178	70	67	adipocytokines	adipocytokine	NOUN
cuesj-178	70	68	that	that	PRON
cuesj-178	70	69	are	be	AUX
cuesj-178	70	70	involved	involve	VERB
cuesj-178	70	71	in	in	ADP
cuesj-178	70	72	energy	energy	NOUN
cuesj-178	70	73	homeostasis	homeostasis	NOUN
cuesj-178	70	74	and	and	CCONJ
cuesj-178	70	75	metabolism.[11	metabolism.[11	PROPN
cuesj-178	70	76	]	]	PUNCT
cuesj-178	70	77	apelin	apelin	PROPN
cuesj-178	70	78	is	be	AUX
cuesj-178	70	79	a	a	DET
cuesj-178	70	80	peptide	peptide	NOUN
cuesj-178	70	81	isolated	isolate	VERB
cuesj-178	70	82	from	from	ADP
cuesj-178	70	83	bovine	bovine	ADJ
cuesj-178	70	84	stomachs	stomach	NOUN
cuesj-178	70	85	,	,	PUNCT
cuesj-178	70	86	but	but	CCONJ
cuesj-178	70	87	it	it	PRON
cuesj-178	70	88	is	be	AUX
cuesj-178	70	89	expressed	express	VERB
cuesj-178	70	90	in	in	ADP
cuesj-178	70	91	several	several	ADJ
cuesj-178	70	92	other	other	ADJ
cuesj-178	70	93	organs	organ	NOUN
cuesj-178	70	94	and	and	CCONJ
cuesj-178	70	95	also	also	ADV
cuesj-178	70	96	in	in	ADP
cuesj-178	70	97	visceral	visceral	ADJ
cuesj-178	70	98	and	and	CCONJ
cuesj-178	70	99	subcutaneous	subcutaneous	ADJ
cuesj-178	70	100	tissues.[4	tissues.[4	NOUN
cuesj-178	70	101	]	]	PUNCT
cuesj-178	70	102	in	in	ADP
cuesj-178	70	103	our	our	PRON
cuesj-178	70	104	present	present	ADJ
cuesj-178	70	105	study	study	NOUN
cuesj-178	70	106	,	,	PUNCT
cuesj-178	70	107	however	however	ADV
cuesj-178	70	108	,	,	PUNCT
cuesj-178	70	109	serum	serum	PROPN
cuesj-178	70	110	apelin	apelin	PROPN
cuesj-178	70	111	levels	level	NOUN
cuesj-178	70	112	are	be	AUX
cuesj-178	70	113	significantly	significantly	ADV
cuesj-178	70	114	higher	high	ADJ
cuesj-178	70	115	in	in	ADP
cuesj-178	70	116	pcos	pcos	ADJ
cuesj-178	70	117	women	woman	NOUN
cuesj-178	70	118	compared	compare	VERB
cuesj-178	70	119	with	with	ADP
cuesj-178	70	120	controls	control	NOUN
cuesj-178	70	121	.	.	PUNCT
cuesj-178	71	1	moreover	moreover	ADV
cuesj-178	71	2	,	,	PUNCT
cuesj-178	71	3	we	we	PRON
cuesj-178	71	4	also	also	ADV
cuesj-178	71	5	observed	observe	VERB
cuesj-178	71	6	that	that	SCONJ
cuesj-178	71	7	apelin	apelin	PROPN
cuesj-178	71	8	level	level	NOUN
cuesj-178	71	9	is	be	AUX
cuesj-178	71	10	significantly	significantly	ADV
cuesj-178	71	11	and	and	CCONJ
cuesj-178	71	12	positively	positively	ADV
cuesj-178	71	13	correlated	correlate	VERB
cuesj-178	71	14	with	with	ADP
cuesj-178	71	15	bmi	bmi	NOUN
cuesj-178	71	16	and	and	CCONJ
cuesj-178	71	17	homa	homa	PROPN
cuesj-178	71	18	-	-	PUNCT
cuesj-178	71	19	ir	ir	PROPN
cuesj-178	71	20	.	.	PUNCT
cuesj-178	72	1	apelin	apelin	PROPN
cuesj-178	72	2	was	be	AUX
cuesj-178	72	3	found	find	VERB
cuesj-178	72	4	to	to	PART
cuesj-178	72	5	be	be	AUX
cuesj-178	72	6	higher	high	ADJ
cuesj-178	72	7	in	in	ADP
cuesj-178	72	8	pcos	pcos	ADJ
cuesj-178	72	9	patients	patient	NOUN
cuesj-178	72	10	by	by	ADP
cuesj-178	72	11	gören	gören	PROPN
cuesj-178	72	12	et	et	PROPN
cuesj-178	72	13	al.[23	al.[23	PROPN
cuesj-178	72	14	]	]	PUNCT
cuesj-178	72	15	but	but	CCONJ
cuesj-178	72	16	without	without	ADP
cuesj-178	72	17	a	a	DET
cuesj-178	72	18	significant	significant	ADJ
cuesj-178	72	19	correlation	correlation	NOUN
cuesj-178	72	20	with	with	ADP
cuesj-178	72	21	homa	homa	NOUN
cuesj-178	72	22	-	-	PUNCT
cuesj-178	72	23	ir	ir	PROPN
cuesj-178	72	24	.	.	PUNCT
cuesj-178	73	1	olszanecka	olszanecka	NOUN
cuesj-178	73	2	-	-	PUNCT
cuesj-178	73	3	glinianowicz	glinianowicz	PROPN
cuesj-178	73	4	et	et	NOUN
cuesj-178	73	5	al.[18	al.[18	PROPN
cuesj-178	73	6	]	]	PUNCT
cuesj-178	73	7	reported	report	VERB
cuesj-178	73	8	an	an	DET
cuesj-178	73	9	inverse	inverse	NOUN
cuesj-178	73	10	association	association	NOUN
cuesj-178	73	11	between	between	ADP
cuesj-178	73	12	apelin	apelin	PROPN
cuesj-178	73	13	and	and	CCONJ
cuesj-178	73	14	glucose	glucose	NOUN
cuesj-178	73	15	,	,	PUNCT
cuesj-178	73	16	insulin	insulin	NOUN
cuesj-178	73	17	,	,	PUNCT
cuesj-178	73	18	and	and	CCONJ
cuesj-178	73	19	homa	homa	PROPN
cuesj-178	73	20	-	-	PUNCT
cuesj-178	73	21	ir	ir	PROPN
cuesj-178	73	22	values	value	NOUN
cuesj-178	73	23	,	,	PUNCT
cuesj-178	73	24	supporting	support	VERB
cuesj-178	73	25	the	the	DET
cuesj-178	73	26	role	role	NOUN
cuesj-178	73	27	of	of	ADP
cuesj-178	73	28	apelin	apelin	PROPN
cuesj-178	73	29	in	in	ADP
cuesj-178	73	30	the	the	DET
cuesj-178	73	31	regulation	regulation	NOUN
cuesj-178	73	32	of	of	ADP
cuesj-178	73	33	insulin	insulin	NOUN
cuesj-178	73	34	sensitivity	sensitivity	NOUN
cuesj-178	73	35	.	.	PUNCT
cuesj-178	74	1	apelin	apelin	PROPN
cuesj-178	74	2	levels	level	NOUN
cuesj-178	74	3	were	be	AUX
cuesj-178	74	4	higher	high	ADJ
cuesj-178	74	5	in	in	ADP
cuesj-178	74	6	non	non	ADJ
cuesj-178	74	7	-	-	ADJ
cuesj-178	74	8	obese	obese	ADJ
cuesj-178	74	9	pcos	pcos	NOUN
cuesj-178	74	10	patients	patient	NOUN
cuesj-178	74	11	,	,	PUNCT
cuesj-178	74	12	suggesting	suggest	VERB
cuesj-178	74	13	a	a	DET
cuesj-178	74	14	compensatory	compensatory	ADJ
cuesj-178	74	15	mechanism	mechanism	NOUN
cuesj-178	74	16	for	for	ADP
cuesj-178	74	17	metabolic	metabolic	NOUN
cuesj-178	74	18	consequences	consequence	NOUN
cuesj-178	74	19	of	of	ADP
cuesj-178	74	20	ir	ir	PROPN
cuesj-178	74	21	.	.	PUNCT
cuesj-178	74	22	lower	low	ADJ
cuesj-178	74	23	serum	serum	NOUN
cuesj-178	74	24	concentrations	concentration	NOUN
cuesj-178	74	25	of	of	ADP
cuesj-178	74	26	apelin	apelin	PROPN
cuesj-178	74	27	were	be	AUX
cuesj-178	74	28	found	find	VERB
cuesj-178	74	29	in	in	ADP
cuesj-178	74	30	pcos	pcos	NOUN
cuesj-178	74	31	subjects	subject	NOUN
cuesj-178	74	32	by	by	ADP
cuesj-178	74	33	altinkaya	altinkaya	PROPN
cuesj-178	74	34	et	et	NOUN
cuesj-178	74	35	al.[19	al.[19	PROPN
cuesj-178	74	36	]	]	PUNCT
cuesj-178	74	37	with	with	ADP
cuesj-178	74	38	positive	positive	ADJ
cuesj-178	74	39	correlation	correlation	NOUN
cuesj-178	74	40	with	with	ADP
cuesj-178	74	41	bmi	bmi	NOUN
cuesj-178	74	42	,	,	PUNCT
cuesj-178	74	43	insulin	insulin	NOUN
cuesj-178	74	44	,	,	PUNCT
cuesj-178	74	45	homa	homa	NOUN
cuesj-178	74	46	-	-	PUNCT
cuesj-178	74	47	ir	ir	PROPN
cuesj-178	74	48	,	,	PUNCT
cuesj-178	74	49	tg	tg	PROPN
cuesj-178	74	50	,	,	PUNCT
cuesj-178	74	51	and	and	CCONJ
cuesj-178	74	52	free	free	ADJ
cuesj-178	74	53	testosterone	testosterone	NOUN
cuesj-178	74	54	,	,	PUNCT
cuesj-178	74	55	speculating	speculate	VERB
cuesj-178	74	56	that	that	SCONJ
cuesj-178	74	57	apelin	apelin	PROPN
cuesj-178	74	58	can	can	AUX
cuesj-178	74	59	be	be	AUX
cuesj-178	74	60	used	use	VERB
cuesj-178	74	61	as	as	ADP
cuesj-178	74	62	a	a	DET
cuesj-178	74	63	marker	marker	NOUN
cuesj-178	74	64	for	for	ADP
cuesj-178	74	65	insulin	insulin	NOUN
cuesj-178	74	66	sensitivity	sensitivity	NOUN
cuesj-178	74	67	.	.	PUNCT
cuesj-178	75	1	conversely	conversely	ADV
cuesj-178	75	2	,	,	PUNCT
cuesj-178	75	3	sun	sun	NOUN
cuesj-178	75	4	et	et	NOUN
cuesj-178	75	5	al.[20	al.[20	NOUN
cuesj-178	75	6	]	]	PUNCT
cuesj-178	75	7	observed	observe	VERB
cuesj-178	75	8	significantly	significantly	ADV
cuesj-178	75	9	enhanced	enhance	VERB
cuesj-178	75	10	apelin	apelin	PROPN
cuesj-178	75	11	concentration	concentration	NOUN
cuesj-178	75	12	in	in	ADP
cuesj-178	75	13	pcos	pcos	PROPN
cuesj-178	75	14	patients	patient	NOUN
cuesj-178	75	15	with	with	ADP
cuesj-178	75	16	positive	positive	ADJ
cuesj-178	75	17	association	association	NOUN
cuesj-178	75	18	with	with	ADP
cuesj-178	75	19	bmi	bmi	NOUN
cuesj-178	75	20	and	and	CCONJ
cuesj-178	75	21	homa	homa	PROPN
cuesj-178	75	22	-	-	PUNCT
cuesj-178	75	23	ir	ir	PROPN
cuesj-178	75	24	;	;	PUNCT
cuesj-178	75	25	treatment	treatment	NOUN
cuesj-178	75	26	with	with	ADP
cuesj-178	75	27	drospirenone	drospirenone	NOUN
cuesj-178	75	28	-	-	PUNCT
cuesj-178	75	29	ethinylestradiol	ethinylestradiol	NOUN
cuesj-178	75	30	plus	plus	CCONJ
cuesj-178	75	31	metformin	metformin	NOUN
cuesj-178	75	32	improved	improve	VERB
cuesj-178	75	33	ir	ir	PROPN
cuesj-178	75	34	and	and	CCONJ
cuesj-178	75	35	apelin	apelin	PROPN
cuesj-178	75	36	levels	level	NOUN
cuesj-178	75	37	.	.	PUNCT
cuesj-178	76	1	discrepant	discrepant	PROPN
cuesj-178	76	2	findings	finding	NOUN
cuesj-178	76	3	among	among	ADP
cuesj-178	76	4	the	the	DET
cuesj-178	76	5	published	publish	VERB
cuesj-178	76	6	studies	study	NOUN
cuesj-178	76	7	may	may	AUX
cuesj-178	76	8	be	be	AUX
cuesj-178	76	9	attributed	attribute	VERB
cuesj-178	76	10	to	to	ADP
cuesj-178	76	11	the	the	DET
cuesj-178	76	12	differences	difference	NOUN
cuesj-178	76	13	in	in	ADP
cuesj-178	76	14	ethnicity	ethnicity	NOUN
cuesj-178	76	15	,	,	PUNCT
cuesj-178	76	16	age	age	NOUN
cuesj-178	76	17	,	,	PUNCT
cuesj-178	76	18	study	study	NOUN
cuesj-178	76	19	design	design	NOUN
cuesj-178	76	20	,	,	PUNCT
cuesj-178	76	21	sample	sample	NOUN
cuesj-178	76	22	size	size	NOUN
cuesj-178	76	23	,	,	PUNCT
cuesj-178	76	24	genetic	genetic	ADJ
cuesj-178	76	25	characteristics	characteristic	NOUN
cuesj-178	76	26	of	of	ADP
cuesj-178	76	27	populations	population	NOUN
cuesj-178	76	28	,	,	PUNCT
cuesj-178	76	29	and	and	CCONJ
cuesj-178	76	30	assessment	assessment	NOUN
cuesj-178	76	31	methodology	methodology	NOUN
cuesj-178	76	32	.	.	PUNCT
cuesj-178	77	1	the	the	DET
cuesj-178	77	2	increase	increase	NOUN
cuesj-178	77	3	of	of	ADP
cuesj-178	77	4	lh	lh	ADJ
cuesj-178	77	5	level	level	NOUN
cuesj-178	77	6	probably	probably	ADV
cuesj-178	77	7	plays	play	VERB
cuesj-178	77	8	an	an	DET
cuesj-178	77	9	important	important	ADJ
cuesj-178	77	10	role	role	NOUN
cuesj-178	77	11	in	in	ADP
cuesj-178	77	12	the	the	DET
cuesj-178	77	13	pathological	pathological	ADJ
cuesj-178	77	14	mechanism	mechanism	NOUN
cuesj-178	77	15	of	of	ADP
cuesj-178	77	16	the	the	DET
cuesj-178	77	17	higher	high	ADJ
cuesj-178	77	18	androgens	androgens	NOUN
cuesj-178	77	19	production	production	NOUN
cuesj-178	77	20	in	in	ADP
cuesj-178	77	21	the	the	DET
cuesj-178	77	22	ovaries	ovary	NOUN
cuesj-178	77	23	,	,	PUNCT
cuesj-178	77	24	which	which	PRON
cuesj-178	77	25	can	can	AUX
cuesj-178	77	26	interfere	interfere	VERB
cuesj-178	77	27	with	with	ADP
cuesj-178	77	28	the	the	DET
cuesj-178	77	29	maturation	maturation	NOUN
cuesj-178	77	30	of	of	ADP
cuesj-178	77	31	the	the	DET
cuesj-178	77	32	oocyte.[21	oocyte.[21	PROPN
cuesj-178	77	33	]	]	PUNCT
cuesj-178	77	34	in	in	ADP
cuesj-178	77	35	the	the	DET
cuesj-178	77	36	present	present	ADJ
cuesj-178	77	37	study	study	NOUN
cuesj-178	77	38	,	,	PUNCT
cuesj-178	77	39	the	the	DET
cuesj-178	77	40	serum	serum	NOUN
cuesj-178	77	41	lh	lh	PROPN
cuesj-178	77	42	levels	level	NOUN
cuesj-178	77	43	are	be	AUX
cuesj-178	77	44	significantly	significantly	ADV
cuesj-178	77	45	higher	high	ADJ
cuesj-178	77	46	,	,	PUNCT
cuesj-178	77	47	while	while	SCONJ
cuesj-178	77	48	fsh	fsh	ADJ
cuesj-178	77	49	level	level	NOUN
cuesj-178	77	50	is	be	AUX
cuesj-178	77	51	lower	low	ADJ
cuesj-178	77	52	in	in	ADP
cuesj-178	77	53	pcos	pcos	ADJ
cuesj-178	77	54	women	woman	NOUN
cuesj-178	77	55	compared	compare	VERB
cuesj-178	77	56	with	with	ADP
cuesj-178	77	57	controls	control	NOUN
cuesj-178	77	58	.	.	PUNCT
cuesj-178	78	1	these	these	DET
cuesj-178	78	2	results	result	NOUN
cuesj-178	78	3	further	far	ADV
cuesj-178	78	4	confirm	confirm	VERB
cuesj-178	78	5	that	that	PRON
cuesj-178	78	6	high	high	ADJ
cuesj-178	78	7	lh	lh	ADJ
cuesj-178	78	8	level	level	NOUN
cuesj-178	78	9	and	and	CCONJ
cuesj-178	78	10	relative	relative	ADJ
cuesj-178	78	11	insufficiency	insufficiency	NOUN
cuesj-178	78	12	of	of	ADP
cuesj-178	78	13	fsh	fsh	NOUN
cuesj-178	78	14	are	be	AUX
cuesj-178	78	15	the	the	DET
cuesj-178	78	16	characteristics	characteristic	NOUN
cuesj-178	78	17	of	of	ADP
cuesj-178	78	18	pcos	pcos	PROPN
cuesj-178	78	19	.	.	PUNCT
cuesj-178	79	1	in	in	ADP
cuesj-178	79	2	line	line	NOUN
cuesj-178	79	3	with	with	ADP
cuesj-178	79	4	our	our	PRON
cuesj-178	79	5	results	result	NOUN
cuesj-178	79	6	,	,	PUNCT
cuesj-178	79	7	tal	tal	PROPN
cuesj-178	79	8	et	et	PROPN
cuesj-178	79	9	al	al	PROPN
cuesj-178	79	10	.	.	PROPN
cuesj-178	79	11	found	find	VERB
cuesj-178	79	12	increased	increase	VERB
cuesj-178	79	13	tgf	tgf	PROPN
cuesj-178	79	14	-	-	PUNCT
cuesj-178	79	15	b1	b1	PROPN
cuesj-178	79	16	and	and	CCONJ
cuesj-178	79	17	decreased	decrease	VERB
cuesj-178	79	18	seng	seng	PROPN
cuesj-178	79	19	in	in	ADP
cuesj-178	79	20	pcos	pcos	PROPN
cuesj-178	79	21	.	.	PUNCT
cuesj-178	80	1	these	these	DET
cuesj-178	80	2	data	datum	NOUN
cuesj-178	80	3	suggest	suggest	VERB
cuesj-178	80	4	that	that	SCONJ
cuesj-178	80	5	increased	increase	VERB
cuesj-178	80	6	tgf	tgf	PROPN
cuesj-178	80	7	-	-	PUNCT
cuesj-178	80	8	b1	b1	NOUN
cuesj-178	80	9	bioavailability	bioavailability	NOUN
cuesj-178	80	10	may	may	AUX
cuesj-178	80	11	contribute	contribute	VERB
cuesj-178	80	12	to	to	ADP
cuesj-178	80	13	the	the	DET
cuesj-178	80	14	pathogenesis	pathogenesis	NOUN
cuesj-178	80	15	of	of	ADP
cuesj-178	80	16	pcos	pcos	PROPN
cuesj-178	80	17	and	and	CCONJ
cuesj-178	80	18	its	its	PRON
cuesj-178	80	19	increased	increased	ADJ
cuesj-178	80	20	risk	risk	NOUN
cuesj-178	80	21	for	for	ADP
cuesj-178	80	22	ovarian	ovarian	ADJ
cuesj-178	80	23	hyperstimulation.[17	hyperstimulation.[17	VERB
cuesj-178	80	24	]	]	PUNCT
cuesj-178	80	25	by	by	ADP
cuesj-178	80	26	contrast	contrast	NOUN
cuesj-178	80	27	,	,	PUNCT
cuesj-178	80	28	the	the	DET
cuesj-178	80	29	study	study	NOUN
cuesj-178	80	30	conducted	conduct	VERB
cuesj-178	80	31	by	by	ADP
cuesj-178	80	32	irani	irani	PROPN
cuesj-178	80	33	et	et	PROPN
cuesj-178	80	34	al	al	PROPN
cuesj-178	80	35	.	.	PROPN
cuesj-178	80	36	found	find	VERB
cuesj-178	80	37	that	that	SCONJ
cuesj-178	80	38	seng	seng	PROPN
cuesj-178	80	39	protein	protein	NOUN
cuesj-178	80	40	concentration	concentration	NOUN
cuesj-178	80	41	was	be	AUX
cuesj-178	80	42	not	not	PART
cuesj-178	80	43	different	different	ADJ
cuesj-178	80	44	between	between	ADP
cuesj-178	80	45	pcos	pcos	PROPN
cuesj-178	80	46	and	and	CCONJ
cuesj-178	80	47	non	non	ADJ
cuesj-178	80	48	-	-	ADJ
cuesj-178	80	49	pcos	pcos	ADJ
cuesj-178	80	50	control	control	NOUN
cuesj-178	80	51	group	group	NOUN
cuesj-178	80	52	at	at	ADP
cuesj-178	80	53	baseline.[15	baseline.[15	NOUN
cuesj-178	80	54	]	]	PUNCT
cuesj-178	80	55	women	woman	NOUN
cuesj-178	80	56	with	with	ADP
cuesj-178	80	57	pcos	pcos	PROPN
cuesj-178	80	58	have	have	VERB
cuesj-178	80	59	abnormal	abnormal	ADJ
cuesj-178	80	60	increase	increase	NOUN
cuesj-178	80	61	in	in	ADP
cuesj-178	80	62	tgf	tgf	NOUN
cuesj-178	80	63	-	-	PUNCT
cuesj-178	80	64	b1	b1	NOUN
cuesj-178	80	65	bioavailability	bioavailability	NOUN
cuesj-178	80	66	(	(	PUNCT
cuesj-178	80	67	tgfb1	tgfb1	NOUN
cuesj-178	80	68	/	/	SYM
cuesj-178	80	69	seng	seng	PROPN
cuesj-178	80	70	)	)	PUNCT
cuesj-178	80	71	due	due	ADP
cuesj-178	80	72	to	to	ADP
cuesj-178	80	73	an	an	DET
cuesj-178	80	74	increase	increase	NOUN
cuesj-178	80	75	in	in	ADP
cuesj-178	80	76	serum	serum	PROPN
cuesj-178	80	77	tgf	tgf	PROPN
cuesj-178	80	78	-	-	PUNCT
cuesj-178	80	79	b1	b1	NOUN
cuesj-178	80	80	and	and	CCONJ
cuesj-178	80	81	decrease	decrease	NOUN
cuesj-178	80	82	in	in	ADP
cuesj-178	80	83	seng	seng	PROPN
cuesj-178	80	84	levels.[17	levels.[17	PROPN
cuesj-178	80	85	]	]	PUNCT
cuesj-178	80	86	conclusion	conclusion	NOUN
cuesj-178	80	87	polycystic	polycystic	ADJ
cuesj-178	80	88	ovary	ovary	ADJ
cuesj-178	80	89	syndrome	syndrome	NOUN
cuesj-178	80	90	(	(	PUNCT
cuesj-178	80	91	pcos	pcos	PROPN
cuesj-178	80	92	)	)	PUNCT
cuesj-178	80	93	is	be	AUX
cuesj-178	80	94	a	a	DET
cuesj-178	80	95	condition	condition	NOUN
cuesj-178	80	96	that	that	PRON
cuesj-178	80	97	affects	affect	VERB
cuesj-178	80	98	a	a	DET
cuesj-178	80	99	woman	woman	NOUN
cuesj-178	80	100	’s	’s	PART
cuesj-178	80	101	hormone	hormone	NOUN
cuesj-178	80	102	levels	level	NOUN
cuesj-178	80	103	.	.	PUNCT
cuesj-178	81	1	levels	level	NOUN
cuesj-178	81	2	of	of	ADP
cuesj-178	81	3	tgf	tgf	PROPN
cuesj-178	81	4	β1	β1	PROPN
cuesj-178	81	5	,	,	PUNCT
cuesj-178	81	6	lh	lh	PROPN
cuesj-178	81	7	,	,	PUNCT
cuesj-178	81	8	lh	lh	PROPN
cuesj-178	81	9	/	/	SYM
cuesj-178	81	10	fsh	fsh	NOUN
cuesj-178	81	11	,	,	PUNCT
cuesj-178	81	12	t	t	PROPN
cuesj-178	81	13	,	,	PUNCT
cuesj-178	81	14	and	and	CCONJ
cuesj-178	81	15	,	,	PUNCT
cuesj-178	81	16	as	as	ADV
cuesj-178	81	17	well	well	ADV
cuesj-178	81	18	as	as	ADP
cuesj-178	81	19	homeostatic	homeostatic	ADJ
cuesj-178	81	20	model	model	NOUN
cuesj-178	81	21	assessment	assessment	NOUN
cuesj-178	81	22	of	of	ADP
cuesj-178	81	23	ir	ir	PROPN
cuesj-178	81	24	(	(	PUNCT
cuesj-178	81	25	homa	homa	NOUN
cuesj-178	81	26	-	-	PUNCT
cuesj-178	81	27	ir	ir	NOUN
cuesj-178	81	28	)	)	PUNCT
cuesj-178	81	29	in	in	ADP
cuesj-178	81	30	pcos	pcos	NOUN
cuesj-178	81	31	patients	patient	NOUN
cuesj-178	81	32	,	,	PUNCT
cuesj-178	81	33	were	be	AUX
cuesj-178	81	34	significantly	significantly	ADV
cuesj-178	81	35	higher	high	ADJ
cuesj-178	81	36	than	than	ADP
cuesj-178	81	37	in	in	ADP
cuesj-178	81	38	the	the	DET
cuesj-178	81	39	control	control	NOUN
cuesj-178	81	40	group	group	NOUN
cuesj-178	81	41	,	,	PUNCT
cuesj-178	81	42	while	while	SCONJ
cuesj-178	81	43	show	show	NOUN
cuesj-178	81	44	decrease	decrease	NOUN
cuesj-178	81	45	levels	level	NOUN
cuesj-178	81	46	of	of	ADP
cuesj-178	81	47	apelin	apelin	PROPN
cuesj-178	81	48	and	and	CCONJ
cuesj-178	81	49	endoglin	endoglin	PROPN
cuesj-178	81	50	levels	level	NOUN
cuesj-178	81	51	.	.	PUNCT
cuesj-178	82	1	therefore	therefore	ADV
cuesj-178	82	2	the	the	DET
cuesj-178	82	3	correlation	correlation	NOUN
cuesj-178	82	4	analysis	analysis	NOUN
cuesj-178	82	5	showed	show	VERB
cuesj-178	82	6	that	that	SCONJ
cuesj-178	82	7	apelin	apelin	PROPN
cuesj-178	82	8	level	level	NOUN
cuesj-178	82	9	was	be	AUX
cuesj-178	82	10	negatively	negatively	ADV
cuesj-178	82	11	correlated	correlate	VERB
cuesj-178	82	12	with	with	ADP
cuesj-178	82	13	body	body	NOUN
cuesj-178	82	14	mass	mass	NOUN
cuesj-178	82	15	index	index	NOUN
cuesj-178	82	16	(	(	PUNCT
cuesj-178	82	17	bmi	bmi	PROPN
cuesj-178	82	18	)	)	PUNCT
cuesj-178	82	19	and	and	CCONJ
cuesj-178	82	20	homa	homa	PROPN
cuesj-178	82	21	-	-	PUNCT
cuesj-178	82	22	ir	ir	PROPN
cuesj-178	82	23	.	.	PUNCT
cuesj-178	82	24	references	reference	NOUN
cuesj-178	82	25	1	1	NUM
cuesj-178	82	26	.	.	PUNCT
cuesj-178	82	27	e.	e.	PROPN
cuesj-178	82	28	karimi	karimi	PROPN
cuesj-178	82	29	,	,	PUNCT
cuesj-178	82	30	a.	a.	PROPN
cuesj-178	82	31	moini	moini	PROPN
cuesj-178	82	32	,	,	PUNCT
cuesj-178	82	33	m.	m.	NOUN
cuesj-178	82	34	yaseri	yaseri	PROPN
cuesj-178	82	35	,	,	PUNCT
cuesj-178	82	36	n.	n.	PROPN
cuesj-178	82	37	shirzad	shirzad	PROPN
cuesj-178	82	38	,	,	PUNCT
cuesj-178	82	39	m.	m.	NOUN
cuesj-178	82	40	sepidarkish	sepidarkish	PROPN
cuesj-178	82	41	,	,	PUNCT
cuesj-178	82	42	m.	m.	PROPN
cuesj-178	82	43	hossein	hossein	PROPN
cuesj-178	82	44	-	-	PUNCT
cuesj-178	82	45	boroujerdi	boroujerdi	PROPN
cuesj-178	82	46	and	and	CCONJ
cuesj-178	82	47	m.	m.	NOUN
cuesj-178	82	48	j	j	PROPN
cuesj-178	82	49	hosseinzadeh	hosseinzadeh	PROPN
cuesj-178	82	50	-	-	PUNCT
cuesj-178	82	51	attar	attar	NOUN
cuesj-178	82	52	.	.	PUNCT
cuesj-178	83	1	“	"	PUNCT
cuesj-178	83	2	effects	effect	NOUN
cuesj-178	83	3	of	of	ADP
cuesj-178	83	4	synbiotic	synbiotic	ADJ
cuesj-178	83	5	supplementation	supplementation	NOUN
cuesj-178	83	6	on	on	ADP
cuesj-178	83	7	metabolic	metabolic	NOUN
cuesj-178	83	8	parameters	parameter	NOUN
cuesj-178	83	9	and	and	CCONJ
cuesj-178	83	10	apelin	apelin	PROPN
cuesj-178	83	11	in	in	ADP
cuesj-178	83	12	women	woman	NOUN
cuesj-178	83	13	with	with	ADP
cuesj-178	83	14	polycystic	polycystic	ADJ
cuesj-178	83	15	ovary	ovary	ADJ
cuesj-178	83	16	syndrome	syndrome	NOUN
cuesj-178	83	17	:	:	PUNCT
cuesj-178	83	18	a	a	DET
cuesj-178	83	19	randomised	randomised	ADJ
cuesj-178	83	20	doubleblind	doubleblind	NOUN
cuesj-178	83	21	placebo	placebo	NOUN
cuesj-178	83	22	-	-	PUNCT
cuesj-178	83	23	controlled	control	VERB
cuesj-178	83	24	trial	trial	NOUN
cuesj-178	83	25	”	"	PUNCT
cuesj-178	83	26	.	.	PUNCT
cuesj-178	84	1	the	the	DET
cuesj-178	84	2	british	british	PROPN
cuesj-178	84	3	journal	journal	PROPN
cuesj-178	84	4	of	of	ADP
cuesj-178	84	5	nutrition	nutrition	NOUN
cuesj-178	84	6	,	,	PUNCT
cuesj-178	84	7	vol	vol	NOUN
cuesj-178	84	8	.	.	PROPN
cuesj-178	84	9	119	119	NUM
cuesj-178	84	10	,	,	PUNCT
cuesj-178	84	11	no	no	INTJ
cuesj-178	84	12	.	.	NOUN
cuesj-178	84	13	4	4	NUM
cuesj-178	84	14	,	,	PUNCT
cuesj-178	84	15	pp	pp	ADJ
cuesj-178	84	16	.	.	PUNCT
cuesj-178	85	1	398	398	NUM
cuesj-178	85	2	-	-	SYM
cuesj-178	85	3	406	406	NUM
cuesj-178	85	4	,	,	PUNCT
cuesj-178	85	5	2018	2018	NUM
cuesj-178	85	6	.	.	PUNCT
cuesj-178	86	1	2	2	X
cuesj-178	86	2	.	.	X
cuesj-178	86	3	g.	g.	PROPN
cuesj-178	86	4	bozdag	bozdag	PROPN
cuesj-178	86	5	,	,	PUNCT
cuesj-178	86	6	s.	s.	PROPN
cuesj-178	86	7	mumusoglu	mumusoglu	PROPN
cuesj-178	86	8	,	,	PUNCT
cuesj-178	86	9	d.	d.	PROPN
cuesj-178	86	10	zengin	zengin	NOUN
cuesj-178	86	11	,	,	PUNCT
cuesj-178	86	12	e.	e.	PROPN
cuesj-178	86	13	karabulut	karabulut	PROPN
cuesj-178	86	14	and	and	CCONJ
cuesj-178	86	15	o.b	o.b	PROPN
cuesj-178	86	16	.	.	PROPN
cuesj-178	86	17	yildiz	yildiz	PROPN
cuesj-178	86	18	.	.	PUNCT
cuesj-178	87	1	“	"	PUNCT
cuesj-178	87	2	the	the	DET
cuesj-178	87	3	prevalence	prevalence	NOUN
cuesj-178	87	4	and	and	CCONJ
cuesj-178	87	5	phenotypic	phenotypic	ADJ
cuesj-178	87	6	features	feature	NOUN
cuesj-178	87	7	of	of	ADP
cuesj-178	87	8	polycystic	polycystic	ADJ
cuesj-178	87	9	ovary	ovary	ADJ
cuesj-178	87	10	syndrome	syndrome	NOUN
cuesj-178	87	11	:	:	PUNCT
cuesj-178	87	12	a	a	DET
cuesj-178	87	13	systematic	systematic	ADJ
cuesj-178	87	14	review	review	NOUN
cuesj-178	87	15	and	and	CCONJ
cuesj-178	87	16	meta	meta	ADJ
cuesj-178	87	17	-	-	PUNCT
cuesj-178	87	18	analysis	analysis	NOUN
cuesj-178	87	19	”	"	PUNCT
cuesj-178	87	20	.	.	PUNCT
cuesj-178	88	1	human	human	ADJ
cuesj-178	88	2	reproduction	reproduction	NOUN
cuesj-178	88	3	,	,	PUNCT
cuesj-178	88	4	vol	vol	NOUN
cuesj-178	88	5	.	.	PROPN
cuesj-178	88	6	31	31	NUM
cuesj-178	88	7	,	,	PUNCT
cuesj-178	88	8	pp	pp	ADJ
cuesj-178	88	9	.	.	PUNCT
cuesj-178	89	1	2841	2841	NUM
cuesj-178	89	2	-	-	SYM
cuesj-178	89	3	2885	2885	NUM
cuesj-178	89	4	,	,	PUNCT
cuesj-178	89	5	2016	2016	NUM
cuesj-178	89	6	.	.	PUNCT
cuesj-178	90	1	3	3	X
cuesj-178	90	2	.	.	X
cuesj-178	90	3	i.	i.	PROPN
cuesj-178	90	4	r.	r.	PROPN
cuesj-178	90	5	indran	indran	PROPN
cuesj-178	90	6	,	,	PUNCT
cuesj-178	90	7	z.	z.	PROPN
cuesj-178	90	8	huang	huang	PROPN
cuesj-178	90	9	,	,	PUNCT
cuesj-178	90	10	l.w	l.w	PROPN
cuesj-178	90	11	.	.	PROPN
cuesj-178	90	12	khin	khin	PROPN
cuesj-178	90	13	,	,	PUNCT
cuesj-178	90	14	j.	j.	PROPN
cuesj-178	90	15	k.	k.	PROPN
cuesj-178	90	16	y.	y.	PROPN
cuesj-178	90	17	chan	chan	PROPN
cuesj-178	90	18	,	,	PUNCT
cuesj-178	90	19	v.	v.	ADP
cuesj-178	90	20	viardot	viardot	NOUN
cuesj-178	90	21	-	-	PUNCT
cuesj-178	90	22	foucault	foucault	PROPN
cuesj-178	90	23	and	and	CCONJ
cuesj-178	90	24	e.	e.	PROPN
cuesj-178	90	25	l.	l.	PROPN
cuesj-178	90	26	yong	yong	PROPN
cuesj-178	90	27	.	.	PUNCT
cuesj-178	91	1	“	"	PUNCT
cuesj-178	91	2	simplified	simplify	VERB
cuesj-178	91	3	4	4	NUM
cuesj-178	91	4	-	-	PUNCT
cuesj-178	91	5	item	item	NOUN
cuesj-178	91	6	criteria	criterion	NOUN
cuesj-178	91	7	for	for	ADP
cuesj-178	91	8	polycystic	polycystic	ADJ
cuesj-178	91	9	ovary	ovary	ADJ
cuesj-178	91	10	syndrome	syndrome	NOUN
cuesj-178	91	11	:	:	PUNCT
cuesj-178	91	12	a	a	DET
cuesj-178	91	13	bridge	bridge	NOUN
cuesj-178	91	14	too	too	ADV
cuesj-178	91	15	far	far	ADV
cuesj-178	91	16	”	"	PUNCT
cuesj-178	91	17	?	?	PUNCT
cuesj-178	92	1	clinical	clinical	ADJ
cuesj-178	92	2	endocrinology	endocrinology	NOUN
cuesj-178	92	3	(	(	PUNCT
cuesj-178	92	4	oxford	oxford	PROPN
cuesj-178	92	5	)	)	PUNCT
cuesj-178	92	6	,	,	PUNCT
cuesj-178	92	7	vol	vol	NOUN
cuesj-178	92	8	.	.	PROPN
cuesj-178	92	9	89	89	NUM
cuesj-178	92	10	,	,	PUNCT
cuesj-178	92	11	no	no	INTJ
cuesj-178	92	12	.	.	NOUN
cuesj-178	92	13	2	2	NUM
cuesj-178	92	14	,	,	PUNCT
cuesj-178	92	15	202	202	NUM
cuesj-178	92	16	-	-	SYM
cuesj-178	92	17	211	211	NUM
cuesj-178	92	18	,	,	PUNCT
cuesj-178	92	19	2018	2018	NUM
cuesj-178	92	20	.	.	PUNCT
cuesj-178	93	1	4	4	NUM
cuesj-178	93	2	.	.	X
cuesj-178	93	3	x.	x.	NOUN
cuesj-178	93	4	z.	z.	PROPN
cuesj-178	93	5	zhang	zhang	PROPN
cuesj-178	93	6	,	,	PUNCT
cuesj-178	93	7	y.	y.	PROPN
cuesj-178	93	8	l.	l.	PROPN
cuesj-178	93	9	pang	pang	PROPN
cuesj-178	93	10	,	,	PUNCT
cuesj-178	93	11	x.	x.	PROPN
cuesj-178	93	12	wang	wang	PROPN
cuesj-178	93	13	and	and	CCONJ
cuesj-178	93	14	y.	y.	PROPN
cuesj-178	93	15	h.	h.	PROPN
cuesj-178	93	16	li	li	PROPN
cuesj-178	93	17	.	.	PUNCT
cuesj-178	94	1	“	"	PUNCT
cuesj-178	94	2	computational	computational	ADJ
cuesj-178	94	3	characterization	characterization	NOUN
cuesj-178	94	4	and	and	CCONJ
cuesj-178	94	5	identification	identification	NOUN
cuesj-178	94	6	of	of	ADP
cuesj-178	94	7	human	human	ADJ
cuesj-178	94	8	polycystic	polycystic	ADJ
cuesj-178	94	9	ovary	ovary	ADJ
cuesj-178	94	10	syndrome	syndrome	NOUN
cuesj-178	94	11	genes	gene	NOUN
cuesj-178	94	12	”	"	PUNCT
cuesj-178	94	13	.	.	PUNCT
cuesj-178	95	1	scientific	scientific	ADJ
cuesj-178	95	2	reports	report	NOUN
cuesj-178	95	3	,	,	PUNCT
cuesj-178	95	4	vol	vol	NOUN
cuesj-178	95	5	.	.	PROPN
cuesj-178	95	6	8	8	NUM
cuesj-178	95	7	,	,	PUNCT
cuesj-178	95	8	no	no	INTJ
cuesj-178	95	9	.	.	NOUN
cuesj-178	95	10	1	1	NUM
cuesj-178	95	11	,	,	PUNCT
cuesj-178	95	12	pp	pp	ADJ
cuesj-178	95	13	.	.	PUNCT
cuesj-178	95	14	12949	12949	NUM
cuesj-178	95	15	,	,	PUNCT
cuesj-178	95	16	2018	2018	NUM
cuesj-178	95	17	.	.	PUNCT
cuesj-178	96	1	5	5	X
cuesj-178	96	2	.	.	PUNCT
cuesj-178	96	3	n.	n.	NOUN
cuesj-178	96	4	naderpoor	naderpoor	PROPN
cuesj-178	96	5	,	,	PUNCT
cuesj-178	96	6	s.	s.	PROPN
cuesj-178	96	7	shorakae	shorakae	PROPN
cuesj-178	96	8	,	,	PUNCT
cuesj-178	96	9	a.	a.	NOUN
cuesj-178	96	10	joham	joham	PROPN
cuesj-178	96	11	,	,	PUNCT
cuesj-178	96	12	j.	j.	PROPN
cuesj-178	96	13	boyle	boyle	PROPN
cuesj-178	96	14	,	,	PUNCT
cuesj-178	96	15	b.	b.	PROPN
cuesj-178	96	16	de	de	PROPN
cuesj-178	96	17	courten	courten	PROPN
cuesj-178	96	18	and	and	CCONJ
cuesj-178	96	19	h.	h.	PROPN
cuesj-178	96	20	j.	j.	PROPN
cuesj-178	96	21	teede	teede	PROPN
cuesj-178	96	22	.	.	PUNCT
cuesj-178	97	1	“	"	PUNCT
cuesj-178	97	2	obesity	obesity	NOUN
cuesj-178	97	3	and	and	CCONJ
cuesj-178	97	4	polycystic	polycystic	ADJ
cuesj-178	97	5	ovary	ovary	ADJ
cuesj-178	97	6	syndrome	syndrome	NOUN
cuesj-178	97	7	”	"	PUNCT
cuesj-178	97	8	.	.	PUNCT
cuesj-178	98	1	minerva	minerva	PROPN
cuesj-178	98	2	endocrinologica	endocrinologica	PROPN
cuesj-178	98	3	,	,	PUNCT
cuesj-178	98	4	vol	vol	NOUN
cuesj-178	98	5	.	.	PROPN
cuesj-178	98	6	15	15	NUM
cuesj-178	98	7	,	,	PUNCT
cuesj-178	98	8	no	no	INTJ
cuesj-178	98	9	.	.	NOUN
cuesj-178	98	10	1	1	NUM
cuesj-178	98	11	,	,	PUNCT
cuesj-178	98	12	pp	pp	ADJ
cuesj-178	98	13	.	.	PUNCT
cuesj-178	99	1	37	37	NUM
cuesj-178	99	2	-	-	SYM
cuesj-178	99	3	51	51	NUM
cuesj-178	99	4	,	,	PUNCT
cuesj-178	99	5	2015	2015	NUM
cuesj-178	99	6	.	.	PUNCT
cuesj-178	100	1	6	6	NUM
cuesj-178	100	2	.	.	PUNCT
cuesj-178	100	3	j.	j.	PROPN
cuesj-178	100	4	kataoka	kataoka	PROPN
cuesj-178	100	5	,	,	PUNCT
cuesj-178	100	6	e.	e.	PROPN
cuesj-178	100	7	c.	c.	PROPN
cuesj-178	100	8	tassone	tassone	PROPN
cuesj-178	100	9	,	,	PUNCT
cuesj-178	100	10	m.	m.	NOUN
cuesj-178	100	11	misso	misso	PROPN
cuesj-178	100	12	,	,	PUNCT
cuesj-178	100	13	a.	a.	PROPN
cuesj-178	100	14	e.	e.	PROPN
cuesj-178	100	15	joham	joham	PROPN
cuesj-178	100	16	,	,	PUNCT
cuesj-178	100	17	e.	e.	PROPN
cuesj-178	100	18	stenervictorin	stenervictorin	PROPN
cuesj-178	100	19	,	,	PUNCT
cuesj-178	100	20	h.	h.	PROPN
cuesj-178	100	21	teede	teede	PROPN
cuesj-178	100	22	and	and	CCONJ
cuesj-178	100	23	l.	l.	PROPN
cuesj-178	100	24	j.	j.	PROPN
cuesj-178	100	25	moran	moran	PROPN
cuesj-178	100	26	.	.	PUNCT
cuesj-178	101	1	“	"	PUNCT
cuesj-178	101	2	weight	weight	NOUN
cuesj-178	101	3	management	management	NOUN
cuesj-178	101	4	interventions	intervention	NOUN
cuesj-178	101	5	in	in	ADP
cuesj-178	101	6	women	woman	NOUN
cuesj-178	101	7	with	with	ADP
cuesj-178	101	8	and	and	CCONJ
cuesj-178	101	9	without	without	ADP
cuesj-178	101	10	pcos	pcos	PROPN
cuesj-178	101	11	:	:	PUNCT
cuesj-178	101	12	a	a	DET
cuesj-178	101	13	systematic	systematic	ADJ
cuesj-178	101	14	review	review	NOUN
cuesj-178	101	15	”	"	PUNCT
cuesj-178	101	16	.	.	PUNCT
cuesj-178	102	1	nutrients	nutrient	NOUN
cuesj-178	102	2	,	,	PUNCT
cuesj-178	102	3	vol	vol	NOUN
cuesj-178	102	4	.	.	PROPN
cuesj-178	102	5	9	9	NUM
cuesj-178	102	6	,	,	PUNCT
cuesj-178	102	7	no	no	INTJ
cuesj-178	102	8	.	.	NOUN
cuesj-178	102	9	9	9	NUM
cuesj-178	102	10	,	,	PUNCT
cuesj-178	102	11	pp	pp	ADJ
cuesj-178	102	12	.	.	PUNCT
cuesj-178	103	1	e996	e996	NUM
cuesj-178	103	2	,	,	PUNCT
cuesj-178	103	3	2017	2017	NUM
cuesj-178	103	4	.	.	PUNCT
cuesj-178	104	1	7	7	X
cuesj-178	104	2	.	.	X
cuesj-178	104	3	m.	m.	NOUN
cuesj-178	104	4	h.	h.	PROPN
cuesj-178	104	5	dahan	dahan	PROPN
cuesj-178	104	6	and	and	CCONJ
cuesj-178	104	7	g.	g.	PROPN
cuesj-178	104	8	reaven	reaven	PROPN
cuesj-178	104	9	.	.	PUNCT
cuesj-178	105	1	“	"	PUNCT
cuesj-178	105	2	relationship	relationship	NOUN
cuesj-178	105	3	among	among	ADP
cuesj-178	105	4	obesity	obesity	NOUN
cuesj-178	105	5	,	,	PUNCT
cuesj-178	105	6	insulin	insulin	NOUN
cuesj-178	105	7	resistance	resistance	NOUN
cuesj-178	105	8	,	,	PUNCT
cuesj-178	105	9	and	and	CCONJ
cuesj-178	105	10	hyperinsulinemia	hyperinsulinemia	NOUN
cuesj-178	105	11	in	in	ADP
cuesj-178	105	12	the	the	DET
cuesj-178	105	13	polycystic	polycystic	ADJ
cuesj-178	105	14	ovary	ovary	ADJ
cuesj-178	105	15	syndrome	syndrome	NOUN
cuesj-178	105	16	”	"	PUNCT
cuesj-178	105	17	.	.	PUNCT
cuesj-178	106	1	endocrine	endocrine	NOUN
cuesj-178	106	2	,	,	PUNCT
cuesj-178	106	3	vol	vol	NOUN
cuesj-178	106	4	.	.	PROPN
cuesj-178	107	1	64	64	NUM
cuesj-178	107	2	,	,	PUNCT
cuesj-178	107	3	no	no	INTJ
cuesj-178	107	4	.	.	NOUN
cuesj-178	107	5	3	3	NUM
cuesj-178	107	6	,	,	PUNCT
cuesj-178	107	7	pp	pp	ADJ
cuesj-178	107	8	.	.	PUNCT
cuesj-178	108	1	685	685	NUM
cuesj-178	108	2	-	-	SYM
cuesj-178	108	3	689	689	NUM
cuesj-178	108	4	,	,	PUNCT
cuesj-178	108	5	2019	2019	NUM
cuesj-178	108	6	.	.	PUNCT
cuesj-178	109	1	8	8	NUM
cuesj-178	109	2	.	.	X
cuesj-178	109	3	i.	i.	PROPN
cuesj-178	109	4	lazúrová	lazúrová	PROPN
cuesj-178	109	5	,	,	PUNCT
cuesj-178	109	6	z.	z.	PROPN
cuesj-178	109	7	lazúrová	lazúrová	PROPN
cuesj-178	109	8	,	,	PUNCT
cuesj-178	109	9	j.	j.	PROPN
cuesj-178	109	10	figurová	figurová	PROPN
cuesj-178	109	11	,	,	PUNCT
cuesj-178	109	12	s.	s.	PROPN
cuesj-178	109	13	ujházi	ujházi	PROPN
cuesj-178	109	14	,	,	PUNCT
cuesj-178	109	15	i.	i.	PROPN
cuesj-178	109	16	dravecká	dravecká	PROPN
cuesj-178	109	17	,	,	PUNCT
cuesj-178	109	18	j.	j.	PROPN
cuesj-178	109	19	mašlanková	mašlanková	PROPN
cuesj-178	109	20	and	and	CCONJ
cuesj-178	109	21	m.	m.	NOUN
cuesj-178	109	22	mareková	mareková	NOUN
cuesj-178	109	23	.	.	PUNCT
cuesj-178	110	1	“	"	PUNCT
cuesj-178	110	2	relationship	relationship	NOUN
cuesj-178	110	3	between	between	ADP
cuesj-178	110	4	steroid	steroid	NOUN
cuesj-178	110	5	hormones	hormone	NOUN
cuesj-178	110	6	and	and	CCONJ
cuesj-178	110	7	metabolic	metabolic	NOUN
cuesj-178	110	8	profile	profile	NOUN
cuesj-178	110	9	in	in	ADP
cuesj-178	110	10	women	woman	NOUN
cuesj-178	110	11	with	with	ADP
cuesj-178	110	12	polycystic	polycystic	ADJ
cuesj-178	110	13	ovary	ovary	ADJ
cuesj-178	110	14	syndrome	syndrome	NOUN
cuesj-178	110	15	”	"	PUNCT
cuesj-178	110	16	.	.	PUNCT
cuesj-178	111	1	physiological	physiological	ADJ
cuesj-178	111	2	research	research	NOUN
cuesj-178	111	3	,	,	PUNCT
cuesj-178	111	4	vol	vol	NOUN
cuesj-178	111	5	.	.	PROPN
cuesj-178	111	6	68	68	NUM
cuesj-178	111	7	,	,	PUNCT
cuesj-178	111	8	no	no	INTJ
cuesj-178	111	9	.	.	NOUN
cuesj-178	111	10	3	3	NUM
cuesj-178	111	11	,	,	PUNCT
cuesj-178	111	12	pp	pp	ADJ
cuesj-178	111	13	.	.	PUNCT
cuesj-178	112	1	457	457	NUM
cuesj-178	112	2	-	-	SYM
cuesj-178	112	3	465	465	NUM
cuesj-178	112	4	,	,	PUNCT
cuesj-178	112	5	2019	2019	NUM
cuesj-178	112	6	.	.	PUNCT
cuesj-178	113	1	ibrahim	ibrahim	PROPN
cuesj-178	113	2	,	,	PUNCT
cuesj-178	113	3	et	et	PROPN
cuesj-178	113	4	al	al	PROPN
cuesj-178	113	5	.	.	PUNCT
cuesj-178	113	6	:	:	PUNCT
cuesj-178	114	1	apelin	apelin	PROPN
cuesj-178	114	2	,	,	PUNCT
cuesj-178	114	3	endoglin	endoglin	PROPN
cuesj-178	114	4	,	,	PUNCT
cuesj-178	114	5	and	and	CCONJ
cuesj-178	114	6	tgf	tgf	PROPN
cuesj-178	114	7	-	-	PUNCT
cuesj-178	114	8	β1	β1	PROPN
cuesj-178	114	9	in	in	ADP
cuesj-178	114	10	polycystic	polycystic	ADJ
cuesj-178	114	11	ovary	ovary	ADJ
cuesj-178	114	12	syndrome	syndrome	NOUN
cuesj-178	114	13	25	25	NUM
cuesj-178	114	14	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-178	114	15	cuesj	cuesj	NOUN
cuesj-178	114	16	2020	2020	NUM
cuesj-178	114	17	,	,	PUNCT
cuesj-178	114	18	4	4	NUM
cuesj-178	114	19	(	(	PUNCT
cuesj-178	114	20	1	1	NUM
cuesj-178	114	21	):	):	PUNCT
cuesj-178	114	22	21	21	NUM
cuesj-178	114	23	-	-	SYM
cuesj-178	114	24	25	25	NUM
cuesj-178	114	25	9	9	NUM
cuesj-178	114	26	.	.	PUNCT
cuesj-178	115	1	e.	e.	PROPN
cuesj-178	115	2	koivuaho	koivuaho	PROPN
cuesj-178	115	3	,	,	PUNCT
cuesj-178	115	4	j.	j.	PROPN
cuesj-178	115	5	laru	laru	PROPN
cuesj-178	115	6	,	,	PUNCT
cuesj-178	115	7	m.	m.	NOUN
cuesj-178	115	8	ojaniemi	ojaniemi	PROPN
cuesj-178	115	9	,	,	PUNCT
cuesj-178	115	10	k.	k.	PROPN
cuesj-178	115	11	puukka	puukka	PROPN
cuesj-178	115	12	,	,	PUNCT
cuesj-178	115	13	j.	j.	PROPN
cuesj-178	115	14	kettunen	kettunen	PROPN
cuesj-178	115	15	,	,	PUNCT
cuesj-178	115	16	j.s	j.s	PROPN
cuesj-178	115	17	.	.	PROPN
cuesj-178	115	18	tapanainen	tapanainen	PROPN
cuesj-178	115	19	,	,	PUNCT
cuesj-178	115	20	s.	s.	PROPN
cuesj-178	115	21	franks	franks	PROPN
cuesj-178	115	22	,	,	PUNCT
cuesj-178	115	23	m.	m.	PROPN
cuesj-178	115	24	r.	r.	PROPN
cuesj-178	115	25	järvelin	järvelin	PROPN
cuesj-178	115	26	,	,	PUNCT
cuesj-178	115	27	l.	l.	PROPN
cuesj-178	115	28	morin	morin	PROPN
cuesj-178	115	29	-	-	PUNCT
cuesj-178	115	30	papunen	papunen	PROPN
cuesj-178	115	31	,	,	PUNCT
cuesj-178	115	32	s.	s.	PROPN
cuesj-178	115	33	sebert	sebert	PROPN
cuesj-178	115	34	and	and	CCONJ
cuesj-178	115	35	t.	t.	PROPN
cuesj-178	115	36	t.	t.	PROPN
cuesj-178	115	37	piltonen	piltonen	PROPN
cuesj-178	115	38	.	.	PUNCT
cuesj-178	116	1	“	"	PUNCT
cuesj-178	116	2	age	age	NOUN
cuesj-178	116	3	at	at	ADP
cuesj-178	116	4	adiposity	adiposity	NOUN
cuesj-178	116	5	rebound	rebound	NOUN
cuesj-178	116	6	in	in	ADP
cuesj-178	116	7	childhood	childhood	NOUN
cuesj-178	116	8	is	be	AUX
cuesj-178	116	9	associated	associate	VERB
cuesj-178	116	10	with	with	ADP
cuesj-178	116	11	pcos	pcos	NOUN
cuesj-178	116	12	diagnosis	diagnosis	NOUN
cuesj-178	116	13	and	and	CCONJ
cuesj-178	116	14	obesity	obesity	NOUN
cuesj-178	116	15	in	in	ADP
cuesj-178	116	16	adulthood	adulthood	NOUN
cuesj-178	116	17	-	-	PUNCT
cuesj-178	116	18	longitudinal	longitudinal	ADJ
cuesj-178	116	19	analysis	analysis	NOUN
cuesj-178	116	20	of	of	ADP
cuesj-178	116	21	bmi	bmi	PROPN
cuesj-178	116	22	data	datum	NOUN
cuesj-178	116	23	from	from	ADP
cuesj-178	116	24	birth	birth	NOUN
cuesj-178	116	25	to	to	ADP
cuesj-178	116	26	age	age	NOUN
cuesj-178	116	27	46	46	NUM
cuesj-178	116	28	in	in	ADP
cuesj-178	116	29	cases	case	NOUN
cuesj-178	116	30	of	of	ADP
cuesj-178	116	31	pcos	pco	NOUN
cuesj-178	116	32	”	"	PUNCT
cuesj-178	116	33	.	.	PUNCT
cuesj-178	117	1	international	international	ADJ
cuesj-178	117	2	journal	journal	PROPN
cuesj-178	117	3	obesity	obesity	PROPN
cuesj-178	117	4	(	(	PUNCT
cuesj-178	117	5	london	london	PROPN
cuesj-178	117	6	)	)	PUNCT
cuesj-178	117	7	,	,	PUNCT
cuesj-178	117	8	vol	vol	NOUN
cuesj-178	117	9	.	.	PROPN
cuesj-178	117	10	43	43	NUM
cuesj-178	117	11	,	,	PUNCT
cuesj-178	117	12	no	no	INTJ
cuesj-178	117	13	.	.	NOUN
cuesj-178	117	14	7	7	NUM
cuesj-178	117	15	,	,	PUNCT
cuesj-178	117	16	pp	pp	ADJ
cuesj-178	117	17	.	.	PUNCT
cuesj-178	117	18	1370	1370	NUM
cuesj-178	117	19	-	-	SYM
cuesj-178	117	20	1379	1379	NUM
cuesj-178	117	21	,	,	PUNCT
cuesj-178	117	22	2019	2019	NUM
cuesj-178	117	23	.	.	PUNCT
cuesj-178	118	1	10	10	NUM
cuesj-178	118	2	.	.	PUNCT
cuesj-178	118	3	i.	i.	PROPN
cuesj-178	118	4	falcão	falcão	PROPN
cuesj-178	118	5	-	-	PUNCT
cuesj-178	118	6	piresi	piresi	NOUN
cuesj-178	118	7	,	,	PUNCT
cuesj-178	118	8	n.	n.	PROPN
cuesj-178	118	9	gonçalves	gonçalves	PROPN
cuesj-178	118	10	,	,	PUNCT
cuesj-178	118	11	t.	t.	PROPN
cuesj-178	118	12	henriques	henrique	NOUN
cuesj-178	118	13	-	-	PUNCT
cuesj-178	118	14	coelho	coelho	PROPN
cuesj-178	118	15	,	,	PUNCT
cuesj-178	118	16	d.	d.	PROPN
cuesj-178	118	17	moreiragonçalves	moreiragonçalves	PROPN
cuesj-178	118	18	,	,	PUNCT
cuesj-178	118	19	r.	r.	PROPN
cuesj-178	118	20	roncon	roncon	PROPN
cuesj-178	118	21	-	-	PUNCT
cuesj-178	118	22	albuquerque	albuquerque	PROPN
cuesj-178	118	23	and	and	CCONJ
cuesj-178	118	24	a.	a.	PROPN
cuesj-178	118	25	f.	f.	PROPN
cuesj-178	118	26	leite	leite	PROPN
cuesj-178	118	27	-	-	PUNCT
cuesj-178	118	28	moreira	moreira	PROPN
cuesj-178	118	29	.	.	PUNCT
cuesj-178	119	1	“	"	PUNCT
cuesj-178	119	2	apelin	apelin	PROPN
cuesj-178	119	3	decreases	decrease	VERB
cuesj-178	119	4	myocardial	myocardial	ADJ
cuesj-178	119	5	injury	injury	NOUN
cuesj-178	119	6	and	and	CCONJ
cuesj-178	119	7	improves	improve	VERB
cuesj-178	119	8	right	right	ADJ
cuesj-178	119	9	ventricular	ventricular	ADJ
cuesj-178	119	10	function	function	NOUN
cuesj-178	119	11	in	in	ADP
cuesj-178	119	12	monocrotaline	monocrotaline	NOUN
cuesj-178	119	13	-	-	PUNCT
cuesj-178	119	14	induced	induce	VERB
cuesj-178	119	15	pulmonary	pulmonary	ADJ
cuesj-178	119	16	hypertension	hypertension	NOUN
cuesj-178	119	17	”	"	PUNCT
cuesj-178	119	18	.	.	PUNCT
cuesj-178	120	1	american	american	PROPN
cuesj-178	120	2	journal	journal	PROPN
cuesj-178	120	3	of	of	ADP
cuesj-178	120	4	physiology	physiology	NOUN
cuesj-178	120	5	heart	heart	NOUN
cuesj-178	120	6	and	and	CCONJ
cuesj-178	120	7	circulatory	circulatory	ADJ
cuesj-178	120	8	physiology	physiology	NOUN
cuesj-178	120	9	,	,	PUNCT
cuesj-178	120	10	vol	vol	NOUN
cuesj-178	120	11	.	.	PROPN
cuesj-178	120	12	296	296	NUM
cuesj-178	120	13	,	,	PUNCT
cuesj-178	120	14	no	no	INTJ
cuesj-178	120	15	.	.	NOUN
cuesj-178	120	16	6	6	NUM
cuesj-178	120	17	,	,	PUNCT
cuesj-178	120	18	pp	pp	ADJ
cuesj-178	120	19	.	.	PUNCT
cuesj-178	121	1	h2007	h2007	PROPN
cuesj-178	121	2	-	-	PUNCT
cuesj-178	121	3	h2014	h2014	PROPN
cuesj-178	121	4	,	,	PUNCT
cuesj-178	121	5	2009	2009	NUM
cuesj-178	121	6	.	.	PUNCT
cuesj-178	122	1	11	11	NUM
cuesj-178	122	2	.	.	PUNCT
cuesj-178	122	3	b.	b.	PROPN
cuesj-178	122	4	masri	masri	PROPN
cuesj-178	122	5	,	,	PUNCT
cuesj-178	122	6	b.	b.	PROPN
cuesj-178	122	7	knibiehler	knibiehler	PROPN
cuesj-178	122	8	and	and	CCONJ
cuesj-178	122	9	y.	y.	PROPN
cuesj-178	122	10	audigier	audigier	PROPN
cuesj-178	122	11	.	.	PUNCT
cuesj-178	123	1	“	"	PUNCT
cuesj-178	123	2	apelin	apelin	PROPN
cuesj-178	123	3	signalling	signalling	NOUN
cuesj-178	123	4	:	:	PUNCT
cuesj-178	123	5	a	a	DET
cuesj-178	123	6	promising	promising	ADJ
cuesj-178	123	7	pathway	pathway	NOUN
cuesj-178	123	8	from	from	ADP
cuesj-178	123	9	cloning	clone	VERB
cuesj-178	123	10	to	to	ADP
cuesj-178	123	11	pharmacology	pharmacology	NOUN
cuesj-178	123	12	”	"	PUNCT
cuesj-178	123	13	.	.	PUNCT
cuesj-178	124	1	cellular	cellular	ADJ
cuesj-178	124	2	signalling	signalling	NOUN
cuesj-178	124	3	,	,	PUNCT
cuesj-178	124	4	vol	vol	NOUN
cuesj-178	124	5	.	.	PROPN
cuesj-178	124	6	17	17	NUM
cuesj-178	124	7	,	,	PUNCT
cuesj-178	124	8	pp	pp	ADJ
cuesj-178	124	9	.	.	PUNCT
cuesj-178	125	1	415	415	NUM
cuesj-178	125	2	-	-	SYM
cuesj-178	125	3	426	426	NUM
cuesj-178	125	4	,	,	PUNCT
cuesj-178	125	5	2005	2005	NUM
cuesj-178	125	6	.	.	PUNCT
cuesj-178	126	1	12	12	NUM
cuesj-178	126	2	.	.	PUNCT
cuesj-178	126	3	l.	l.	PROPN
cuesj-178	126	4	li	li	PROPN
cuesj-178	126	5	,	,	PUNCT
cuesj-178	126	6	g.	g.	PROPN
cuesj-178	126	7	yang	yang	PROPN
cuesj-178	126	8	,	,	PUNCT
cuesj-178	126	9	q.	q.	PROPN
cuesj-178	126	10	li	li	PROPN
cuesj-178	126	11	,	,	PUNCT
cuesj-178	126	12	y.	y.	PROPN
cuesj-178	126	13	tang	tang	PROPN
cuesj-178	126	14	,	,	PUNCT
cuesj-178	126	15	m.	m.	PROPN
cuesj-178	126	16	yang	yang	PROPN
cuesj-178	126	17	,	,	PUNCT
cuesj-178	126	18	h.	h.	PROPN
cuesj-178	126	19	yang	yang	PROPN
cuesj-178	126	20	and	and	CCONJ
cuesj-178	126	21	k.	k.	PROPN
cuesj-178	126	22	li	li	PROPN
cuesj-178	126	23	.	.	PUNCT
cuesj-178	127	1	“	"	PUNCT
cuesj-178	127	2	changes	change	NOUN
cuesj-178	127	3	and	and	CCONJ
cuesj-178	127	4	relations	relation	NOUN
cuesj-178	127	5	of	of	ADP
cuesj-178	127	6	circulating	circulate	VERB
cuesj-178	127	7	visfatin	visfatin	NOUN
cuesj-178	127	8	,	,	PUNCT
cuesj-178	127	9	apelin	apelin	NOUN
cuesj-178	127	10	,	,	PUNCT
cuesj-178	127	11	and	and	CCONJ
cuesj-178	127	12	resistin	resistin	NOUN
cuesj-178	127	13	levels	level	NOUN
cuesj-178	127	14	in	in	ADP
cuesj-178	127	15	normal	normal	ADJ
cuesj-178	127	16	,	,	PUNCT
cuesj-178	127	17	impaired	impaired	ADJ
cuesj-178	127	18	glucose	glucose	NOUN
cuesj-178	127	19	tolerance	tolerance	NOUN
cuesj-178	127	20	,	,	PUNCT
cuesj-178	127	21	and	and	CCONJ
cuesj-178	127	22	type	type	NOUN
cuesj-178	127	23	2	2	NUM
cuesj-178	127	24	diabetic	diabetic	ADJ
cuesj-178	127	25	subjects	subject	NOUN
cuesj-178	127	26	”	"	PUNCT
cuesj-178	127	27	.	.	PUNCT
cuesj-178	128	1	experimental	experimental	ADJ
cuesj-178	128	2	and	and	CCONJ
cuesj-178	128	3	clinical	clinical	ADJ
cuesj-178	128	4	endocrinology	endocrinology	NOUN
cuesj-178	128	5	diabetes	diabetes	NOUN
cuesj-178	128	6	,	,	PUNCT
cuesj-178	128	7	vol	vol	NOUN
cuesj-178	128	8	.	.	PROPN
cuesj-178	128	9	114	114	NUM
cuesj-178	128	10	,	,	PUNCT
cuesj-178	128	11	pp	pp	ADJ
cuesj-178	128	12	.	.	PUNCT
cuesj-178	129	1	544	544	NUM
cuesj-178	129	2	-	-	SYM
cuesj-178	129	3	548	548	NUM
cuesj-178	129	4	,	,	PUNCT
cuesj-178	129	5	2006	2006	NUM
cuesj-178	129	6	.	.	PUNCT
cuesj-178	130	1	13	13	NUM
cuesj-178	130	2	.	.	PUNCT
cuesj-178	131	1	j.	j.	PROPN
cuesj-178	131	2	boucher	boucher	PROPN
cuesj-178	131	3	,	,	PUNCT
cuesj-178	131	4	b.	b.	PROPN
cuesj-178	131	5	masri	masri	PROPN
cuesj-178	131	6	,	,	PUNCT
cuesj-178	131	7	d.	d.	PROPN
cuesj-178	131	8	daviaud	daviaud	PROPN
cuesj-178	131	9	,	,	PUNCT
cuesj-178	131	10	s.	s.	PROPN
cuesj-178	131	11	gesta	gesta	PROPN
cuesj-178	131	12	,	,	PUNCT
cuesj-178	131	13	c.	c.	PROPN
cuesj-178	131	14	guigné	guigné	PROPN
cuesj-178	131	15	,	,	PUNCT
cuesj-178	131	16	a.	a.	NOUN
cuesj-178	131	17	mazzucotelli	mazzucotelli	PROPN
cuesj-178	131	18	,	,	PUNCT
cuesj-178	131	19	i.	i.	PROPN
cuesj-178	131	20	castan	castan	PROPN
cuesj-178	131	21	-	-	PUNCT
cuesj-178	131	22	laurell	laurell	PROPN
cuesj-178	131	23	,	,	PUNCT
cuesj-178	131	24	i.	i.	NOUN
cuesj-178	131	25	tack	tack	PROPN
cuesj-178	131	26	,	,	PUNCT
cuesj-178	131	27	b.	b.	PROPN
cuesj-178	131	28	knibiehler	knibiehler	PROPN
cuesj-178	131	29	,	,	PUNCT
cuesj-178	131	30	c.	c.	PROPN
cuesj-178	131	31	carpéné	carpéné	PROPN
cuesj-178	131	32	,	,	PUNCT
cuesj-178	131	33	y.	y.	PROPN
cuesj-178	131	34	audigier	audigier	PROPN
cuesj-178	131	35	,	,	PUNCT
cuesj-178	131	36	j.	j.	PROPN
cuesj-178	131	37	s.	s.	PROPN
cuesj-178	131	38	saulnier	saulnier	PROPN
cuesj-178	131	39	-	-	PUNCT
cuesj-178	131	40	blache	blache	PROPN
cuesj-178	131	41	and	and	CCONJ
cuesj-178	131	42	p.	p.	NOUN
cuesj-178	131	43	valet	valet	NOUN
cuesj-178	131	44	.	.	PUNCT
cuesj-178	132	1	“	"	PUNCT
cuesj-178	132	2	apelin	apelin	PROPN
cuesj-178	132	3	,	,	PUNCT
cuesj-178	132	4	a	a	DET
cuesj-178	132	5	newly	newly	ADV
cuesj-178	132	6	identified	identify	VERB
cuesj-178	132	7	adipokine	adipokine	ADJ
cuesj-178	132	8	up	up	ADV
cuesj-178	132	9	-	-	PUNCT
cuesj-178	132	10	regulated	regulate	VERB
cuesj-178	132	11	by	by	ADP
cuesj-178	132	12	insulin	insulin	NOUN
cuesj-178	132	13	and	and	CCONJ
cuesj-178	132	14	obesity	obesity	NOUN
cuesj-178	132	15	”	"	PUNCT
cuesj-178	132	16	.	.	PUNCT
cuesj-178	133	1	endocrinology	endocrinology	NOUN
cuesj-178	133	2	,	,	PUNCT
cuesj-178	133	3	vol	vol	NOUN
cuesj-178	133	4	.	.	PROPN
cuesj-178	133	5	146	146	NUM
cuesj-178	133	6	,	,	PUNCT
cuesj-178	133	7	pp	pp	ADJ
cuesj-178	133	8	.	.	PUNCT
cuesj-178	133	9	1764	1764	NUM
cuesj-178	133	10	-	-	SYM
cuesj-178	133	11	1771	1771	NUM
cuesj-178	133	12	,	,	PUNCT
cuesj-178	133	13	2005	2005	NUM
cuesj-178	133	14	.	.	PUNCT
cuesj-178	134	1	14	14	NUM
cuesj-178	134	2	.	.	PUNCT
cuesj-178	135	1	k.	k.	PROPN
cuesj-178	135	2	polak	polak	PROPN
cuesj-178	135	3	,	,	PUNCT
cuesj-178	135	4	a.	a.	NOUN
cuesj-178	135	5	czyzyk	czyzyk	PROPN
cuesj-178	135	6	,	,	PUNCT
cuesj-178	135	7	t.	t.	PROPN
cuesj-178	135	8	simoncini	simoncini	PROPN
cuesj-178	135	9	and	and	CCONJ
cuesj-178	135	10	b.	b.	PROPN
cuesj-178	135	11	meczekalski	meczekalski	PROPN
cuesj-178	135	12	.	.	PUNCT
cuesj-178	136	1	“	"	PUNCT
cuesj-178	136	2	new	new	ADJ
cuesj-178	136	3	markers	marker	NOUN
cuesj-178	136	4	of	of	ADP
cuesj-178	136	5	insulin	insulin	NOUN
cuesj-178	136	6	resistance	resistance	NOUN
cuesj-178	136	7	in	in	ADP
cuesj-178	136	8	polycystic	polycystic	ADJ
cuesj-178	136	9	ovary	ovary	ADJ
cuesj-178	136	10	syndrome	syndrome	NOUN
cuesj-178	136	11	”	"	PUNCT
cuesj-178	136	12	.	.	PUNCT
cuesj-178	137	1	journal	journal	PROPN
cuesj-178	137	2	endocrinology	endocrinology	PROPN
cuesj-178	137	3	invest	invest	VERB
cuesj-178	137	4	,	,	PUNCT
cuesj-178	137	5	vol	vol	NOUN
cuesj-178	137	6	.	.	PROPN
cuesj-178	138	1	40	40	NUM
cuesj-178	138	2	,	,	PUNCT
cuesj-178	138	3	no	no	INTJ
cuesj-178	138	4	.	.	NOUN
cuesj-178	138	5	1	1	NUM
cuesj-178	138	6	,	,	PUNCT
cuesj-178	138	7	pp	pp	ADJ
cuesj-178	138	8	.	.	PUNCT
cuesj-178	139	1	1	1	NUM
cuesj-178	139	2	-	-	SYM
cuesj-178	139	3	8	8	NUM
cuesj-178	139	4	,	,	PUNCT
cuesj-178	139	5	2017	2017	NUM
cuesj-178	139	6	.	.	PUNCT
cuesj-178	140	1	15	15	NUM
cuesj-178	140	2	.	.	PUNCT
cuesj-178	140	3	m.	m.	NOUN
cuesj-178	140	4	irani	irani	PROPN
cuesj-178	140	5	,	,	PUNCT
cuesj-178	140	6	d.b	d.b	PROPN
cuesj-178	140	7	.	.	PROPN
cuesj-178	140	8	seifer	seifer	PROPN
cuesj-178	140	9	,	,	PUNCT
cuesj-178	140	10	r.	r.	PROPN
cuesj-178	140	11	v.	v.	PROPN
cuesj-178	140	12	grazi	grazi	PROPN
cuesj-178	140	13	,	,	PUNCT
cuesj-178	140	14	n.	n.	PROPN
cuesj-178	140	15	julka	julka	PROPN
cuesj-178	140	16	,	,	PUNCT
cuesj-178	140	17	d.	d.	PROPN
cuesj-178	140	18	bhatt	bhatt	PROPN
cuesj-178	140	19	,	,	PUNCT
cuesj-178	140	20	b.	b.	PROPN
cuesj-178	140	21	kalgi	kalgi	PROPN
cuesj-178	140	22	,	,	PUNCT
cuesj-178	140	23	s.	s.	PROPN
cuesj-178	140	24	irani	irani	PROPN
cuesj-178	140	25	,	,	PUNCT
cuesj-178	140	26	o.	o.	PROPN
cuesj-178	140	27	tal	tal	PROPN
cuesj-178	140	28	,	,	PUNCT
cuesj-178	140	29	g.	g.	PROPN
cuesj-178	140	30	lambert	lambert	PROPN
cuesj-178	140	31	-	-	PUNCT
cuesj-178	140	32	messerlian	messerlian	PROPN
cuesj-178	140	33	and	and	CCONJ
cuesj-178	140	34	r.	r.	PROPN
cuesj-178	140	35	tal	tal	PROPN
cuesj-178	140	36	.	.	PUNCT
cuesj-178	141	1	“	"	PUNCT
cuesj-178	141	2	vitamin	vitamin	NOUN
cuesj-178	141	3	d	d	NOUN
cuesj-178	141	4	supplementation	supplementation	NOUN
cuesj-178	141	5	decreases	decrease	VERB
cuesj-178	141	6	tgf	tgf	PROPN
cuesj-178	141	7	-	-	PUNCT
cuesj-178	141	8	β1	β1	NOUN
cuesj-178	141	9	bioavailability	bioavailability	NOUN
cuesj-178	141	10	in	in	ADP
cuesj-178	141	11	pcos	pcos	PROPN
cuesj-178	141	12	:	:	PUNCT
cuesj-178	141	13	a	a	DET
cuesj-178	141	14	randomized	randomized	ADJ
cuesj-178	141	15	placebo	placebo	NOUN
cuesj-178	141	16	-	-	PUNCT
cuesj-178	141	17	controlled	control	VERB
cuesj-178	141	18	trial	trial	NOUN
cuesj-178	141	19	”	"	PUNCT
cuesj-178	141	20	.	.	PUNCT
cuesj-178	142	1	the	the	DET
cuesj-178	142	2	journal	journal	PROPN
cuesj-178	142	3	clinical	clinical	ADJ
cuesj-178	142	4	endocrinology	endocrinology	NOUN
cuesj-178	142	5	metabolism	metabolism	NOUN
cuesj-178	142	6	,	,	PUNCT
cuesj-178	142	7	vol	vol	NOUN
cuesj-178	142	8	.	.	PROPN
cuesj-178	142	9	100	100	NUM
cuesj-178	142	10	,	,	PUNCT
cuesj-178	142	11	no	no	INTJ
cuesj-178	142	12	.	.	NOUN
cuesj-178	142	13	11	11	NUM
cuesj-178	142	14	,	,	PUNCT
cuesj-178	142	15	pp	pp	ADJ
cuesj-178	142	16	.	.	PUNCT
cuesj-178	142	17	4307	4307	NUM
cuesj-178	142	18	-	-	SYM
cuesj-178	142	19	4314	4314	NUM
cuesj-178	142	20	,	,	PUNCT
cuesj-178	142	21	2015	2015	NUM
cuesj-178	142	22	.	.	PUNCT
cuesj-178	143	1	16	16	NUM
cuesj-178	143	2	.	.	PUNCT
cuesj-178	143	3	n.	n.	PROPN
cuesj-178	143	4	m.	m.	PROPN
cuesj-178	143	5	rashad	rashad	PROPN
cuesj-178	143	6	,	,	PUNCT
cuesj-178	143	7	a.	a.	PROPN
cuesj-178	143	8	i.	i.	PROPN
cuesj-178	143	9	amin	amin	PROPN
cuesj-178	143	10	,	,	PUNCT
cuesj-178	143	11	a.	a.	PROPN
cuesj-178	143	12	e.	e.	PROPN
cuesj-178	143	13	ali	ali	PROPN
cuesj-178	143	14	and	and	CCONJ
cuesj-178	143	15	m.	m.	PROPN
cuesj-178	143	16	h.	h.	PROPN
cuesj-178	143	17	soliman	soliman	PROPN
cuesj-178	143	18	.	.	PUNCT
cuesj-178	144	1	“	"	PUNCT
cuesj-178	144	2	influence	influence	NOUN
cuesj-178	144	3	of	of	ADP
cuesj-178	144	4	obesity	obesity	NOUN
cuesj-178	144	5	on	on	ADP
cuesj-178	144	6	soluble	soluble	ADJ
cuesj-178	144	7	endoglin	endoglin	NOUN
cuesj-178	144	8	and	and	CCONJ
cuesj-178	144	9	transforming	transform	VERB
cuesj-178	144	10	growth	growth	NOUN
cuesj-178	144	11	factorb1	factorb1	ADV
cuesj-178	144	12	in	in	ADP
cuesj-178	144	13	women	woman	NOUN
cuesj-178	144	14	with	with	ADP
cuesj-178	144	15	polycystic	polycystic	ADJ
cuesj-178	144	16	ovary	ovary	ADJ
cuesj-178	144	17	syndrome	syndrome	NOUN
cuesj-178	144	18	”	"	PUNCT
cuesj-178	144	19	.	.	PUNCT
cuesj-178	145	1	middle	middle	PROPN
cuesj-178	145	2	east	east	PROPN
cuesj-178	145	3	fertility	fertility	PROPN
cuesj-178	145	4	society	society	PROPN
cuesj-178	145	5	journal	journal	PROPN
cuesj-178	145	6	,	,	PUNCT
cuesj-178	145	7	vol	vol	NOUN
cuesj-178	145	8	.	.	PROPN
cuesj-178	145	9	23	23	NUM
cuesj-178	145	10	,	,	PUNCT
cuesj-178	145	11	pp	pp	ADJ
cuesj-178	145	12	.	.	PUNCT
cuesj-178	146	1	418	418	NUM
cuesj-178	146	2	-	-	SYM
cuesj-178	146	3	424	424	NUM
cuesj-178	146	4	,	,	PUNCT
cuesj-178	146	5	2018	2018	NUM
cuesj-178	146	6	.	.	PUNCT
cuesj-178	147	1	17	17	NUM
cuesj-178	147	2	.	.	PUNCT
cuesj-178	147	3	r.	r.	PROPN
cuesj-178	147	4	tal	tal	PROPN
cuesj-178	147	5	,	,	PUNCT
cuesj-178	147	6	d.	d.	PROPN
cuesj-178	147	7	b.	b.	PROPN
cuesj-178	147	8	seifer	seifer	PROPN
cuesj-178	147	9	,	,	PUNCT
cuesj-178	147	10	a.	a.	PROPN
cuesj-178	147	11	shohat	shohat	PROPN
cuesj-178	147	12	-	-	PUNCT
cuesj-178	147	13	tal	tal	PROPN
cuesj-178	147	14	,	,	PUNCT
cuesj-178	147	15	r.v	r.v	PROPN
cuesj-178	147	16	.	.	PROPN
cuesj-178	147	17	grazi	grazi	PROPN
cuesj-178	147	18	and	and	CCONJ
cuesj-178	147	19	h.	h.	PROPN
cuesj-178	147	20	e.	e.	PROPN
cuesj-178	147	21	malter	malter	PROPN
cuesj-178	147	22	.	.	PUNCT
cuesj-178	148	1	transforming	transform	VERB
cuesj-178	148	2	growth	growth	NOUN
cuesj-178	148	3	factor	factor	NOUN
cuesj-178	148	4	-	-	PUNCT
cuesj-178	148	5	β1	β1	PROPN
cuesj-178	148	6	and	and	CCONJ
cuesj-178	148	7	its	its	PRON
cuesj-178	148	8	receptor	receptor	NOUN
cuesj-178	148	9	soluble	soluble	ADJ
cuesj-178	148	10	endoglin	endoglin	NOUN
cuesj-178	148	11	are	be	AUX
cuesj-178	148	12	altered	alter	VERB
cuesj-178	148	13	in	in	ADP
cuesj-178	148	14	polycystic	polycystic	ADJ
cuesj-178	148	15	ovary	ovary	ADJ
cuesj-178	148	16	syndrome	syndrome	NOUN
cuesj-178	148	17	during	during	ADP
cuesj-178	148	18	controlled	control	VERB
cuesj-178	148	19	ovarian	ovarian	ADJ
cuesj-178	148	20	stimulation	stimulation	NOUN
cuesj-178	148	21	”	"	PUNCT
cuesj-178	148	22	.	.	PUNCT
cuesj-178	149	1	fertility	fertility	NOUN
cuesj-178	149	2	sterility	sterility	NOUN
cuesj-178	149	3	,	,	PUNCT
cuesj-178	149	4	100	100	NUM
cuesj-178	149	5	,	,	PUNCT
cuesj-178	149	6	no	no	INTJ
cuesj-178	149	7	.	.	NOUN
cuesj-178	149	8	2	2	NUM
cuesj-178	149	9	,	,	PUNCT
cuesj-178	149	10	pp	pp	ADJ
cuesj-178	149	11	.	.	PUNCT
cuesj-178	150	1	538	538	NUM
cuesj-178	150	2	-	-	SYM
cuesj-178	150	3	543	543	NUM
cuesj-178	150	4	,	,	PUNCT
cuesj-178	150	5	2013	2013	NUM
cuesj-178	150	6	.	.	PUNCT
cuesj-178	151	1	18	18	NUM
cuesj-178	151	2	.	.	PUNCT
cuesj-178	151	3	m.	m.	NOUN
cuesj-178	151	4	olszanecka	olszanecka	NOUN
cuesj-178	151	5	-	-	PUNCT
cuesj-178	151	6	glinianowicz	glinianowicz	NOUN
cuesj-178	151	7	,	,	PUNCT
cuesj-178	151	8	p.	p.	NOUN
cuesj-178	151	9	madej	madej	NOUN
cuesj-178	151	10	,	,	PUNCT
cuesj-178	151	11	m.	m.	NOUN
cuesj-178	151	12	nylec	nylec	PROPN
cuesj-178	151	13	,	,	PUNCT
cuesj-178	151	14	a.	a.	NOUN
cuesj-178	151	15	owczarek	owczarek	PROPN
cuesj-178	151	16	,	,	PUNCT
cuesj-178	151	17	w.	w.	PROPN
cuesj-178	151	18	szanecki	szanecki	PROPN
cuesj-178	151	19	,	,	PUNCT
cuesj-178	151	20	p.	p.	PROPN
cuesj-178	151	21	skałba	skałba	PROPN
cuesj-178	151	22	and	and	CCONJ
cuesj-178	151	23	j.	j.	PROPN
cuesj-178	151	24	chudek	chudek	PROPN
cuesj-178	151	25	.	.	PUNCT
cuesj-178	152	1	“	"	PUNCT
cuesj-178	152	2	circulating	circulate	VERB
cuesj-178	152	3	apelin	apelin	ADJ
cuesj-178	152	4	level	level	NOUN
cuesj-178	152	5	in	in	ADP
cuesj-178	152	6	relation	relation	NOUN
cuesj-178	152	7	to	to	ADP
cuesj-178	152	8	nutritional	nutritional	ADJ
cuesj-178	152	9	status	status	NOUN
cuesj-178	152	10	in	in	ADP
cuesj-178	152	11	polycystic	polycystic	ADJ
cuesj-178	152	12	ovary	ovary	ADJ
cuesj-178	152	13	syndrome	syndrome	NOUN
cuesj-178	152	14	and	and	CCONJ
cuesj-178	152	15	its	its	PRON
cuesj-178	152	16	association	association	NOUN
cuesj-178	152	17	with	with	ADP
cuesj-178	152	18	metabolic	metabolic	NOUN
cuesj-178	152	19	and	and	CCONJ
cuesj-178	152	20	hormonal	hormonal	ADJ
cuesj-178	152	21	disturbances	disturbance	NOUN
cuesj-178	152	22	”	"	PUNCT
cuesj-178	152	23	.	.	PUNCT
cuesj-178	153	1	clinical	clinical	ADJ
cuesj-178	153	2	endocrinology	endocrinology	NOUN
cuesj-178	153	3	(	(	PUNCT
cuesj-178	153	4	oxford	oxford	PROPN
cuesj-178	153	5	)	)	PUNCT
cuesj-178	153	6	,	,	PUNCT
cuesj-178	153	7	vol	vol	NOUN
cuesj-178	153	8	.	.	PROPN
cuesj-178	153	9	79	79	NUM
cuesj-178	153	10	,	,	PUNCT
cuesj-178	153	11	no	no	INTJ
cuesj-178	153	12	.	.	NOUN
cuesj-178	153	13	2	2	NUM
cuesj-178	153	14	,	,	PUNCT
cuesj-178	153	15	pp	pp	ADJ
cuesj-178	153	16	.	.	PUNCT
cuesj-178	154	1	238	238	NUM
cuesj-178	154	2	-	-	SYM
cuesj-178	154	3	242	242	NUM
cuesj-178	154	4	,	,	PUNCT
cuesj-178	154	5	2013	2013	NUM
cuesj-178	154	6	.	.	PUNCT
cuesj-178	155	1	19	19	NUM
cuesj-178	155	2	.	.	PUNCT
cuesj-178	155	3	s.	s.	PROPN
cuesj-178	155	4	ö.	ö.	PROPN
cuesj-178	155	5	altinkaya	altinkaya	PROPN
cuesj-178	155	6	,	,	PUNCT
cuesj-178	155	7	s.	s.	PROPN
cuesj-178	155	8	nergiz	nergiz	PROPN
cuesj-178	155	9	,	,	PUNCT
cuesj-178	155	10	m.	m.	NOUN
cuesj-178	155	11	küçük	küçük	PROPN
cuesj-178	155	12	and	and	CCONJ
cuesj-178	155	13	h.	h.	PROPN
cuesj-178	155	14	yüksel	yüksel	PROPN
cuesj-178	155	15	.	.	PUNCT
cuesj-178	156	1	“	"	PUNCT
cuesj-178	156	2	apelin	apelin	PROPN
cuesj-178	156	3	levels	level	NOUN
cuesj-178	156	4	in	in	ADP
cuesj-178	156	5	relation	relation	NOUN
cuesj-178	156	6	with	with	ADP
cuesj-178	156	7	hormonal	hormonal	ADJ
cuesj-178	156	8	and	and	CCONJ
cuesj-178	156	9	metabolic	metabolic	NOUN
cuesj-178	156	10	profile	profile	NOUN
cuesj-178	156	11	in	in	ADP
cuesj-178	156	12	patients	patient	NOUN
cuesj-178	156	13	with	with	ADP
cuesj-178	156	14	polycystic	polycystic	ADJ
cuesj-178	156	15	ovary	ovary	ADJ
cuesj-178	156	16	syndrome	syndrome	NOUN
cuesj-178	156	17	”	"	PUNCT
cuesj-178	156	18	.	.	PUNCT
cuesj-178	157	1	european	european	ADJ
cuesj-178	157	2	journal	journal	PROPN
cuesj-178	157	3	obstetrics	obstetric	NOUN
cuesj-178	157	4	and	and	CCONJ
cuesj-178	157	5	gynecology	gynecology	NOUN
cuesj-178	157	6	reproductive	reproductive	ADJ
cuesj-178	157	7	biology	biology	NOUN
cuesj-178	157	8	,	,	PUNCT
cuesj-178	157	9	vol	vol	NOUN
cuesj-178	157	10	.	.	PROPN
cuesj-178	157	11	176	176	NUM
cuesj-178	157	12	,	,	PUNCT
cuesj-178	157	13	pp	pp	ADJ
cuesj-178	157	14	.	.	PUNCT
cuesj-178	158	1	168	168	NUM
cuesj-178	158	2	-	-	SYM
cuesj-178	158	3	672	672	NUM
cuesj-178	158	4	,	,	PUNCT
cuesj-178	158	5	2014	2014	NUM
cuesj-178	158	6	.	.	PUNCT
cuesj-178	159	1	20	20	NUM
cuesj-178	159	2	.	.	PUNCT
cuesj-178	159	3	x.	x.	PROPN
cuesj-178	159	4	sun	sun	PROPN
cuesj-178	159	5	,	,	PUNCT
cuesj-178	159	6	x.	x.	PROPN
cuesj-178	159	7	wu	wu	PROPN
cuesj-178	159	8	,	,	PUNCT
cuesj-178	159	9	y.	y.	PROPN
cuesj-178	159	10	zhou	zhou	PROPN
cuesj-178	159	11	,	,	PUNCT
cuesj-178	159	12	x.	x.	PROPN
cuesj-178	159	13	yu	yu	PROPN
cuesj-178	159	14	and	and	CCONJ
cuesj-178	159	15	w.	w.	PROPN
cuesj-178	159	16	zhang	zhang	PROPN
cuesj-178	159	17	.	.	PUNCT
cuesj-178	160	1	“	"	PUNCT
cuesj-178	160	2	evaluation	evaluation	NOUN
cuesj-178	160	3	of	of	ADP
cuesj-178	160	4	apelin	apelin	NOUN
cuesj-178	160	5	and	and	CCONJ
cuesj-178	160	6	insulin	insulin	NOUN
cuesj-178	160	7	resistance	resistance	NOUN
cuesj-178	160	8	in	in	ADP
cuesj-178	160	9	patients	patient	NOUN
cuesj-178	160	10	with	with	ADP
cuesj-178	160	11	pcos	pcos	PROPN
cuesj-178	160	12	and	and	CCONJ
cuesj-178	160	13	therapeutic	therapeutic	ADJ
cuesj-178	160	14	effect	effect	NOUN
cuesj-178	160	15	of	of	ADP
cuesj-178	160	16	drospirenone	drospirenone	NOUN
cuesj-178	160	17	-	-	PUNCT
cuesj-178	160	18	ethinylestradiol	ethinylestradiol	NOUN
cuesj-178	160	19	plus	plus	CCONJ
cuesj-178	160	20	metformin	metformin	NOUN
cuesj-178	160	21	.	.	PUNCT
cuesj-178	161	1	medical	medical	PROPN
cuesj-178	161	2	science	science	PROPN
cuesj-178	161	3	monitor	monitor	PROPN
cuesj-178	161	4	,	,	PUNCT
cuesj-178	161	5	vol	vol	NOUN
cuesj-178	161	6	.	.	PROPN
cuesj-178	161	7	21	21	NUM
cuesj-178	161	8	,	,	PUNCT
cuesj-178	161	9	pp	pp	ADJ
cuesj-178	161	10	.	.	PUNCT
cuesj-178	161	11	2547	2547	NUM
cuesj-178	161	12	-	-	SYM
cuesj-178	161	13	2552	2552	NUM
cuesj-178	161	14	,	,	PUNCT
cuesj-178	161	15	2015	2015	NUM
cuesj-178	161	16	.	.	PUNCT
cuesj-178	162	1	21	21	NUM
cuesj-178	162	2	.	.	PUNCT
cuesj-178	162	3	c.	c.	PROPN
cuesj-178	162	4	k.	k.	PROPN
cuesj-178	162	5	nath	nath	PROPN
cuesj-178	162	6	,	,	PUNCT
cuesj-178	162	7	b.	b.	PROPN
cuesj-178	162	8	barman	barman	PROPN
cuesj-178	162	9	,	,	PUNCT
cuesj-178	162	10	a.	a.	NOUN
cuesj-178	162	11	das	das	PROPN
cuesj-178	162	12	,	,	PUNCT
cuesj-178	162	13	p.	p.	NOUN
cuesj-178	162	14	rajkhowa	rajkhowa	NOUN
cuesj-178	162	15	,	,	PUNCT
cuesj-178	162	16	p.	p.	NOUN
cuesj-178	162	17	baruah	baruah	PROPN
cuesj-178	162	18	,	,	PUNCT
cuesj-178	162	19	m.	m.	NOUN
cuesj-178	162	20	baruah	baruah	PROPN
cuesj-178	162	21	and	and	CCONJ
cuesj-178	162	22	a.	a.	NOUN
cuesj-178	162	23	baruah	baruah	NOUN
cuesj-178	162	24	.	.	PUNCT
cuesj-178	163	1	“	"	PUNCT
cuesj-178	163	2	prolactin	prolactin	X
cuesj-178	163	3	and	and	CCONJ
cuesj-178	163	4	thyroid	thyroid	VERB
cuesj-178	163	5	stimulating	stimulate	VERB
cuesj-178	163	6	hormone	hormone	NOUN
cuesj-178	163	7	affecting	affect	VERB
cuesj-178	163	8	the	the	DET
cuesj-178	163	9	pattern	pattern	NOUN
cuesj-178	163	10	of	of	ADP
cuesj-178	163	11	lh	lh	PROPN
cuesj-178	163	12	/	/	SYM
cuesj-178	163	13	fsh	fsh	PROPN
cuesj-178	163	14	secretion	secretion	NOUN
cuesj-178	163	15	in	in	ADP
cuesj-178	163	16	patients	patient	NOUN
cuesj-178	163	17	with	with	ADP
cuesj-178	163	18	polycystic	polycystic	ADJ
cuesj-178	163	19	ovary	ovary	ADJ
cuesj-178	163	20	syndrome	syndrome	NOUN
cuesj-178	163	21	:	:	PUNCT
cuesj-178	163	22	a	a	DET
cuesj-178	163	23	hospital	hospital	NOUN
cuesj-178	163	24	-	-	PUNCT
cuesj-178	163	25	based	base	VERB
cuesj-178	163	26	study	study	NOUN
cuesj-178	163	27	from	from	ADP
cuesj-178	163	28	north	north	PROPN
cuesj-178	163	29	east	east	PROPN
cuesj-178	163	30	india	india	PROPN
cuesj-178	163	31	”	"	PUNCT
cuesj-178	163	32	.	.	PUNCT
cuesj-178	164	1	journal	journal	PROPN
cuesj-178	164	2	family	family	NOUN
cuesj-178	164	3	medicine	medicine	NOUN
cuesj-178	164	4	and	and	CCONJ
cuesj-178	164	5	primary	primary	ADJ
cuesj-178	164	6	care	care	NOUN
cuesj-178	164	7	,	,	PUNCT
cuesj-178	164	8	vol	vol	NOUN
cuesj-178	164	9	.	.	PROPN
cuesj-178	164	10	8	8	NUM
cuesj-178	164	11	,	,	PUNCT
cuesj-178	164	12	no	no	INTJ
cuesj-178	164	13	.	.	NOUN
cuesj-178	164	14	1	1	NUM
cuesj-178	164	15	,	,	PUNCT
cuesj-178	164	16	pp	pp	ADJ
cuesj-178	164	17	.	.	PUNCT
cuesj-178	165	1	256	256	NUM
cuesj-178	165	2	-	-	SYM
cuesj-178	165	3	260	260	NUM
cuesj-178	165	4	,	,	PUNCT
cuesj-178	165	5	2019	2019	NUM
cuesj-178	165	6	.	.	PUNCT
cuesj-178	166	1	22	22	NUM
cuesj-178	166	2	.	.	PUNCT
cuesj-178	166	3	b.	b.	PROPN
cuesj-178	166	4	wiweko	wiweko	PROPN
cuesj-178	166	5	,	,	PUNCT
cuesj-178	166	6	i.	i.	PROPN
cuesj-178	166	7	indra	indra	PROPN
cuesj-178	166	8	,	,	PUNCT
cuesj-178	166	9	c.	c.	PROPN
cuesj-178	166	10	susanto	susanto	PROPN
cuesj-178	166	11	,	,	PUNCT
cuesj-178	166	12	m.	m.	NOUN
cuesj-178	166	13	natadisastra	natadisastra	PROPN
cuesj-178	166	14	and	and	CCONJ
cuesj-178	166	15	a.	a.	NOUN
cuesj-178	166	16	hestiantoro	hestiantoro	PROPN
cuesj-178	166	17	.	.	PUNCT
cuesj-178	167	1	“	"	PUNCT
cuesj-178	167	2	the	the	DET
cuesj-178	167	3	correlation	correlation	NOUN
cuesj-178	167	4	between	between	ADP
cuesj-178	167	5	serum	serum	PROPN
cuesj-178	167	6	amh	amh	PROPN
cuesj-178	167	7	and	and	CCONJ
cuesj-178	167	8	homa	homa	PROPN
cuesj-178	167	9	-	-	PUNCT
cuesj-178	167	10	ir	ir	PROPN
cuesj-178	167	11	among	among	ADP
cuesj-178	167	12	pcos	pcos	PROPN
cuesj-178	167	13	phenotypes	phenotype	NOUN
cuesj-178	167	14	”	"	PUNCT
cuesj-178	167	15	.	.	PUNCT
cuesj-178	168	1	bmc	bmc	PROPN
cuesj-178	168	2	research	research	NOUN
cuesj-178	168	3	notes	note	NOUN
cuesj-178	168	4	,	,	PUNCT
cuesj-178	168	5	vol	vol	NOUN
cuesj-178	168	6	.	.	PROPN
cuesj-178	168	7	11	11	NUM
cuesj-178	168	8	,	,	PUNCT
cuesj-178	168	9	no	no	INTJ
cuesj-178	168	10	.	.	NOUN
cuesj-178	168	11	1	1	NUM
cuesj-178	168	12	,	,	PUNCT
cuesj-178	168	13	pp	pp	ADJ
cuesj-178	168	14	.	.	PUNCT
cuesj-178	168	15	114	114	NUM
cuesj-178	168	16	,	,	PUNCT
cuesj-178	168	17	2018	2018	NUM
cuesj-178	168	18	.	.	PUNCT
cuesj-178	169	1	23	23	NUM
cuesj-178	169	2	.	.	PUNCT
cuesj-178	170	1	k.	k.	PROPN
cuesj-178	170	2	gören	gören	PROPN
cuesj-178	170	3	,	,	PUNCT
cuesj-178	170	4	n.	n.	PROPN
cuesj-178	170	5	sağsöz	sağsöz	PROPN
cuesj-178	170	6	,	,	PUNCT
cuesj-178	170	7	v.	v.	PROPN
cuesj-178	170	8	noyan	noyan	ADJ
cuesj-178	170	9	,	,	PUNCT
cuesj-178	170	10	a.	a.	NOUN
cuesj-178	170	11	yücel	yücel	NOUN
cuesj-178	170	12	,	,	PUNCT
cuesj-178	170	13	o.	o.	PROPN
cuesj-178	170	14	cağlayan	cağlayan	PROPN
cuesj-178	170	15	and	and	CCONJ
cuesj-178	170	16	m.	m.	PROPN
cuesj-178	170	17	s.	s.	PROPN
cuesj-178	170	18	bostancı	bostancı	PROPN
cuesj-178	170	19	.	.	PUNCT
cuesj-178	171	1	“	"	PUNCT
cuesj-178	171	2	plasma	plasma	NOUN
cuesj-178	171	3	apelin	apelin	PROPN
cuesj-178	171	4	levels	level	NOUN
cuesj-178	171	5	in	in	ADP
cuesj-178	171	6	patients	patient	NOUN
cuesj-178	171	7	with	with	ADP
cuesj-178	171	8	polycystic	polycystic	ADJ
cuesj-178	171	9	ovary	ovary	ADJ
cuesj-178	171	10	syndrome	syndrome	NOUN
cuesj-178	171	11	”	"	PUNCT
cuesj-178	171	12	.	.	PUNCT
cuesj-178	172	1	journal	journal	NOUN
cuesj-178	172	2	of	of	ADP
cuesj-178	172	3	the	the	DET
cuesj-178	172	4	turkish	turkish	ADJ
cuesj-178	172	5	german	german	ADJ
cuesj-178	172	6	gynecological	gynecological	ADJ
cuesj-178	172	7	association	association	NOUN
cuesj-178	172	8	,	,	PUNCT
cuesj-178	172	9	vol	vol	NOUN
cuesj-178	172	10	.	.	PROPN
cuesj-178	172	11	13	13	NUM
cuesj-178	172	12	,	,	PUNCT
cuesj-178	172	13	no	no	INTJ
cuesj-178	172	14	.	.	NOUN
cuesj-178	172	15	1	1	NUM
cuesj-178	172	16	,	,	PUNCT
cuesj-178	172	17	pp	pp	ADJ
cuesj-178	172	18	.	.	PUNCT
cuesj-178	173	1	27	27	NUM
cuesj-178	173	2	-	-	SYM
cuesj-178	173	3	31	31	NUM
cuesj-178	173	4	,	,	PUNCT
cuesj-178	173	5	2012	2012	NUM
cuesj-178	173	6	.	.	PUNCT